data_1tus_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1tus _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.848 0.356 . . . . 0.0 110.348 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.432 HG12 ' CZ ' ' A' ' 53' ' ' PHE . 0.6 OUTLIER -146.11 -175.18 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.206 -165.551 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -145.97 63.87 1.23 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.037 -155.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.455 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 76.6 m -117.11 42.49 2.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.279 -165.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.8 m -89.76 61.57 5.45 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.343 172.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -173.01 -24.44 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.349 -175.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.559 ' HB3' ' HA ' ' A' ' 12' ' ' PRO . 29.2 m-85 -58.18 158.12 14.79 Favored Pre-proline 0 C--O 1.236 0.382 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.636 163.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.559 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.3 Cg_endo -86.67 154.46 48.3 Favored 'Cis proline' 0 C--O 1.232 0.22 0 C-N-CA 122.914 -1.702 . . . . 0.0 109.449 10.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.531 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.894 166.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 . . . . . 0 N--CA 1.473 0.699 0 CA-C-O 121.267 0.556 . . . . 0.0 109.882 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -87.67 -51.61 5.78 Favored 'General case' 0 C--O 1.251 1.145 0 CA-C-O 117.581 -1.2 . . . . 0.0 109.368 171.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.433 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.4 ptp180 -54.13 131.05 59.96 Favored Pre-proline 0 CA--C 1.54 0.583 0 O-C-N 120.427 -1.421 . . . . 0.0 110.768 -145.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 21' ' ' ARG . 72.5 Cg_endo -93.67 166.71 2.21 Favored 'Trans proline' 0 CA--C 1.517 -0.347 0 C-N-CA 124.293 3.329 . . . . 0.0 109.526 -150.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.452 HD11 ' CG ' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -126.33 -170.7 2.24 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.939 164.185 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.463 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 17.8 t -131.1 119.62 22.22 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.612 157.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.1 174.5 7.35 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 172.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.07 40.57 1.17 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.009 -0.596 . . . . 0.0 110.471 167.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.8 p-10 -131.4 13.76 5.04 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.595 -177.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 69.73 33.64 2.89 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.62 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -139.12 132.44 30.01 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.532 178.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.46 HG21 ' N ' ' A' ' 31' ' ' TYR . 84.9 m -78.71 154.22 30.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.316 165.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.46 ' N ' HG21 ' A' ' 30' ' ' THR . 27.5 m-85 -127.17 126.73 43.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.454 -170.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.01 -9.18 86.89 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.224 -169.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -159.57 176.22 12.3 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.099 -0.551 . . . . 0.0 110.498 171.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.5 mttp -61.65 -22.36 65.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.398 166.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 95.5 m -75.72 -43.91 44.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.359 -169.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -82.13 -22.81 35.99 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.866 178.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.471 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 29.8 t80 -61.86 -67.94 0.37 Allowed 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.028 167.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.455 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 71.9 m -69.56 -25.35 63.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.271 -167.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -65.93 -31.07 71.79 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.118 171.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.428 ' HB2' HD23 ' A' ' 48' ' ' LEU . . . -69.68 -36.2 75.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.491 172.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.424 ' HA ' HD21 ' A' ' 48' ' ' LEU . 84.7 t -65.89 -53.93 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.511 -179.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.421 HG12 ' CB ' ' A' ' 11' ' ' TYR . 5.1 m -62.3 -35.27 68.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.121 -172.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -37.16 84.25 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 114.125 -1.398 . . . . 0.0 110.419 171.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.412 ' HB2' ' CG2' ' A' ' 47' ' ' THR . 10.8 p -72.15 -24.4 61.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.41 -170.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 69.12 36.73 2.33 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.41 -172.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.67 94.28 0.01 OUTLIER Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -170.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.415 HG21 ' N ' ' A' ' 48' ' ' LEU . 6.1 t -169.99 -35.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.437 -0.381 . . . . 0.0 110.183 173.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.428 HD23 ' HB2' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -61.47 -83.19 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.314 166.731 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.85 171.69 0.12 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.45 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.471 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 8.2 tp -91.84 120.28 32.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.111 -166.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.8 t -64.21 -41.91 96.84 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.595 166.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.463 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.9 p80 174.25 146.17 0.06 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.156 -178.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.465 ' CE1' HD22 ' A' ' 50' ' ' LEU . 20.4 m-85 -67.88 170.1 8.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.2 171.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.87 170.49 8.07 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -164.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.433 ' HG3' ' HG2' ' A' ' 22' ' ' PRO . 4.2 mttm -62.47 176.31 0.65 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.339 -0.431 . . . . 0.0 110.246 170.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.459 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.8 OUTLIER . . . . . 0 N--CA 1.472 0.628 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.732 -158.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.7 p . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.795 0.331 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.413 HG22 ' CD2' ' A' ' 50' ' ' LEU . 98.3 t -151.49 127.08 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.29 -164.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -87.77 114.75 24.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.358 -172.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 57.1 m -138.85 35.5 2.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.958 -166.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.3 t -89.83 59.92 4.79 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.389 -176.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.43 -25.56 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.264 -175.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.551 ' HB3' ' HA ' ' A' ' 12' ' ' PRO . 97.5 m-85 -60.17 160.47 16.75 Favored Pre-proline 0 C--O 1.238 0.474 0 CA-C-N 113.904 -1.498 . . . . 0.0 110.375 168.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.551 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 56.5 Cg_endo -79.12 147.3 79.82 Favored 'Cis proline' 0 C--O 1.233 0.273 0 C-N-CA 122.58 -1.842 . . . . 0.0 109.371 4.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.561 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.849 162.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 . . . . . 0 N--CA 1.475 0.816 0 CA-C-O 121.548 0.69 . . . . 0.0 109.809 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -93.09 -50.04 5.71 Favored 'General case' 0 C--O 1.249 1.07 0 CA-C-O 117.468 -1.253 . . . . 0.0 108.918 168.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.5 ptp85 -53.75 140.77 48.39 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 120.47 -1.393 . . . . 0.0 111.152 -144.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.434 ' HB2' ' HG2' ' A' ' 55' ' ' LYS . 60.4 Cg_endo -99.11 153.47 0.62 Allowed 'Trans proline' 0 N--CA 1.475 0.387 0 C-N-CA 124.133 3.222 . . . . 0.0 109.253 -150.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.46 -166.88 1.32 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.956 160.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.465 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 18.7 t -121.4 116.68 25.23 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.464 159.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.467 ' HA3' ' CE2' ' A' ' 31' ' ' TYR . . . -61.67 152.61 41.97 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 167.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.38 39.73 1.23 Allowed 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 115.196 -0.502 . . . . 0.0 110.403 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.412 ' HB3' ' CD1' ' A' ' 48' ' ' LEU . 13.7 p-10 -113.53 -48.73 2.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.362 174.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -176.34 -26.82 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.128 178.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.28 158.07 21.91 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.304 -156.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 60.1 m -77.03 133.29 39.16 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.901 157.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.467 ' CE2' ' HA3' ' A' ' 25' ' ' GLY . 18.1 m-85 -96.88 138.07 35.0 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.445 176.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.05 -69.76 1.22 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -177.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -131.92 167.32 19.82 Favored 'General case' 0 C--O 1.232 0.163 0 O-C-N 121.794 -0.827 . . . . 0.0 110.597 -178.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.98 -14.06 20.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.705 -169.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.8 m -72.35 -60.14 2.38 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.453 176.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -61.31 -25.6 67.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.798 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.453 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 53.5 t80 -62.12 -66.22 0.57 Allowed 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.872 170.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 96.7 m -66.21 -31.57 72.48 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.671 -160.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -72.16 -23.79 61.34 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.119 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.415 ' HB2' HD23 ' A' ' 48' ' ' LEU . . . -69.33 -27.98 65.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.294 166.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.431 ' HA ' HD21 ' A' ' 48' ' ' LEU . 89.8 t -75.89 -45.62 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.578 -178.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.47 HG23 ' N ' ' A' ' 12' ' ' PRO . 20.3 m -70.71 -35.32 60.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.084 -172.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.88 -33.8 73.66 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.335 168.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.98 -39.42 72.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.291 -169.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 69.09 24.16 6.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.223 -163.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.16 40.82 7.31 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 166.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.45 HG21 ' N ' ' A' ' 48' ' ' LEU . 6.1 t -100.88 -39.06 7.96 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.199 0.524 . . . . 0.0 110.268 165.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.45 ' N ' HG21 ' A' ' 47' ' ' THR . 0.3 OUTLIER -62.14 -86.99 0.01 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.408 -179.326 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 67.17 164.13 0.2 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.488 174.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.469 HD22 ' CE1' ' A' ' 53' ' ' PHE . 5.0 tp -86.6 137.13 32.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.276 -168.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.7 t -92.4 -43.48 9.2 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.409 177.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.465 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.6 p80 -177.51 150.09 0.67 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.217 177.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.469 ' CE1' HD22 ' A' ' 50' ' ' LEU . 9.1 m-85 -76.78 157.17 31.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.303 175.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.6 166.29 23.47 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 -163.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.434 ' HG2' ' HB2' ' A' ' 22' ' ' PRO . 4.4 mtmm -63.22 -179.0 0.28 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.419 -0.39 . . . . 0.0 110.267 177.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.458 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.8 OUTLIER . . . . . 0 N--CA 1.473 0.689 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.819 -155.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.1 p . . . . . 0 C--O 1.233 0.2 0 CA-C-O 120.71 0.29 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -156.36 -176.01 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.25 -167.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -146.24 80.74 1.57 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.939 -156.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.47 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 62.4 m -125.49 48.03 2.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.22 -165.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.5 p -96.13 55.69 1.57 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.191 -175.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -173.2 -23.76 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.181 -1.372 . . . . 0.0 109.648 -174.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.501 ' HB3' ' HA ' ' A' ' 12' ' ' PRO . 67.3 m-85 -59.83 161.63 11.4 Favored Pre-proline 0 C--O 1.239 0.52 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.505 170.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.501 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 35.9 Cg_endo -77.09 156.63 97.25 Favored 'Cis proline' 0 C--O 1.233 0.26 0 C-N-CA 122.676 -1.802 . . . . 0.0 109.14 -0.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.463 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 2.1 mtpm? . . . . . 0 C--O 1.234 0.263 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.135 -164.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 . . . . . 0 N--CA 1.474 0.733 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.466 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 31.5 t80 -63.19 -52.82 60.77 Favored 'General case' 0 C--O 1.247 0.943 0 CA-C-O 118.114 -0.946 . . . . 0.0 109.279 -166.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.457 ' HB3' ' NH1' ' A' ' 21' ' ' ARG . 2.0 ptp180 -54.4 142.75 49.24 Favored Pre-proline 0 CA--C 1.539 0.527 0 O-C-N 120.734 -1.229 . . . . 0.0 110.941 -146.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.466 ' HG3' ' CE2' ' A' ' 20' ' ' TYR 0.259 91.4 Cg_endo -119.47 -179.34 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 123.314 2.676 . . . . 0.0 108.907 -142.676 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.422 HD21 HD12 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -142.2 -164.17 1.75 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.968 162.354 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.458 ' HB3' ' NE2' ' A' ' 52' ' ' HIS . 34.3 t -125.37 126.89 45.74 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 158.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.55 -171.95 48.52 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.3 p -97.74 34.43 1.87 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.001 -0.6 . . . . 0.0 110.312 163.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.419 ' HB3' ' CD1' ' A' ' 48' ' ' LEU . 24.2 p-10 -96.4 11.09 36.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.485 170.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.5 m120 62.76 42.95 7.57 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.594 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.69 168.51 9.01 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.846 173.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.5 m -67.53 138.13 56.29 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.997 164.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -93.76 143.32 26.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.358 167.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.94 -56.48 22.31 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -174.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 39.6 p-10 -142.72 179.14 7.17 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 114.636 -0.782 . . . . 0.0 110.624 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.71 -38.84 89.36 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.524 -178.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.6 m -70.99 -39.34 72.5 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.177 -169.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -74.32 -24.08 59.15 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.054 174.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -62.21 -64.37 0.95 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.057 169.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.464 ' HB2' ' CD2' ' A' ' 11' ' ' TYR . 74.1 m -60.25 -29.32 68.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.99 -171.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.416 ' HA ' HG21 ' A' ' 42' ' ' VAL . 31.6 m-20 -73.24 -31.38 64.08 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.173 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.421 ' HB2' HD23 ' A' ' 48' ' ' LEU . . . -61.67 -29.23 69.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.377 168.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.416 ' CG2' HD21 ' A' ' 48' ' ' LEU . 35.6 t -82.12 -42.58 18.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.524 -176.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.436 HG22 ' HG3' ' A' ' 12' ' ' PRO . 18.8 m -78.37 -34.29 18.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.209 -171.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -64.09 -32.25 73.74 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.238 167.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.96 -21.79 63.82 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.734 -172.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 69.17 25.53 5.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.131 -168.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.5 85.96 0.09 OUTLIER Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 -170.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.468 HG21 ' N ' ' A' ' 48' ' ' LEU . 2.9 t -151.77 -36.67 0.12 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.083 0.468 . . . . 0.0 110.514 166.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.468 ' N ' HG21 ' A' ' 47' ' ' THR . 0.8 OUTLIER -79.87 160.27 26.12 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.584 175.832 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.454 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 2.7 t -174.18 164.19 3.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.991 -174.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.459 HD22 ' CE1' ' A' ' 53' ' ' PHE . 5.8 tp -76.29 129.02 36.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.131 -164.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.6 t -77.23 -42.24 38.08 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.454 171.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.462 ' N ' ' CD2' ' A' ' 52' ' ' HIS . 1.0 OUTLIER -174.06 167.42 4.22 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.267 175.05 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.459 ' CE1' HD22 ' A' ' 50' ' ' LEU . 20.3 m-85 -94.72 89.23 5.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.248 168.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -155.96 -139.24 2.72 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.496 -1.041 . . . . 0.0 110.496 -175.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.414 ' HG2' ' HG2' ' A' ' 22' ' ' PRO . 6.8 mtpp -139.82 41.11 2.0 Allowed 'General case' 0 C--O 1.24 0.602 0 CA-C-N 115.26 -0.47 . . . . 0.0 109.874 170.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 C--O 1.241 0.647 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.022 161.915 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.3 p . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.844 0.354 . . . . 0.0 110.427 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.428 HG22 HD21 ' A' ' 50' ' ' LEU . 11.7 t -145.34 117.02 2.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.118 -164.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -73.27 117.74 15.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.466 169.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.466 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 59.8 m -138.08 44.38 2.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.115 177.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.66 58.56 3.12 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.373 -177.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -172.81 -24.33 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.539 -177.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.549 ' HB3' ' HA ' ' A' ' 12' ' ' PRO . 71.2 m-85 -60.69 159.73 23.66 Favored Pre-proline 0 C--O 1.236 0.345 0 CA-C-N 114.024 -1.443 . . . . 0.0 110.414 172.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.549 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 56.2 Cg_endo -78.63 163.98 85.26 Favored 'Cis proline' 0 CA--C 1.519 -0.23 0 C-N-CA 122.511 -1.87 . . . . 0.0 109.337 5.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.258 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.736 -166.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.465 ' HG3' ' N ' ' A' ' 20' ' ' TYR . 2.2 tp10 . . . . . 0 N--CA 1.475 0.823 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.465 ' CD1' ' HA ' ' A' ' 21' ' ' ARG . 10.0 t80 -105.92 142.43 35.63 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.072 164.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.476 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 1.0 OUTLIER 177.36 133.77 0.21 Allowed Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.582 154.117 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 21' ' ' ARG . 71.9 Cg_endo -88.25 139.52 4.35 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.53 2.82 . . . . 0.0 109.413 -160.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.92 -163.84 1.1 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.884 160.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.465 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 17.5 t -127.24 142.94 51.35 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.702 159.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -78.08 179.38 51.62 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 169.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 60.0 p -98.28 26.59 5.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.434 0.635 . . . . 0.0 110.404 169.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.413 ' HB3' HD11 ' A' ' 48' ' ' LEU . 42.4 p-10 -123.1 13.49 9.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.615 -168.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 69.66 32.35 3.33 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.519 -176.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.1 mtpt -141.51 127.7 19.71 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.205 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.467 HG21 ' N ' ' A' ' 31' ' ' TYR . 84.5 m -62.03 163.39 7.96 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.179 162.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.467 ' N ' HG21 ' A' ' 30' ' ' THR . 25.4 m-85 -138.04 123.72 19.82 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.403 178.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.48 -43.54 99.18 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -167.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.426 ' HB3' ' HA ' ' A' ' 20' ' ' TYR . 0.9 OUTLIER -149.54 166.88 27.86 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 114.755 -0.723 . . . . 0.0 110.399 178.526 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -61.37 -28.46 69.25 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.522 -164.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.0 p -71.12 -39.43 72.03 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.366 -176.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -75.96 -24.0 55.41 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.42 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -61.37 -63.36 1.31 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.803 164.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.465 ' HB2' ' CD2' ' A' ' 11' ' ' TYR . 86.1 m -62.19 -32.82 73.51 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.538 -161.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.437 ' HB3' ' HB3' ' A' ' 12' ' ' PRO . 6.3 p30 -78.13 -22.17 49.23 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 114.607 -1.178 . . . . 0.0 110.172 -176.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.36 -26.07 67.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.247 164.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.1 t -80.44 -46.74 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.094 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.474 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.435 HG12 ' HB2' ' A' ' 11' ' ' TYR . 15.6 m -74.78 -35.44 36.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.174 -169.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.73 -32.47 71.75 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.348 167.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.412 ' CB ' ' HB ' ' A' ' 47' ' ' THR . 0.3 OUTLIER -68.24 -32.64 72.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.404 -173.492 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 69.57 50.96 0.49 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.437 176.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.87 24.34 55.7 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 176.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.412 ' HB ' ' CB ' ' A' ' 44' ' ' SER . 97.8 m -96.12 -87.84 0.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.378 -0.411 . . . . 0.0 110.169 169.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' A' ' 27' ' ' ASP . 1.0 OUTLIER -68.25 151.24 47.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.29 -161.917 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 31.9 p -151.34 -178.87 6.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.188 168.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.454 HD22 ' CE1' ' A' ' 53' ' ' PHE . 3.6 tp -79.55 140.84 37.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.158 -166.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.5 t -96.39 -35.02 11.33 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.451 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.465 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.6 p80 174.73 157.49 0.16 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.335 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.454 ' CE1' HD22 ' A' ' 50' ' ' LEU . 20.7 m-85 -91.37 141.32 28.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.345 173.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 113.11 40.67 1.04 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 166.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.44 ' HG2' ' HB2' ' A' ' 22' ' ' PRO . 0.2 OUTLIER 60.73 171.44 0.1 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.441 -0.88 . . . . 0.0 110.553 -174.757 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.462 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 1.8 t . . . . . 0 C--O 1.241 0.621 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.032 -157.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.5 p . . . . . 0 C--O 1.233 0.188 0 CA-C-O 120.84 0.352 . . . . 0.0 110.349 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.467 HG23 ' CZ ' ' A' ' 53' ' ' PHE . 9.0 t -129.44 140.32 49.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.848 -172.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.83 90.53 3.17 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.736 -156.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.469 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 66.4 m -138.58 39.41 2.22 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.089 -158.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.4 t -90.81 61.51 4.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.213 169.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.38 -23.75 0.01 OUTLIER 'General case' 0 C--O 1.235 0.315 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.794 -175.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.495 ' HB3' ' HA ' ' A' ' 12' ' ' PRO . 41.2 m-85 -59.25 161.43 9.87 Favored Pre-proline 0 C--O 1.239 0.543 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.541 167.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.495 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 35.0 Cg_endo -77.93 150.16 88.94 Favored 'Cis proline' 0 CA--C 1.517 -0.339 0 C-N-CA 122.779 -1.759 . . . . 0.0 109.304 1.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.471 ' HG2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.237 0.411 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.225 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 . . . . . 0 N--CA 1.475 0.78 0 CA-C-O 121.076 0.465 . . . . 0.0 109.783 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.497 ' CD1' ' N ' ' A' ' 21' ' ' ARG . 27.9 t80 -61.79 154.2 26.43 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.157 174.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.497 ' N ' ' CD1' ' A' ' 20' ' ' TYR . 6.2 ptp180 176.72 154.98 0.42 Allowed Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.671 154.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.419 ' HB2' ' CG ' ' A' ' 55' ' ' LYS . 61.6 Cg_endo -90.55 100.45 0.27 Allowed 'Trans proline' 0 C--O 1.237 0.43 0 C-N-CA 123.776 2.984 . . . . 0.0 109.278 -162.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.67 178.61 4.31 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 121.971 -0.455 . . . . 0.0 109.924 157.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 36.7 t -132.03 124.38 29.14 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 154.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.28 -165.49 1.89 Allowed Glycine 0 CA--C 1.529 0.968 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 173.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.8 t -98.26 39.13 1.26 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.591 0.71 . . . . 0.0 110.387 165.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.417 ' HB3' HD11 ' A' ' 48' ' ' LEU . 31.4 p-10 -123.24 13.58 9.63 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.672 -171.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.3 m120 66.17 32.27 8.17 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.663 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.12 159.89 18.15 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 114.691 -1.141 . . . . 0.0 110.767 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 1.0 OUTLIER -71.71 165.28 24.34 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.347 178.247 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.468 ' CD2' ' HA ' ' A' ' 37' ' ' PHE . 62.1 m-85 -126.66 141.76 51.75 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.067 162.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.3 -85.82 0.31 Allowed Glycine 0 CA--C 1.525 0.658 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.551 177.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.424 ' ND2' ' HB2' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -78.0 158.0 29.43 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.932 -0.634 . . . . 0.0 109.755 -178.865 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -61.06 -27.68 68.52 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.859 172.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 25.6 p -90.12 -26.13 20.36 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.722 -169.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.424 ' HB2' ' ND2' ' A' ' 33' ' ' ASN . 0.9 OUTLIER -79.34 -24.91 42.43 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.326 168.855 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.468 ' HA ' ' CD2' ' A' ' 31' ' ' TYR . 30.4 t80 -62.18 -69.96 0.22 Allowed 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.628 164.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 96.6 m -67.77 -25.7 65.74 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.366 -164.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -65.08 -28.86 69.75 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.766 171.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.94 -33.22 61.92 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.425 174.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.418 HG23 ' CD2' ' A' ' 48' ' ' LEU . 97.2 t -62.98 -60.19 3.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.251 175.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.44 HG12 ' HB2' ' A' ' 11' ' ' TYR . 5.9 m -63.56 -34.08 65.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.19 -169.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -36.57 84.63 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.43 174.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.438 ' HB2' HG21 ' A' ' 47' ' ' THR . 20.5 p -71.99 -19.28 61.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.438 -174.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 69.69 30.36 3.91 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.378 177.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.64 44.65 4.83 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 167.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.45 HG21 ' N ' ' A' ' 48' ' ' LEU . 3.5 t -115.8 -37.55 3.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.281 -0.459 . . . . 0.0 110.51 171.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.45 ' N ' HG21 ' A' ' 47' ' ' THR . 1.4 tt -74.21 -82.61 0.06 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.507 -164.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.45 ' N ' HD22 ' A' ' 48' ' ' LEU . 0.2 OUTLIER 61.96 161.84 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.326 -179.769 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.463 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 3.3 tp -83.47 132.8 34.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.125 -165.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.2 t -78.23 -39.92 38.87 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 114.302 -1.317 . . . . 0.0 110.509 175.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.467 ' NE2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -176.57 174.51 1.86 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.137 176.671 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.467 ' CZ ' HG23 ' A' ' 6' ' ' VAL . 19.2 m-85 -98.39 71.6 2.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.078 163.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -142.56 -156.97 6.97 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 178.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.419 ' CG ' ' HB2' ' A' ' 22' ' ' PRO . 14.9 mtpp -119.17 40.61 3.28 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 114.931 -0.635 . . . . 0.0 109.942 -178.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.419 ' HB2' HG21 ' A' ' 30' ' ' THR . 2.0 t . . . . . 0 C--O 1.241 0.611 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.137 156.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.428 ' HA ' HD21 ' A' ' 50' ' ' LEU . 1.9 t . . . . . 0 C--O 1.233 0.204 0 CA-C-O 120.712 0.292 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.457 HG23 ' CZ ' ' A' ' 53' ' ' PHE . 8.7 t -145.62 134.76 17.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.247 -166.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -99.71 97.42 8.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.485 -174.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.503 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 58.6 m -125.8 31.08 5.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.922 -171.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.6 t -87.46 60.87 6.28 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.192 -176.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -173.81 -25.17 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.064 -1.426 . . . . 0.0 109.214 -172.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.528 ' HB3' ' HA ' ' A' ' 12' ' ' PRO . 63.1 m-85 -58.27 162.39 6.02 Favored Pre-proline 0 C--O 1.238 0.496 0 CA-C-N 113.948 -1.478 . . . . 0.0 110.636 163.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.528 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.3 Cg_endo -78.72 138.28 49.03 Favored 'Cis proline' 0 CA--C 1.516 -0.377 0 C-N-CA 122.838 -1.734 . . . . 0.0 109.239 1.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.3 mttp . . . . . 0 C--O 1.24 0.596 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.986 172.939 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' A' ' 21' ' ' ARG . 10.2 t80 -78.93 147.67 32.94 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.055 -165.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.481 ' N ' ' CD1' ' A' ' 20' ' ' TYR . 0.0 OUTLIER 177.73 134.86 0.22 Allowed Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.535 155.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 21' ' ' ARG . 55.3 Cg_endo -83.45 127.74 4.53 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 123.684 2.922 . . . . 0.0 109.457 -160.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.423 HD21 ' HA ' ' A' ' 53' ' ' PHE . 0.2 OUTLIER -111.43 -170.12 1.59 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.903 160.304 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.458 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 17.4 t -124.16 145.32 49.38 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.643 158.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -78.97 176.13 54.82 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 166.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -98.09 43.73 1.06 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.357 -0.422 . . . . 0.0 110.319 164.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.428 ' HB3' HD11 ' A' ' 48' ' ' LEU . 26.8 p-10 -129.96 12.45 5.69 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.701 178.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 69.68 34.05 2.8 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.581 -177.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -137.53 127.12 25.16 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.273 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.458 HG21 ' N ' ' A' ' 31' ' ' TYR . 57.8 m -66.73 155.51 37.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.245 163.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.458 ' N ' HG21 ' A' ' 30' ' ' THR . 8.1 m-85 -135.31 128.69 32.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.439 -172.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.17 -49.34 79.11 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 -165.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -126.17 -169.4 2.01 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.269 -0.465 . . . . 0.0 109.825 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.9 tptp -68.21 -33.35 74.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.277 160.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.3 m -81.75 -21.11 38.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.223 -168.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -89.65 -25.37 21.29 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.313 174.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.42 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 49.1 t80 -61.28 -66.4 0.54 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.109 166.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.503 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 72.9 m -61.12 -33.68 73.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.516 -164.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -71.43 -30.37 65.98 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.106 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.444 ' CB ' ' CZ ' ' A' ' 31' ' ' TYR . . . -61.54 -33.58 74.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.333 168.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.413 ' CG2' HD21 ' A' ' 48' ' ' LEU . 66.7 t -76.37 -52.76 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.515 -172.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.43 HG22 ' HG3' ' A' ' 12' ' ' PRO . 10.5 m -62.14 -29.22 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.205 -178.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.3 -39.42 74.84 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 113.804 -1.544 . . . . 0.0 110.499 173.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.2 p -61.98 -16.6 52.62 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.5 -175.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 67.86 35.31 3.91 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.393 176.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.62 80.67 0.66 Allowed Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 173.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.456 HG21 ' N ' ' A' ' 48' ' ' LEU . 5.9 t -171.47 -39.89 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.973 -0.613 . . . . 0.0 110.566 -170.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.456 ' N ' HG21 ' A' ' 47' ' ' THR . 4.9 tt -75.82 -83.02 0.07 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.379 -168.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.44 ' N ' ' CD2' ' A' ' 48' ' ' LEU . 6.7 p 59.09 163.47 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.072 -178.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.47 ' HG ' ' N ' ' A' ' 51' ' ' SER . 2.9 tp -81.1 159.84 24.61 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.303 -159.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.47 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 41.3 t -113.07 -39.84 4.1 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 114.482 -1.236 . . . . 0.0 110.63 174.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.466 ' CE1' ' HA ' ' A' ' 56' ' ' CYS . 0.2 OUTLIER -175.92 160.49 2.34 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.327 -176.903 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.457 ' CZ ' HG23 ' A' ' 6' ' ' VAL . 29.8 m-85 -100.54 22.89 11.08 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.564 -165.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -119.07 -174.69 15.95 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 164.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.424 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -61.38 170.12 1.93 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.137 -0.531 . . . . 0.0 109.977 163.077 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.466 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 1.2 t . . . . . 0 N--CA 1.471 0.604 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.879 -155.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.454 -0.258 0 CA-C-O 120.643 0.259 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.466 HG11 ' N ' ' A' ' 7' ' ' ASP . 97.2 t -139.3 145.47 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.054 -171.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.466 ' N ' HG11 ' A' ' 6' ' ' VAL . 1.2 m-20 -132.4 94.75 3.49 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.993 -156.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.477 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 61.1 m -133.43 35.23 3.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.195 -161.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.34 61.45 6.65 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.272 174.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.03 -24.81 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.159 -1.382 . . . . 0.0 109.356 -175.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.634 ' HB3' ' HA ' ' A' ' 12' ' ' PRO . 41.2 m-85 -57.92 160.66 8.02 Favored Pre-proline 0 C--O 1.237 0.413 0 CA-C-N 114.083 -1.417 . . . . 0.0 110.544 161.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.634 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 33.0 Cg_endo -88.17 165.22 42.38 Favored 'Cis proline' 0 CA--C 1.519 -0.264 0 C-N-CA 123.185 -1.59 . . . . 0.0 109.364 9.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.2 mttt . . . . . 0 C--O 1.237 0.4 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.266 -170.857 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.6 pm0 . . . . . 0 N--CA 1.474 0.73 0 CA-C-O 121.124 0.487 . . . . 0.0 109.754 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.457 ' CD1' ' HA ' ' A' ' 21' ' ' ARG . 10.6 t80 -91.76 144.42 25.52 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.161 171.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.477 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 1.1 ptm180 177.37 131.91 0.2 Allowed Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.531 154.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 21' ' ' ARG . 66.8 Cg_endo -85.48 139.21 6.71 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 123.684 2.923 . . . . 0.0 109.512 -159.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.2 -168.92 1.56 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.88 159.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.464 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 21.8 t -119.78 118.61 31.3 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.413 158.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.444 ' HA3' ' CE2' ' A' ' 31' ' ' TYR . . . -86.53 144.11 19.6 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 168.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.72 40.08 1.15 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.379 -0.41 . . . . 0.0 110.314 -164.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.413 ' HB3' ' CD1' ' A' ' 48' ' ' LEU . 22.1 p-10 -99.49 -45.71 5.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.013 167.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -175.03 -30.1 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.043 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -119.66 154.4 34.1 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.446 -155.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.457 HG21 ' N ' ' A' ' 31' ' ' TYR . 69.9 m -75.71 146.82 39.85 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.047 159.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.457 ' N ' HG21 ' A' ' 30' ' ' THR . 19.9 m-85 -114.66 127.35 55.72 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.445 -173.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.49 -47.29 91.48 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -167.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -137.64 171.77 13.95 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-O 121.416 0.627 . . . . 0.0 110.438 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.8 tttm -70.68 -27.44 64.02 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.531 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.5 t -73.45 -20.66 60.66 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.074 -0.967 . . . . 0.0 110.635 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -102.13 -22.12 14.28 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.833 -178.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -62.21 -60.04 4.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.952 164.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.477 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 72.1 m -60.19 -28.87 68.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.946 -173.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.42 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 2.2 m-80 -73.98 -31.27 62.91 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.215 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.33 -28.59 69.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.326 168.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.422 HG22 ' HA ' ' A' ' 38' ' ' CYS . 28.7 t -88.4 -46.66 15.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.525 -168.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.437 HG22 ' HG3' ' A' ' 12' ' ' PRO . 8.7 m -61.94 -35.36 67.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.346 174.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.11 -46.58 86.67 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.373 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.7 p -76.72 -10.12 59.16 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.847 -168.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.294 0.0 OUTLIER 75.29 27.52 1.08 Allowed 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.209 -1.36 . . . . 0.0 109.626 173.113 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.58 40.32 4.76 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 166.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 14.6 t -126.67 -37.47 2.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.981 0.42 . . . . 0.0 110.329 -171.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.417 ' CD2' HG21 ' A' ' 41' ' ' VAL . 1.3 tt -78.94 148.58 32.61 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.171 168.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.8 m -157.14 167.85 29.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.327 174.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.469 HD22 ' CE1' ' A' ' 53' ' ' PHE . 7.6 tp -74.65 130.95 40.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.157 -169.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.5 t -84.64 -37.28 21.25 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.535 174.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.464 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.6 p80 176.96 151.16 0.17 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.204 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.469 ' CE1' HD22 ' A' ' 50' ' ' LEU . 45.4 m-85 -78.16 166.1 23.16 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.318 177.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 62.71 -179.41 5.06 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.331 -1.107 . . . . 0.0 110.331 -162.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.57 -175.62 1.69 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 114.93 -0.635 . . . . 0.0 110.333 -174.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.453 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 3.0 t . . . . . 0 C--O 1.241 0.632 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.215 -155.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.1 p . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.645 0.26 . . . . 0.0 110.375 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.417 ' CG2' HD23 ' A' ' 50' ' ' LEU . 11.3 t -131.43 110.96 18.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.283 -166.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -72.35 123.58 23.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.44 166.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 60.7 m -138.51 41.9 2.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.126 175.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.1 59.17 3.49 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.295 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -173.27 -24.58 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 114.137 -1.392 . . . . 0.0 109.467 -174.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.531 ' HB3' ' HA ' ' A' ' 12' ' ' PRO . 42.6 m-85 -58.98 162.82 6.45 Favored Pre-proline 0 C--O 1.24 0.571 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.605 167.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.531 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 31.6 Cg_endo -77.74 141.69 67.98 Favored 'Cis proline' 0 CA--C 1.517 -0.331 0 C-N-CA 122.947 -1.689 . . . . 0.0 109.325 0.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.44 ' HD2' ' CD2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.213 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.163 -178.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.411 ' HG3' ' NH1' ' A' ' 21' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.474 0.771 0 CA-C-O 121.658 0.742 . . . . 0.0 109.758 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.408 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 37.4 t80 -83.06 -52.66 6.44 Favored 'General case' 0 C--O 1.248 1.023 0 CA-C-O 117.576 -1.202 . . . . 0.0 109.054 165.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.411 ' NH1' ' HG3' ' A' ' 19' ' ' GLU . 4.0 ptp85 -53.9 138.07 54.7 Favored Pre-proline 0 CA--C 1.537 0.454 0 O-C-N 120.456 -1.402 . . . . 0.0 110.967 -145.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.408 ' HG3' ' CE2' ' A' ' 20' ' ' TYR . 63.4 Cg_endo -101.88 167.34 0.31 Allowed 'Trans proline' 0 N--CA 1.476 0.444 0 C-N-CA 123.978 3.119 . . . . 0.0 109.405 -148.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.88 -162.27 1.22 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 158.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.412 ' HB2' ' CA ' ' A' ' 56' ' ' CYS . 19.9 t -130.18 146.53 51.82 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.478 157.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.04 -167.65 41.69 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.069 -1.213 . . . . 0.0 110.069 175.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.22 27.04 4.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.457 0.646 . . . . 0.0 110.42 166.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.435 ' HB3' HD11 ' A' ' 48' ' ' LEU . 54.5 p-10 -122.48 11.81 9.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.869 -167.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 68.55 34.48 3.56 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.629 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.1 mttp -141.16 138.88 33.73 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.323 -178.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.3 m -76.89 145.94 37.96 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.281 163.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.425 ' CZ ' ' HB1' ' A' ' 40' ' ' ALA . 3.2 m-85 -121.81 133.69 54.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.434 -175.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.8 -73.11 0.54 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -169.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.406 ' ND2' ' HB3' ' A' ' 35' ' ' CYS . 1.0 OUTLIER -110.13 165.29 11.86 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.256 0.551 . . . . 0.0 110.56 175.464 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -62.84 -15.9 56.31 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.457 172.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.406 ' HB3' ' ND2' ' A' ' 33' ' ' ASN . 2.4 t -80.9 -18.23 47.91 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.463 178.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -103.89 -21.73 13.6 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.656 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.463 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 52.3 t80 -61.47 -64.92 0.79 Allowed 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.779 162.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 81.0 m -59.9 -26.64 66.07 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.228 -172.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.412 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 2.2 m-80 -73.29 -29.97 63.08 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.135 177.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.426 ' HB2' HD23 ' A' ' 48' ' ' LEU . . . -61.87 -39.24 91.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.309 165.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.418 ' CG2' HD22 ' A' ' 48' ' ' LEU . 86.4 t -70.48 -48.79 57.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.476 -174.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.43 HG12 ' HB2' ' A' ' 11' ' ' TYR . 12.8 m -73.49 -34.98 44.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.154 -172.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -31.82 72.75 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.291 -1.322 . . . . 0.0 110.57 170.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.7 t -68.56 -27.95 66.53 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.298 -177.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.8 m120 61.77 16.89 8.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.498 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.43 92.08 2.13 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 176.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.461 HG21 ' N ' ' A' ' 48' ' ' LEU . 5.3 t -175.21 -33.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.362 -0.419 . . . . 0.0 110.171 163.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.461 ' N ' HG21 ' A' ' 47' ' ' THR . 1.0 OUTLIER -67.53 -81.03 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.473 -164.16 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.44 153.1 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.293 178.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.466 ' HG ' ' N ' ' A' ' 51' ' ' SER . 2.7 tp -81.59 158.63 24.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.324 -164.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.466 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 35.8 t -109.11 -46.09 3.65 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.602 177.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.488 ' N ' ' CD2' ' A' ' 52' ' ' HIS . 0.8 OUTLIER -165.99 -178.8 4.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.47 173.055 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.447 ' CE1' ' CD2' ' A' ' 50' ' ' LEU . 1.8 m-85 -112.44 106.87 15.46 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.271 167.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -170.93 -105.6 0.18 Allowed Glycine 0 CA--C 1.53 1.028 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 164.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.5 64.95 0.88 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 123.121 1.438 . . . . 0.0 110.16 156.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.412 ' CA ' ' HB2' ' A' ' 24' ' ' CYS . 1.1 t . . . . . 0 N--CA 1.47 0.538 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.194 159.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.16 0 CA-C-O 120.715 0.293 . . . . 0.0 110.328 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.457 HG21 ' CZ ' ' A' ' 53' ' ' PHE . 11.3 t -135.04 120.28 29.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.283 -166.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -72.84 80.65 1.16 Allowed 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.407 177.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.514 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 60.8 m -103.02 42.22 1.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.217 174.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.2 59.34 3.03 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.231 -178.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -173.66 -24.6 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 114.074 -1.421 . . . . 0.0 109.239 -173.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.604 ' HB3' ' HA ' ' A' ' 12' ' ' PRO . 47.9 m-85 -58.05 160.3 9.04 Favored Pre-proline 0 C--O 1.237 0.409 0 CA-C-N 113.98 -1.464 . . . . 0.0 110.714 164.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.604 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 33.6 Cg_endo -83.06 139.96 38.51 Favored 'Cis proline' 0 C--O 1.235 0.334 0 C-N-CA 122.894 -1.711 . . . . 0.0 109.409 8.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.9 tttp . . . . . 0 C--O 1.237 0.421 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.937 164.932 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.459 ' HG2' ' N ' ' A' ' 20' ' ' TYR . 4.1 tt0 . . . . . 0 N--CA 1.475 0.803 0 CA-C-O 121.114 0.483 . . . . 0.0 109.715 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.467 ' CD1' ' HA ' ' A' ' 21' ' ' ARG . 11.2 t80 -71.63 144.62 49.37 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.165 -175.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.467 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 0.0 OUTLIER 177.3 133.49 0.21 Allowed Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.359 155.179 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 21' ' ' ARG . 57.9 Cg_endo -83.14 134.23 6.85 Favored 'Trans proline' 0 CA--C 1.515 -0.434 0 C-N-CA 123.729 2.953 . . . . 0.0 109.549 -159.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.94 -170.12 1.69 Allowed 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.874 166.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 18.5 t -133.81 102.9 5.62 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.416 158.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.93 155.49 45.34 Favored Glycine 0 N--CA 1.467 0.722 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 164.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.0 p -96.25 41.38 1.11 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.144 -0.528 . . . . 0.0 110.33 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.42 ' HB3' HD11 ' A' ' 48' ' ' LEU . 32.1 p-10 -108.08 21.85 16.79 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.862 0.839 . . . . 0.0 109.994 164.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . 0.399 0.0 OUTLIER 90.79 -17.55 0.18 Allowed 'General case' 0 C--O 1.239 0.53 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.948 -173.232 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.7 mttm -100.94 135.71 41.94 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 122.179 -0.326 . . . . 0.0 110.417 -159.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 67.3 m -79.46 130.03 35.03 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.852 157.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -102.21 123.59 46.31 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.449 -168.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.59 -42.21 99.72 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -169.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.432 ' HB3' ' HA ' ' A' ' 20' ' ' TYR . 1.0 OUTLIER -156.64 161.85 39.87 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 114.918 -0.641 . . . . 0.0 110.231 -175.614 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.82 -29.18 69.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.737 -163.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.2 p -66.54 -31.35 72.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.312 -175.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -92.65 -25.72 18.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.505 -175.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.463 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 37.2 t80 -62.72 -71.65 0.15 Allowed 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.642 166.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.514 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 71.1 m -61.45 -32.56 72.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.44 -165.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -67.25 -23.57 65.71 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.019 177.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.419 ' CB ' HD23 ' A' ' 48' ' ' LEU . . . -82.38 -22.31 35.48 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 114.351 -1.295 . . . . 0.0 110.377 175.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.42 ' HA ' HD21 ' A' ' 48' ' ' LEU . 90.2 t -72.27 -59.01 3.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.519 171.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.419 HG22 ' HG3' ' A' ' 12' ' ' PRO . 22.6 m -61.92 -27.28 42.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.07 -170.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.32 -47.42 64.52 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 113.697 -1.592 . . . . 0.0 110.584 174.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.42 ' HB2' ' CG2' ' A' ' 47' ' ' THR . 1.1 p -62.11 -17.79 58.82 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.697 -177.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 24.8 m120 62.16 16.61 8.47 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.319 -176.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.99 68.24 0.83 Allowed Glycine 0 CA--C 1.527 0.798 0 CA-C-N 114.618 -1.173 . . . . 0.0 110.475 -173.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.447 HG21 ' N ' ' A' ' 48' ' ' LEU . 1.4 t -136.29 -36.28 0.73 Allowed 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.373 0.606 . . . . 0.0 110.684 161.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.447 ' N ' HG21 ' A' ' 47' ' ' THR . 0.2 OUTLIER -75.24 -92.42 0.02 OUTLIER 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.529 -178.52 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 17.3 p 52.3 176.75 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 121.513 -0.742 . . . . 0.0 112.594 -172.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.463 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 3.3 tp -91.4 123.03 34.51 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.287 -159.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.9 t -60.64 -61.96 2.21 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.317 162.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.475 ' N ' ' CD2' ' A' ' 52' ' ' HIS . 2.5 p80 -158.97 163.11 36.76 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.112 173.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.457 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 36.2 m-85 -77.66 176.03 9.35 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.333 169.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.48 173.4 3.31 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -164.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.436 ' HG2' ' HB2' ' A' ' 22' ' ' PRO . 7.7 mmmt -61.56 171.89 1.37 Allowed 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.261 -0.469 . . . . 0.0 110.208 169.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.464 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 1.5 t . . . . . 0 C--O 1.24 0.599 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.932 -158.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.3 t . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.836 0.35 . . . . 0.0 110.683 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.465 HG12 ' NZ ' ' A' ' 34' ' ' LYS . 6.5 t -107.48 129.84 60.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.976 -159.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -107.58 107.85 18.87 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.537 170.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.492 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 35.2 m -111.71 47.1 1.06 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.436 -177.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.6 m -96.24 39.12 1.16 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 114.196 -1.365 . . . . 0.0 110.374 166.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -129.91 25.48 5.29 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.977 161.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.514 ' HB3' ' HA ' ' A' ' 12' ' ' PRO . 85.1 m-85 -126.63 166.87 19.42 Favored Pre-proline 0 C--O 1.236 0.386 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.704 -170.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.514 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.2 Cg_endo -72.42 138.88 57.18 Favored 'Cis proline' 0 CA--C 1.518 -0.319 0 C-N-CA 122.064 -2.057 . . . . 0.0 108.98 -7.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.47 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.184 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.264 176.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 N--CA 1.473 0.678 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.469 ' CD1' ' N ' ' A' ' 21' ' ' ARG . 10.9 t80 -76.85 147.05 37.34 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.211 -169.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.469 ' N ' ' CD1' ' A' ' 20' ' ' TYR . 0.0 OUTLIER 177.73 135.61 0.22 Allowed Pre-proline 0 CA--C 1.536 0.413 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.531 155.848 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.426 ' HB2' ' HB3' ' A' ' 55' ' ' LYS . 47.7 Cg_endo -84.09 143.93 10.49 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.775 2.983 . . . . 0.0 109.593 -158.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.12 -165.52 1.69 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.055 158.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.419 ' HB3' ' NE2' ' A' ' 52' ' ' HIS . 21.1 t -132.6 148.53 52.37 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.293 158.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -81.87 -169.63 43.2 Favored Glycine 0 CA--C 1.531 1.093 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 174.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.4 m -97.62 19.9 12.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.98 -0.61 . . . . 0.0 110.454 161.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.422 ' HB3' HD11 ' A' ' 48' ' ' LEU . 34.1 p-10 -107.14 9.23 30.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.147 -175.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.9 m120 67.91 38.61 2.78 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.587 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.91 137.6 34.95 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 114.583 -1.189 . . . . 0.0 110.342 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.6 m -72.48 147.65 45.84 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.24 162.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -122.74 125.04 44.73 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.394 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.34 -50.27 68.6 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -167.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.434 ' HB3' ' HA ' ' A' ' 20' ' ' TYR . 1.7 p30 -125.04 175.38 7.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.203 -0.498 . . . . 0.0 110.482 170.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.465 ' NZ ' HG12 ' A' ' 6' ' ' VAL . 4.8 tttp -69.23 -17.57 63.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.414 169.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 22.8 m -60.99 -51.61 68.52 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.545 172.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -80.4 -21.33 42.37 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.859 -171.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.462 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 57.7 t80 -61.29 -67.64 0.39 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.967 165.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.492 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 96.8 m -65.05 -29.85 70.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.638 -163.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -65.37 -33.78 76.76 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.02 173.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.35 -24.22 63.87 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.324 174.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.413 HG23 ' CD2' ' A' ' 48' ' ' LEU . 59.3 t -87.9 -55.18 6.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.387 -172.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.424 HG13 ' HB2' ' A' ' 11' ' ' TYR . 6.6 m -62.33 -23.09 31.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.149 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.13 -37.99 52.95 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 113.774 -1.557 . . . . 0.0 110.621 173.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.424 ' HB2' HG21 ' A' ' 47' ' ' THR . 14.1 p -62.28 -19.99 63.82 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.628 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 69.27 41.61 1.33 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.274 -171.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.68 88.12 0.03 OUTLIER Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 172.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.424 HG21 ' HB2' ' A' ' 44' ' ' SER . 6.1 t -176.4 -42.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.262 -0.469 . . . . 0.0 110.322 -167.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.468 HD22 ' N ' ' A' ' 49' ' ' THR . 1.0 OUTLIER -61.71 -73.93 0.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.367 172.25 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.468 ' N ' HD22 ' A' ' 48' ' ' LEU . 0.2 OUTLIER 66.89 160.31 0.15 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.431 175.621 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.469 HD22 ' CE1' ' A' ' 53' ' ' PHE . 5.6 tp -82.7 162.05 21.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.286 -168.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.455 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 16.2 t -112.95 -41.44 3.75 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.671 173.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.426 ' N ' ' CD2' ' A' ' 52' ' ' HIS . 0.2 OUTLIER -177.79 167.63 2.12 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.371 -173.332 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.469 ' CE1' HD22 ' A' ' 50' ' ' LEU . 2.2 m-85 -108.25 30.81 6.07 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.347 -177.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.67 -140.25 6.6 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 168.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 22' ' ' PRO . 1.2 pttm -131.82 63.84 1.61 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 123.2 1.476 . . . . 0.0 110.29 161.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.24 0.57 0 O-C-N 121.345 -0.847 . . . . 0.0 110.187 158.983 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.455 -0.198 0 CA-C-O 121.329 0.585 . . . . 0.0 110.448 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.429 HG12 ' HD2' ' A' ' 34' ' ' LYS . 4.9 t -145.91 111.77 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.998 -177.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -67.81 114.22 6.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.408 167.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 57.8 m -133.39 37.16 3.36 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.036 177.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.1 m -91.23 58.7 3.75 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.221 -175.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -173.31 -24.19 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 114.081 -1.418 . . . . 0.0 109.488 -174.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.526 ' HB3' ' HA ' ' A' ' 12' ' ' PRO . 74.3 m-85 -58.69 160.38 10.55 Favored Pre-proline 0 C--O 1.238 0.459 0 CA-C-N 113.987 -1.461 . . . . 0.0 110.617 166.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.526 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 31.9 Cg_endo -78.32 139.99 58.33 Favored 'Cis proline' 0 C--O 1.233 0.261 0 C-N-CA 122.771 -1.762 . . . . 0.0 109.369 3.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.24 0.575 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.834 164.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.721 0 CA-C-O 121.592 0.71 . . . . 0.0 109.841 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.5 ' CD2' ' N ' ' A' ' 21' ' ' ARG . 93.7 t80 -61.62 167.0 3.75 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.026 -177.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.5 ' N ' ' CD2' ' A' ' 20' ' ' TYR . 1.7 ptm180 178.52 172.28 0.44 Allowed Pre-proline 0 C--O 1.248 0.983 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.406 151.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.438 ' HB2' ' HG2' ' A' ' 55' ' ' LYS 0.253 82.6 Cg_endo -110.15 92.52 0.02 OUTLIER 'Trans proline' 0 CA--C 1.515 -0.435 0 C-N-CA 122.252 1.968 . . . . 0.0 109.232 -178.7 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.443 ' CD2' ' CD2' ' A' ' 53' ' ' PHE . 0.2 OUTLIER -90.15 -171.22 3.04 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.855 162.439 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.432 ' HB3' ' NE2' ' A' ' 52' ' ' HIS . 21.6 t -146.06 135.93 23.45 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.221 156.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.27 -171.75 41.56 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 114.387 -1.278 . . . . 0.0 110.316 -177.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.25 26.62 5.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.42 0.629 . . . . 0.0 110.479 170.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.421 ' HB3' HD11 ' A' ' 48' ' ' LEU . 24.9 p-10 -126.9 13.09 7.33 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.827 -166.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.5 m120 69.24 32.51 3.58 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.289 -0.868 . . . . 0.0 110.59 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.73 137.9 38.78 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.285 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.441 HG22 ' HB2' ' A' ' 56' ' ' CYS . 1.3 m -77.73 148.95 34.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.337 164.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -121.55 129.99 53.23 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.455 -176.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.55 -93.01 0.01 OUTLIER Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 168.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.0 p-10 -99.9 157.6 16.41 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.998 -0.601 . . . . 0.0 110.577 -168.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.429 ' HD2' HG12 ' A' ' 6' ' ' VAL . 1.3 ttpt -61.59 -15.53 39.89 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.569 -178.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.1 m -66.13 -45.44 81.06 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.471 173.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -89.59 -23.33 21.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.373 -168.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.458 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 36.2 t80 -61.84 -69.11 0.26 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.877 162.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 85.2 m -61.79 -30.92 71.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.574 -168.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.415 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 90.0 m-20 -67.07 -31.44 71.95 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.942 175.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.17 -17.24 62.55 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.372 174.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.43 HG23 HD21 ' A' ' 48' ' ' LEU . 43.7 t -85.8 -52.5 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.501 177.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.429 HG12 ' HB2' ' A' ' 11' ' ' TYR . 4.4 m -70.1 -32.99 53.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.245 -170.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -70.51 -29.81 66.42 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.498 170.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.44 ' HB3' ' HB ' ' A' ' 47' ' ' THR . 0.5 OUTLIER -61.66 -30.61 70.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.548 175.937 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 70.22 51.93 0.38 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.301 -166.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.69 21.93 55.95 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.192 176.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.44 ' HB ' ' HB3' ' A' ' 44' ' ' SER . 40.5 m -66.9 -86.82 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 157.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.43 HD21 HG23 ' A' ' 41' ' ' VAL . 1.0 OUTLIER -61.3 148.66 40.49 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.302 -163.333 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 77.0 p -138.89 -172.43 3.32 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.921 165.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.458 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 5.8 tp -86.8 133.19 33.67 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.369 -173.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.6 t -82.82 -37.04 24.98 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 113.921 -1.49 . . . . 0.0 110.597 173.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.432 ' NE2' ' HB3' ' A' ' 24' ' ' CYS . 0.7 OUTLIER 173.47 162.66 0.15 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.334 -178.676 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.448 ' CE1' ' CD2' ' A' ' 50' ' ' LEU . 1.3 m-85 -98.78 74.9 2.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.894 160.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -152.39 21.79 0.84 Allowed Glycine 0 CA--C 1.523 0.57 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.811 -172.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.438 ' HG2' ' HB2' ' A' ' 22' ' ' PRO . 9.1 mttp 61.27 35.25 18.27 Favored 'General case' 0 C--O 1.239 0.506 0 O-C-N 122.753 -0.263 . . . . 0.0 110.307 164.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.441 ' HB2' HG22 ' A' ' 30' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.474 0.734 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.734 156.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.7 p . . . . . 0 C--O 1.231 0.103 0 CA-C-O 121.043 0.449 . . . . 0.0 110.261 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -136.79 -175.58 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.282 -167.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -153.94 65.86 0.72 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.342 -168.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.532 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 59.4 m -99.83 32.78 2.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.973 -174.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.72 60.5 5.59 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.196 -176.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -173.71 -24.98 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.326 -172.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.55 ' HB3' ' HA ' ' A' ' 12' ' ' PRO . 79.1 m-85 -58.33 160.29 9.82 Favored Pre-proline 0 C--O 1.236 0.374 0 CA-C-N 113.894 -1.503 . . . . 0.0 110.529 163.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.55 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 30.5 Cg_endo -78.69 135.83 38.53 Favored 'Cis proline' 0 CA--C 1.518 -0.277 0 C-N-CA 122.667 -1.806 . . . . 0.0 109.378 6.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.459 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.8 OUTLIER . . . . . 0 C--O 1.238 0.459 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.065 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.475 0.799 0 CA-C-O 121.465 0.65 . . . . 0.0 109.808 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.486 ' CD1' ' N ' ' A' ' 21' ' ' ARG . 10.5 t80 -108.87 146.86 33.04 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.288 -177.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.486 ' N ' ' CD1' ' A' ' 20' ' ' TYR . 0.0 OUTLIER 177.44 135.14 0.21 Allowed Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.712 155.586 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.434 ' HB2' ' HG2' ' A' ' 55' ' ' LYS . 59.5 Cg_endo -86.11 139.14 6.08 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.539 2.826 . . . . 0.0 109.368 -161.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.88 -165.09 1.3 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.999 161.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.447 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 15.9 t -134.58 118.09 16.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.874 165.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.54 -173.9 2.03 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.7 t -98.81 30.78 3.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.724 0.773 . . . . 0.0 110.356 165.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.415 ' HB3' ' CD1' ' A' ' 48' ' ' LEU . 32.2 p-10 -123.84 13.71 9.24 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.473 -166.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 66.74 31.97 7.17 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.532 178.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.37 141.96 19.83 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.81 173.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.47 HG21 ' N ' ' A' ' 31' ' ' TYR . 94.0 m -65.82 148.53 51.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.261 165.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.47 ' N ' HG21 ' A' ' 30' ' ' THR . 30.8 m-85 -106.85 138.41 43.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.353 166.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.02 -53.58 41.65 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.433 ' HB3' ' HA ' ' A' ' 20' ' ' TYR . 5.0 p-10 -128.08 169.78 13.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.418 -0.391 . . . . 0.0 110.301 -173.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.38 -31.88 73.26 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.497 174.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.2 t -74.73 -21.84 59.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.573 -173.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -97.75 -22.75 16.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.66 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -61.59 -68.09 0.35 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.762 164.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.532 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 64.4 m -61.0 -32.69 72.27 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.538 -167.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -73.45 -25.0 60.3 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.209 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.31 -43.0 92.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.183 165.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.8 t -61.82 -51.97 66.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.54 -175.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.426 HG12 ' HB2' ' A' ' 11' ' ' TYR . 18.8 m -74.3 -34.07 36.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.1 -168.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.48 -29.51 70.18 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.442 169.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.5 t -80.75 -17.26 51.55 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.332 -172.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 53.3 t30 71.33 50.72 0.28 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.568 167.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.88 -21.2 47.3 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 164.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 46.0 m -62.02 -85.71 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.238 -0.481 . . . . 0.0 110.002 177.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.415 ' CD1' ' HB3' ' A' ' 27' ' ' ASP . 1.4 tt -59.98 148.19 36.2 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.495 -157.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.435 HG21 ' N ' ' A' ' 50' ' ' LEU . 0.9 OUTLIER -146.81 -163.21 1.7 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.619 167.108 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.467 HD22 ' CE1' ' A' ' 53' ' ' PHE . 6.6 tp -94.45 118.68 32.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.15 -169.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.8 t -61.62 -42.16 98.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.493 167.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.459 ' CE1' ' HA ' ' A' ' 56' ' ' CYS . 1.8 p80 173.73 158.1 0.13 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.182 178.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.467 ' CE1' HD22 ' A' ' 50' ' ' LEU . 5.2 m-85 -84.51 170.97 12.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.217 168.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.59 32.08 10.67 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 168.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.434 ' HG2' ' HB2' ' A' ' 22' ' ' PRO . 4.9 mttp 61.14 167.7 0.09 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 114.541 -0.829 . . . . 0.0 110.455 -174.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.459 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 2.2 t . . . . . 0 C--O 1.24 0.594 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.034 -160.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 8.2 tt . . . . . 0 N--CA 1.473 0.708 0 CA-C-O 121.308 0.575 . . . . 0.0 109.982 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.07 129.83 42.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.311 -171.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -154.49 103.33 2.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.17 172.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.434 HG13 ' HA ' ' A' ' 52' ' ' HIS . 11.6 t -126.68 68.89 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.244 -165.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.24 -175.55 4.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.348 170.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.432 HG12 ' CZ ' ' A' ' 53' ' ' PHE . 0.6 OUTLIER -146.11 -175.18 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.206 -165.551 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -145.97 63.87 1.23 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.037 -155.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.455 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 76.6 m -117.11 42.49 2.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.279 -165.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.8 m -89.76 61.57 5.45 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.343 172.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -173.01 -24.44 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.349 -175.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.559 ' HB3' ' HA ' ' A' ' 12' ' ' PRO . 29.2 m-85 -58.18 158.12 14.79 Favored Pre-proline 0 C--O 1.236 0.382 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.636 163.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.559 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.3 Cg_endo -86.67 154.46 48.3 Favored 'Cis proline' 0 C--O 1.232 0.22 0 C-N-CA 122.914 -1.702 . . . . 0.0 109.449 10.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.421 ' HG3' ' HD3' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -88.45 158.73 48.36 Favored Pre-proline 0 C--O 1.239 0.531 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.894 166.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.421 ' HD3' ' HG3' ' A' ' 13' ' ' LYS . 11.7 Cg_endo -76.71 -22.66 11.74 Favored 'Trans proline' 0 CA--C 1.514 -0.494 0 C-N-CA 122.672 2.248 . . . . 0.0 110.695 -171.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -171.04 172.9 5.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.345 -168.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.5 t -172.31 159.94 4.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.981 -166.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.7 p -100.26 44.24 1.03 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.334 -164.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.241 0.622 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.377 168.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 . . . . . 0 N--CA 1.473 0.699 0 CA-C-O 121.267 0.556 . . . . 0.0 109.882 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -87.67 -51.61 5.78 Favored 'General case' 0 C--O 1.251 1.145 0 CA-C-O 117.581 -1.2 . . . . 0.0 109.368 171.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.433 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.4 ptp180 -54.13 131.05 59.96 Favored Pre-proline 0 CA--C 1.54 0.583 0 O-C-N 120.427 -1.421 . . . . 0.0 110.768 -145.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 21' ' ' ARG . 72.5 Cg_endo -93.67 166.71 2.21 Favored 'Trans proline' 0 CA--C 1.517 -0.347 0 C-N-CA 124.293 3.329 . . . . 0.0 109.526 -150.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.452 HD11 ' CG ' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -126.33 -170.7 2.24 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.939 164.185 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.463 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 17.8 t -131.1 119.62 22.22 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.612 157.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.1 174.5 7.35 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 172.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.07 40.57 1.17 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.009 -0.596 . . . . 0.0 110.471 167.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.8 p-10 -131.4 13.76 5.04 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.595 -177.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 69.73 33.64 2.89 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.62 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -139.12 132.44 30.01 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.532 178.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.46 HG21 ' N ' ' A' ' 31' ' ' TYR . 84.9 m -78.71 154.22 30.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.316 165.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.46 ' N ' HG21 ' A' ' 30' ' ' THR . 27.5 m-85 -127.17 126.73 43.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.454 -170.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.01 -9.18 86.89 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.224 -169.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -159.57 176.22 12.3 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.099 -0.551 . . . . 0.0 110.498 171.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.5 mttp -61.65 -22.36 65.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.398 166.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 95.5 m -75.72 -43.91 44.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.359 -169.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -82.13 -22.81 35.99 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.866 178.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.471 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 29.8 t80 -61.86 -67.94 0.37 Allowed 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.028 167.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.455 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 71.9 m -69.56 -25.35 63.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.271 -167.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -65.93 -31.07 71.79 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.118 171.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.428 ' HB2' HD23 ' A' ' 48' ' ' LEU . . . -69.68 -36.2 75.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.491 172.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.424 ' HA ' HD21 ' A' ' 48' ' ' LEU . 84.7 t -65.89 -53.93 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.511 -179.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.421 HG12 ' CB ' ' A' ' 11' ' ' TYR . 5.1 m -62.3 -35.27 68.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.121 -172.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -37.16 84.25 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 114.125 -1.398 . . . . 0.0 110.419 171.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.412 ' HB2' ' CG2' ' A' ' 47' ' ' THR . 10.8 p -72.15 -24.4 61.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.41 -170.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 69.12 36.73 2.33 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.41 -172.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.67 94.28 0.01 OUTLIER Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -170.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.415 HG21 ' N ' ' A' ' 48' ' ' LEU . 6.1 t -169.99 -35.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.437 -0.381 . . . . 0.0 110.183 173.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.428 HD23 ' HB2' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -61.47 -83.19 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.314 166.731 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.85 171.69 0.12 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.45 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.471 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 8.2 tp -91.84 120.28 32.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.111 -166.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.8 t -64.21 -41.91 96.84 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.595 166.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.463 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.9 p80 174.25 146.17 0.06 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.156 -178.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.465 ' CE1' HD22 ' A' ' 50' ' ' LEU . 20.4 m-85 -67.88 170.1 8.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.2 171.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.87 170.49 8.07 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -164.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.433 ' HG3' ' HG2' ' A' ' 22' ' ' PRO . 4.2 mttm -62.47 176.31 0.65 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.339 -0.431 . . . . 0.0 110.246 170.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.459 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.8 OUTLIER . . . . . 0 N--CA 1.472 0.628 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.732 -158.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.7 mp . . . . . 0 N--CA 1.473 0.705 0 CA-C-O 121.211 0.529 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.34 -24.37 66.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.421 -170.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -115.7 97.63 6.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.373 172.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.4 m -112.73 94.46 3.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.012 164.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.7 p -117.58 177.94 4.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.357 -164.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.413 HG22 ' CD2' ' A' ' 50' ' ' LEU . 98.3 t -151.49 127.08 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.29 -164.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -87.77 114.75 24.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.358 -172.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 57.1 m -138.85 35.5 2.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.958 -166.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.3 t -89.83 59.92 4.79 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.389 -176.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.43 -25.56 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.264 -175.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.551 ' HB3' ' HA ' ' A' ' 12' ' ' PRO . 97.5 m-85 -60.17 160.47 16.75 Favored Pre-proline 0 C--O 1.238 0.474 0 CA-C-N 113.904 -1.498 . . . . 0.0 110.375 168.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.551 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 56.5 Cg_endo -79.12 147.3 79.82 Favored 'Cis proline' 0 C--O 1.233 0.273 0 C-N-CA 122.58 -1.842 . . . . 0.0 109.371 4.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.417 ' HB3' ' CD ' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -74.33 178.11 1.84 Allowed Pre-proline 0 C--O 1.24 0.561 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.849 162.601 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.417 ' CD ' ' HB3' ' A' ' 13' ' ' LYS . 17.8 Cg_endo -90.63 -54.2 0.02 OUTLIER 'Trans proline' 0 CA--C 1.517 -0.336 0 C-N-CA 122.576 2.184 . . . . 0.0 109.533 170.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -148.5 138.01 22.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.29 -171.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.6 m -130.7 168.69 16.75 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.398 172.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 86.4 m -158.34 -40.2 0.06 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.268 167.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER . . . . . 0 C--O 1.24 0.572 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.319 167.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 18' ' ' LEU . 2.3 mt-10 . . . . . 0 N--CA 1.475 0.816 0 CA-C-O 121.548 0.69 . . . . 0.0 109.809 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -93.09 -50.04 5.71 Favored 'General case' 0 C--O 1.249 1.07 0 CA-C-O 117.468 -1.253 . . . . 0.0 108.918 168.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.5 ptp85 -53.75 140.77 48.39 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 120.47 -1.393 . . . . 0.0 111.152 -144.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.434 ' HB2' ' HG2' ' A' ' 55' ' ' LYS . 60.4 Cg_endo -99.11 153.47 0.62 Allowed 'Trans proline' 0 N--CA 1.475 0.387 0 C-N-CA 124.133 3.222 . . . . 0.0 109.253 -150.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.46 -166.88 1.32 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.956 160.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.465 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 18.7 t -121.4 116.68 25.23 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.464 159.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.467 ' HA3' ' CE2' ' A' ' 31' ' ' TYR . . . -61.67 152.61 41.97 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 167.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.38 39.73 1.23 Allowed 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 115.196 -0.502 . . . . 0.0 110.403 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.412 ' HB3' ' CD1' ' A' ' 48' ' ' LEU . 13.7 p-10 -113.53 -48.73 2.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.362 174.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -176.34 -26.82 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.128 178.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.28 158.07 21.91 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.304 -156.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 60.1 m -77.03 133.29 39.16 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.901 157.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.467 ' CE2' ' HA3' ' A' ' 25' ' ' GLY . 18.1 m-85 -96.88 138.07 35.0 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.445 176.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.05 -69.76 1.22 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -177.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -131.92 167.32 19.82 Favored 'General case' 0 C--O 1.232 0.163 0 O-C-N 121.794 -0.827 . . . . 0.0 110.597 -178.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.98 -14.06 20.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.705 -169.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.8 m -72.35 -60.14 2.38 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.453 176.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -61.31 -25.6 67.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.798 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.453 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 53.5 t80 -62.12 -66.22 0.57 Allowed 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.872 170.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 96.7 m -66.21 -31.57 72.48 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.671 -160.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -72.16 -23.79 61.34 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.119 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.415 ' HB2' HD23 ' A' ' 48' ' ' LEU . . . -69.33 -27.98 65.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.294 166.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.431 ' HA ' HD21 ' A' ' 48' ' ' LEU . 89.8 t -75.89 -45.62 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.578 -178.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.47 HG23 ' N ' ' A' ' 12' ' ' PRO . 20.3 m -70.71 -35.32 60.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.084 -172.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.88 -33.8 73.66 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.335 168.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.98 -39.42 72.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.291 -169.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 69.09 24.16 6.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.223 -163.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.16 40.82 7.31 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 166.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.45 HG21 ' N ' ' A' ' 48' ' ' LEU . 6.1 t -100.88 -39.06 7.96 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.199 0.524 . . . . 0.0 110.268 165.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.45 ' N ' HG21 ' A' ' 47' ' ' THR . 0.3 OUTLIER -62.14 -86.99 0.01 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.408 -179.326 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 67.17 164.13 0.2 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.488 174.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.469 HD22 ' CE1' ' A' ' 53' ' ' PHE . 5.0 tp -86.6 137.13 32.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.276 -168.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.7 t -92.4 -43.48 9.2 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.409 177.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.465 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.6 p80 -177.51 150.09 0.67 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.217 177.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.469 ' CE1' HD22 ' A' ' 50' ' ' LEU . 9.1 m-85 -76.78 157.17 31.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.303 175.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.6 166.29 23.47 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 -163.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.434 ' HG2' ' HB2' ' A' ' 22' ' ' PRO . 4.4 mtmm -63.22 -179.0 0.28 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.419 -0.39 . . . . 0.0 110.267 177.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.458 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.8 OUTLIER . . . . . 0 N--CA 1.473 0.689 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.819 -155.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 33.4 tp . . . . . 0 N--CA 1.474 0.737 0 CA-C-O 121.265 0.555 . . . . 0.0 109.827 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.24 -79.77 0.05 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.306 175.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 61.69 -164.49 0.24 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.308 171.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.415 ' HB ' ' HA ' ' A' ' 52' ' ' HIS . 17.7 m -113.16 63.69 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.318 -167.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.1 p -121.77 -175.96 3.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.33 169.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -156.36 -176.01 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.25 -167.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -146.24 80.74 1.57 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.939 -156.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.47 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 62.4 m -125.49 48.03 2.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.22 -165.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.5 p -96.13 55.69 1.57 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.191 -175.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -173.2 -23.76 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.181 -1.372 . . . . 0.0 109.648 -174.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.501 ' HB3' ' HA ' ' A' ' 12' ' ' PRO . 67.3 m-85 -59.83 161.63 11.4 Favored Pre-proline 0 C--O 1.239 0.52 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.505 170.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.501 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 35.9 Cg_endo -77.09 156.63 97.25 Favored 'Cis proline' 0 C--O 1.233 0.26 0 C-N-CA 122.676 -1.802 . . . . 0.0 109.14 -0.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.463 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 2.1 mtpm? -109.77 163.8 16.27 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.135 -164.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -55.86 -69.71 0.05 OUTLIER 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 122.306 2.004 . . . . 0.0 110.061 175.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -108.09 107.44 18.09 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.361 -153.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.4 m -149.67 128.34 12.41 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.427 156.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.58 127.7 49.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.437 -165.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.6 mt . . . . . 0 C--O 1.241 0.631 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.324 -168.435 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 . . . . . 0 N--CA 1.474 0.733 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.466 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 31.5 t80 -63.19 -52.82 60.77 Favored 'General case' 0 C--O 1.247 0.943 0 CA-C-O 118.114 -0.946 . . . . 0.0 109.279 -166.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.457 ' HB3' ' NH1' ' A' ' 21' ' ' ARG . 2.0 ptp180 -54.4 142.75 49.24 Favored Pre-proline 0 CA--C 1.539 0.527 0 O-C-N 120.734 -1.229 . . . . 0.0 110.941 -146.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.466 ' HG3' ' CE2' ' A' ' 20' ' ' TYR 0.259 91.4 Cg_endo -119.47 -179.34 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 123.314 2.676 . . . . 0.0 108.907 -142.676 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.422 HD21 HD12 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -142.2 -164.17 1.75 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.968 162.354 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.458 ' HB3' ' NE2' ' A' ' 52' ' ' HIS . 34.3 t -125.37 126.89 45.74 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 158.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.55 -171.95 48.52 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.3 p -97.74 34.43 1.87 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.001 -0.6 . . . . 0.0 110.312 163.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.419 ' HB3' ' CD1' ' A' ' 48' ' ' LEU . 24.2 p-10 -96.4 11.09 36.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.485 170.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.5 m120 62.76 42.95 7.57 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.594 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.69 168.51 9.01 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.846 173.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.5 m -67.53 138.13 56.29 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.997 164.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -93.76 143.32 26.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.358 167.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.94 -56.48 22.31 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -174.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 39.6 p-10 -142.72 179.14 7.17 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 114.636 -0.782 . . . . 0.0 110.624 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.71 -38.84 89.36 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.524 -178.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.6 m -70.99 -39.34 72.5 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.177 -169.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -74.32 -24.08 59.15 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.054 174.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -62.21 -64.37 0.95 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.057 169.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.464 ' HB2' ' CD2' ' A' ' 11' ' ' TYR . 74.1 m -60.25 -29.32 68.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.99 -171.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.416 ' HA ' HG21 ' A' ' 42' ' ' VAL . 31.6 m-20 -73.24 -31.38 64.08 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.173 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.421 ' HB2' HD23 ' A' ' 48' ' ' LEU . . . -61.67 -29.23 69.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.377 168.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.416 ' CG2' HD21 ' A' ' 48' ' ' LEU . 35.6 t -82.12 -42.58 18.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.524 -176.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.436 HG22 ' HG3' ' A' ' 12' ' ' PRO . 18.8 m -78.37 -34.29 18.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.209 -171.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -64.09 -32.25 73.74 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.238 167.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.96 -21.79 63.82 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.734 -172.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 69.17 25.53 5.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.131 -168.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.5 85.96 0.09 OUTLIER Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 -170.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.468 HG21 ' N ' ' A' ' 48' ' ' LEU . 2.9 t -151.77 -36.67 0.12 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.083 0.468 . . . . 0.0 110.514 166.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.468 ' N ' HG21 ' A' ' 47' ' ' THR . 0.8 OUTLIER -79.87 160.27 26.12 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.584 175.832 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.454 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 2.7 t -174.18 164.19 3.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.991 -174.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.459 HD22 ' CE1' ' A' ' 53' ' ' PHE . 5.8 tp -76.29 129.02 36.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.131 -164.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.6 t -77.23 -42.24 38.08 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.454 171.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.462 ' N ' ' CD2' ' A' ' 52' ' ' HIS . 1.0 OUTLIER -174.06 167.42 4.22 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.267 175.05 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.459 ' CE1' HD22 ' A' ' 50' ' ' LEU . 20.3 m-85 -94.72 89.23 5.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.248 168.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -155.96 -139.24 2.72 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.496 -1.041 . . . . 0.0 110.496 -175.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.414 ' HG2' ' HG2' ' A' ' 22' ' ' PRO . 6.8 mtpp -139.82 41.11 2.0 Allowed 'General case' 0 C--O 1.24 0.602 0 CA-C-N 115.26 -0.47 . . . . 0.0 109.874 170.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 C--O 1.241 0.647 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.022 161.915 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.8 pt? . . . . . 0 N--CA 1.474 0.771 0 CA-C-O 121.173 0.511 . . . . 0.0 109.905 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.73 -165.55 1.28 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.261 170.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -141.51 19.95 2.2 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.193 163.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.421 HG11 ' HA ' ' A' ' 52' ' ' HIS . 8.6 t 61.8 27.64 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.505 163.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.3 p -130.69 159.41 37.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.427 -168.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.428 HG22 HD21 ' A' ' 50' ' ' LEU . 11.7 t -145.34 117.02 2.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.118 -164.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -73.27 117.74 15.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.466 169.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.466 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 59.8 m -138.08 44.38 2.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.115 177.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.66 58.56 3.12 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.373 -177.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -172.81 -24.33 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.539 -177.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.549 ' HB3' ' HA ' ' A' ' 12' ' ' PRO . 71.2 m-85 -60.69 159.73 23.66 Favored Pre-proline 0 C--O 1.236 0.345 0 CA-C-N 114.024 -1.443 . . . . 0.0 110.414 172.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.549 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 56.2 Cg_endo -78.63 163.98 85.26 Favored 'Cis proline' 0 CA--C 1.519 -0.23 0 C-N-CA 122.511 -1.87 . . . . 0.0 109.337 5.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.432 ' HG3' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -78.83 165.6 48.19 Favored Pre-proline 0 C--O 1.234 0.258 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.736 -166.496 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.432 ' HD2' ' HG3' ' A' ' 13' ' ' LYS . 3.6 Cg_exo -55.54 -63.9 0.17 Allowed 'Trans proline' 0 C--N 1.362 1.277 0 C-N-CA 122.215 1.943 . . . . 0.0 110.236 172.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -163.59 116.07 1.47 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.125 167.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.1 t -61.56 152.07 31.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.279 -167.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.6 p -148.11 125.29 11.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.434 -165.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.24 0.573 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.398 -170.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.465 ' HG3' ' N ' ' A' ' 20' ' ' TYR . 2.2 tp10 . . . . . 0 N--CA 1.475 0.823 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.465 ' CD1' ' HA ' ' A' ' 21' ' ' ARG . 10.0 t80 -105.92 142.43 35.63 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.072 164.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.476 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 1.0 OUTLIER 177.36 133.77 0.21 Allowed Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.582 154.117 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 21' ' ' ARG . 71.9 Cg_endo -88.25 139.52 4.35 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.53 2.82 . . . . 0.0 109.413 -160.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.92 -163.84 1.1 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.884 160.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.465 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 17.5 t -127.24 142.94 51.35 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.702 159.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -78.08 179.38 51.62 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 169.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 60.0 p -98.28 26.59 5.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.434 0.635 . . . . 0.0 110.404 169.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.413 ' HB3' HD11 ' A' ' 48' ' ' LEU . 42.4 p-10 -123.1 13.49 9.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.615 -168.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 69.66 32.35 3.33 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.519 -176.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.1 mtpt -141.51 127.7 19.71 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.205 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.467 HG21 ' N ' ' A' ' 31' ' ' TYR . 84.5 m -62.03 163.39 7.96 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.179 162.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.467 ' N ' HG21 ' A' ' 30' ' ' THR . 25.4 m-85 -138.04 123.72 19.82 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.403 178.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.48 -43.54 99.18 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -167.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.426 ' HB3' ' HA ' ' A' ' 20' ' ' TYR . 0.9 OUTLIER -149.54 166.88 27.86 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 114.755 -0.723 . . . . 0.0 110.399 178.526 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -61.37 -28.46 69.25 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.522 -164.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.0 p -71.12 -39.43 72.03 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.366 -176.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -75.96 -24.0 55.41 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.42 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -61.37 -63.36 1.31 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.803 164.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.465 ' HB2' ' CD2' ' A' ' 11' ' ' TYR . 86.1 m -62.19 -32.82 73.51 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.538 -161.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.437 ' HB3' ' HB3' ' A' ' 12' ' ' PRO . 6.3 p30 -78.13 -22.17 49.23 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 114.607 -1.178 . . . . 0.0 110.172 -176.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.36 -26.07 67.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.247 164.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.1 t -80.44 -46.74 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.094 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.474 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.435 HG12 ' HB2' ' A' ' 11' ' ' TYR . 15.6 m -74.78 -35.44 36.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.174 -169.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.73 -32.47 71.75 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.348 167.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.412 ' CB ' ' HB ' ' A' ' 47' ' ' THR . 0.3 OUTLIER -68.24 -32.64 72.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.404 -173.492 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 69.57 50.96 0.49 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.437 176.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.87 24.34 55.7 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 176.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.412 ' HB ' ' CB ' ' A' ' 44' ' ' SER . 97.8 m -96.12 -87.84 0.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.378 -0.411 . . . . 0.0 110.169 169.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' A' ' 27' ' ' ASP . 1.0 OUTLIER -68.25 151.24 47.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.29 -161.917 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 31.9 p -151.34 -178.87 6.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.188 168.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.454 HD22 ' CE1' ' A' ' 53' ' ' PHE . 3.6 tp -79.55 140.84 37.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.158 -166.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.5 t -96.39 -35.02 11.33 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.451 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.465 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.6 p80 174.73 157.49 0.16 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.335 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.454 ' CE1' HD22 ' A' ' 50' ' ' LEU . 20.7 m-85 -91.37 141.32 28.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.345 173.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 113.11 40.67 1.04 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 166.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.44 ' HG2' ' HB2' ' A' ' 22' ' ' PRO . 0.2 OUTLIER 60.73 171.44 0.1 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.441 -0.88 . . . . 0.0 110.553 -174.757 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.462 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 1.8 t . . . . . 0 C--O 1.241 0.621 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.032 -157.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 7.0 tt . . . . . 0 N--CA 1.473 0.686 0 CA-C-O 121.149 0.5 . . . . 0.0 109.849 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -175.02 162.38 3.07 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.267 -170.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -143.7 106.61 4.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.245 168.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.432 HG21 ' CE1' ' A' ' 53' ' ' PHE . 7.3 p -120.19 94.68 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.459 169.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.5 p -123.17 174.84 7.0 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.349 -173.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.467 HG23 ' CZ ' ' A' ' 53' ' ' PHE . 9.0 t -129.44 140.32 49.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.848 -172.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.83 90.53 3.17 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.736 -156.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.469 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 66.4 m -138.58 39.41 2.22 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.089 -158.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.4 t -90.81 61.51 4.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.213 169.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.38 -23.75 0.01 OUTLIER 'General case' 0 C--O 1.235 0.315 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.794 -175.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.495 ' HB3' ' HA ' ' A' ' 12' ' ' PRO . 41.2 m-85 -59.25 161.43 9.87 Favored Pre-proline 0 C--O 1.239 0.543 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.541 167.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.495 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 35.0 Cg_endo -77.93 150.16 88.94 Favored 'Cis proline' 0 CA--C 1.517 -0.339 0 C-N-CA 122.779 -1.759 . . . . 0.0 109.304 1.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.471 ' HG2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -109.65 152.12 42.65 Favored Pre-proline 0 C--O 1.237 0.411 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.225 -179.628 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 11.7 Cg_endo -76.29 -21.53 13.44 Favored 'Trans proline' 0 CA--C 1.514 -0.511 0 C-N-CA 122.647 2.231 . . . . 0.0 110.721 -172.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -121.4 118.13 28.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.267 -166.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.9 m -97.41 -176.05 3.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.982 165.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.6 t -125.43 35.81 4.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.175 169.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.8 tt . . . . . 0 C--O 1.24 0.581 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.306 -168.819 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 . . . . . 0 N--CA 1.475 0.78 0 CA-C-O 121.076 0.465 . . . . 0.0 109.783 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.497 ' CD1' ' N ' ' A' ' 21' ' ' ARG . 27.9 t80 -61.79 154.2 26.43 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.157 174.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.497 ' N ' ' CD1' ' A' ' 20' ' ' TYR . 6.2 ptp180 176.72 154.98 0.42 Allowed Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.671 154.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.419 ' HB2' ' CG ' ' A' ' 55' ' ' LYS . 61.6 Cg_endo -90.55 100.45 0.27 Allowed 'Trans proline' 0 C--O 1.237 0.43 0 C-N-CA 123.776 2.984 . . . . 0.0 109.278 -162.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.67 178.61 4.31 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 121.971 -0.455 . . . . 0.0 109.924 157.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 36.7 t -132.03 124.38 29.14 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 154.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.28 -165.49 1.89 Allowed Glycine 0 CA--C 1.529 0.968 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 173.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.8 t -98.26 39.13 1.26 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.591 0.71 . . . . 0.0 110.387 165.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.417 ' HB3' HD11 ' A' ' 48' ' ' LEU . 31.4 p-10 -123.24 13.58 9.63 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.672 -171.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.3 m120 66.17 32.27 8.17 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.663 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.12 159.89 18.15 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 114.691 -1.141 . . . . 0.0 110.767 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 1.0 OUTLIER -71.71 165.28 24.34 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.347 178.247 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.468 ' CD2' ' HA ' ' A' ' 37' ' ' PHE . 62.1 m-85 -126.66 141.76 51.75 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.067 162.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.3 -85.82 0.31 Allowed Glycine 0 CA--C 1.525 0.658 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.551 177.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.424 ' ND2' ' HB2' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -78.0 158.0 29.43 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.932 -0.634 . . . . 0.0 109.755 -178.865 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -61.06 -27.68 68.52 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.859 172.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 25.6 p -90.12 -26.13 20.36 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.722 -169.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.424 ' HB2' ' ND2' ' A' ' 33' ' ' ASN . 0.9 OUTLIER -79.34 -24.91 42.43 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.326 168.855 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.468 ' HA ' ' CD2' ' A' ' 31' ' ' TYR . 30.4 t80 -62.18 -69.96 0.22 Allowed 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.628 164.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 96.6 m -67.77 -25.7 65.74 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.366 -164.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -65.08 -28.86 69.75 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.766 171.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.94 -33.22 61.92 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.425 174.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.418 HG23 ' CD2' ' A' ' 48' ' ' LEU . 97.2 t -62.98 -60.19 3.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.251 175.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.44 HG12 ' HB2' ' A' ' 11' ' ' TYR . 5.9 m -63.56 -34.08 65.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.19 -169.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -36.57 84.63 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.43 174.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.438 ' HB2' HG21 ' A' ' 47' ' ' THR . 20.5 p -71.99 -19.28 61.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.438 -174.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 69.69 30.36 3.91 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.378 177.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.64 44.65 4.83 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 167.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.45 HG21 ' N ' ' A' ' 48' ' ' LEU . 3.5 t -115.8 -37.55 3.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.281 -0.459 . . . . 0.0 110.51 171.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.45 ' N ' HG21 ' A' ' 47' ' ' THR . 1.4 tt -74.21 -82.61 0.06 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.507 -164.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.45 ' N ' HD22 ' A' ' 48' ' ' LEU . 0.2 OUTLIER 61.96 161.84 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.326 -179.769 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.463 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 3.3 tp -83.47 132.8 34.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.125 -165.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.2 t -78.23 -39.92 38.87 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 114.302 -1.317 . . . . 0.0 110.509 175.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.467 ' NE2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -176.57 174.51 1.86 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.137 176.671 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.467 ' CZ ' HG23 ' A' ' 6' ' ' VAL . 19.2 m-85 -98.39 71.6 2.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.078 163.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -142.56 -156.97 6.97 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 178.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.419 ' CG ' ' HB2' ' A' ' 22' ' ' PRO . 14.9 mtpp -119.17 40.61 3.28 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 114.931 -0.635 . . . . 0.0 109.942 -178.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.419 ' HB2' HG21 ' A' ' 30' ' ' THR . 2.0 t . . . . . 0 C--O 1.241 0.611 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.137 156.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.473 0.716 0 CA-C-O 121.054 0.454 . . . . 0.0 109.835 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -100.47 -82.9 0.45 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.313 -169.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 61.58 74.2 0.45 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.273 172.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.6 m -78.69 85.29 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.316 -165.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.428 ' HA ' HD21 ' A' ' 50' ' ' LEU . 1.9 t -132.36 -177.93 4.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.25 165.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.457 HG23 ' CZ ' ' A' ' 53' ' ' PHE . 8.7 t -145.62 134.76 17.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.247 -166.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -99.71 97.42 8.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.485 -174.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.503 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 58.6 m -125.8 31.08 5.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.922 -171.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.6 t -87.46 60.87 6.28 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.192 -176.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -173.81 -25.17 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.064 -1.426 . . . . 0.0 109.214 -172.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.528 ' HB3' ' HA ' ' A' ' 12' ' ' PRO . 63.1 m-85 -58.27 162.39 6.02 Favored Pre-proline 0 C--O 1.238 0.496 0 CA-C-N 113.948 -1.478 . . . . 0.0 110.636 163.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.528 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.3 Cg_endo -78.72 138.28 49.03 Favored 'Cis proline' 0 CA--C 1.516 -0.377 0 C-N-CA 122.838 -1.734 . . . . 0.0 109.239 1.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.457 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 1.3 mttp -88.13 170.4 11.57 Favored Pre-proline 0 C--O 1.24 0.596 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.986 172.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 13' ' ' LYS 0.253 11.5 Cg_endo -91.7 -18.84 0.86 Allowed 'Trans proline' 0 CA--C 1.512 -0.599 0 C-N-CA 122.595 2.196 . . . . 0.0 110.768 173.373 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.51 -170.45 0.52 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.001 0.429 . . . . 0.0 110.295 -172.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 61.2 m 64.46 139.65 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.492 174.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 t -172.12 23.77 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.369 -169.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.241 0.623 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.335 178.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' A' ' 21' ' ' ARG . 10.2 t80 -78.93 147.67 32.94 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.055 -165.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.481 ' N ' ' CD1' ' A' ' 20' ' ' TYR . 0.0 OUTLIER 177.73 134.86 0.22 Allowed Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.535 155.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 21' ' ' ARG . 55.3 Cg_endo -83.45 127.74 4.53 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 123.684 2.922 . . . . 0.0 109.457 -160.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.423 HD21 ' HA ' ' A' ' 53' ' ' PHE . 0.2 OUTLIER -111.43 -170.12 1.59 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.903 160.304 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.458 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 17.4 t -124.16 145.32 49.38 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.643 158.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -78.97 176.13 54.82 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 166.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -98.09 43.73 1.06 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.357 -0.422 . . . . 0.0 110.319 164.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.428 ' HB3' HD11 ' A' ' 48' ' ' LEU . 26.8 p-10 -129.96 12.45 5.69 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.701 178.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 69.68 34.05 2.8 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.581 -177.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -137.53 127.12 25.16 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.273 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.458 HG21 ' N ' ' A' ' 31' ' ' TYR . 57.8 m -66.73 155.51 37.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.245 163.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.458 ' N ' HG21 ' A' ' 30' ' ' THR . 8.1 m-85 -135.31 128.69 32.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.439 -172.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.17 -49.34 79.11 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 -165.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -126.17 -169.4 2.01 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.269 -0.465 . . . . 0.0 109.825 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.9 tptp -68.21 -33.35 74.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.277 160.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.3 m -81.75 -21.11 38.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.223 -168.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -89.65 -25.37 21.29 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.313 174.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.42 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 49.1 t80 -61.28 -66.4 0.54 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.109 166.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.503 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 72.9 m -61.12 -33.68 73.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.516 -164.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -71.43 -30.37 65.98 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.106 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.444 ' CB ' ' CZ ' ' A' ' 31' ' ' TYR . . . -61.54 -33.58 74.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.333 168.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.413 ' CG2' HD21 ' A' ' 48' ' ' LEU . 66.7 t -76.37 -52.76 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.515 -172.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.43 HG22 ' HG3' ' A' ' 12' ' ' PRO . 10.5 m -62.14 -29.22 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.205 -178.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.3 -39.42 74.84 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 113.804 -1.544 . . . . 0.0 110.499 173.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.2 p -61.98 -16.6 52.62 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.5 -175.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 67.86 35.31 3.91 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.393 176.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.62 80.67 0.66 Allowed Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 173.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.456 HG21 ' N ' ' A' ' 48' ' ' LEU . 5.9 t -171.47 -39.89 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.973 -0.613 . . . . 0.0 110.566 -170.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.456 ' N ' HG21 ' A' ' 47' ' ' THR . 4.9 tt -75.82 -83.02 0.07 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.379 -168.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.44 ' N ' ' CD2' ' A' ' 48' ' ' LEU . 6.7 p 59.09 163.47 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.072 -178.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.47 ' HG ' ' N ' ' A' ' 51' ' ' SER . 2.9 tp -81.1 159.84 24.61 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.303 -159.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.47 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 41.3 t -113.07 -39.84 4.1 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 114.482 -1.236 . . . . 0.0 110.63 174.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.466 ' CE1' ' HA ' ' A' ' 56' ' ' CYS . 0.2 OUTLIER -175.92 160.49 2.34 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.327 -176.903 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.457 ' CZ ' HG23 ' A' ' 6' ' ' VAL . 29.8 m-85 -100.54 22.89 11.08 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.564 -165.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -119.07 -174.69 15.95 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 164.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.424 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -61.38 170.12 1.93 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.137 -0.531 . . . . 0.0 109.977 163.077 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.466 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 1.2 t . . . . . 0 N--CA 1.471 0.604 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.879 -155.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.474 0.748 0 CA-C-O 121.207 0.527 . . . . 0.0 109.812 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.07 169.23 7.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.229 170.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -108.09 74.4 0.94 Allowed 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.229 -173.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.5 p 59.05 27.13 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.339 -176.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.2 p -108.11 179.43 4.22 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.46 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.466 HG11 ' N ' ' A' ' 7' ' ' ASP . 97.2 t -139.3 145.47 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.054 -171.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.466 ' N ' HG11 ' A' ' 6' ' ' VAL . 1.2 m-20 -132.4 94.75 3.49 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.993 -156.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.477 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 61.1 m -133.43 35.23 3.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.195 -161.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.34 61.45 6.65 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.272 174.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.03 -24.81 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.159 -1.382 . . . . 0.0 109.356 -175.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.634 ' HB3' ' HA ' ' A' ' 12' ' ' PRO . 41.2 m-85 -57.92 160.66 8.02 Favored Pre-proline 0 C--O 1.237 0.413 0 CA-C-N 114.083 -1.417 . . . . 0.0 110.544 161.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.634 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 33.0 Cg_endo -88.17 165.22 42.38 Favored 'Cis proline' 0 CA--C 1.519 -0.264 0 C-N-CA 123.185 -1.59 . . . . 0.0 109.364 9.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -136.2 97.09 12.25 Favored Pre-proline 0 C--O 1.237 0.4 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.266 -170.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -51.85 -20.84 10.57 Favored 'Trans proline' 0 C--N 1.36 1.149 0 C-N-CA 122.841 2.361 . . . . 0.0 110.871 175.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.02 88.03 2.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.359 165.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 81.3 m -113.61 -172.11 2.01 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.966 166.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.2 20.82 5.3 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.446 162.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.8 mt . . . . . 0 C--O 1.24 0.582 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.306 173.653 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.6 pm0 . . . . . 0 N--CA 1.474 0.73 0 CA-C-O 121.124 0.487 . . . . 0.0 109.754 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.457 ' CD1' ' HA ' ' A' ' 21' ' ' ARG . 10.6 t80 -91.76 144.42 25.52 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.161 171.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.477 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 1.1 ptm180 177.37 131.91 0.2 Allowed Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.531 154.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 21' ' ' ARG . 66.8 Cg_endo -85.48 139.21 6.71 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 123.684 2.923 . . . . 0.0 109.512 -159.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.2 -168.92 1.56 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.88 159.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.464 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 21.8 t -119.78 118.61 31.3 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.413 158.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.444 ' HA3' ' CE2' ' A' ' 31' ' ' TYR . . . -86.53 144.11 19.6 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 168.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.72 40.08 1.15 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.379 -0.41 . . . . 0.0 110.314 -164.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.413 ' HB3' ' CD1' ' A' ' 48' ' ' LEU . 22.1 p-10 -99.49 -45.71 5.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.013 167.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -175.03 -30.1 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.043 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -119.66 154.4 34.1 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.446 -155.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.457 HG21 ' N ' ' A' ' 31' ' ' TYR . 69.9 m -75.71 146.82 39.85 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.047 159.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.457 ' N ' HG21 ' A' ' 30' ' ' THR . 19.9 m-85 -114.66 127.35 55.72 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.445 -173.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.49 -47.29 91.48 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -167.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -137.64 171.77 13.95 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-O 121.416 0.627 . . . . 0.0 110.438 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.8 tttm -70.68 -27.44 64.02 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.531 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.5 t -73.45 -20.66 60.66 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.074 -0.967 . . . . 0.0 110.635 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -102.13 -22.12 14.28 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.833 -178.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -62.21 -60.04 4.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.952 164.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.477 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 72.1 m -60.19 -28.87 68.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.946 -173.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.42 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 2.2 m-80 -73.98 -31.27 62.91 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.215 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.33 -28.59 69.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.326 168.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.422 HG22 ' HA ' ' A' ' 38' ' ' CYS . 28.7 t -88.4 -46.66 15.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.525 -168.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.437 HG22 ' HG3' ' A' ' 12' ' ' PRO . 8.7 m -61.94 -35.36 67.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.346 174.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.11 -46.58 86.67 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.373 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.7 p -76.72 -10.12 59.16 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.847 -168.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.294 0.0 OUTLIER 75.29 27.52 1.08 Allowed 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.209 -1.36 . . . . 0.0 109.626 173.113 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.58 40.32 4.76 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 166.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 14.6 t -126.67 -37.47 2.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.981 0.42 . . . . 0.0 110.329 -171.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.417 ' CD2' HG21 ' A' ' 41' ' ' VAL . 1.3 tt -78.94 148.58 32.61 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.171 168.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.8 m -157.14 167.85 29.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.327 174.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.469 HD22 ' CE1' ' A' ' 53' ' ' PHE . 7.6 tp -74.65 130.95 40.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.157 -169.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.5 t -84.64 -37.28 21.25 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.535 174.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.464 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.6 p80 176.96 151.16 0.17 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.204 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.469 ' CE1' HD22 ' A' ' 50' ' ' LEU . 45.4 m-85 -78.16 166.1 23.16 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.318 177.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 62.71 -179.41 5.06 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.331 -1.107 . . . . 0.0 110.331 -162.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.57 -175.62 1.69 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 114.93 -0.635 . . . . 0.0 110.333 -174.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.453 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 3.0 t . . . . . 0 C--O 1.241 0.632 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.215 -155.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 16.9 tp . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.47 75.67 0.4 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.384 -171.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -116.62 25.24 10.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.233 -167.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.8 p -108.54 19.14 6.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.423 167.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.1 p -118.94 165.62 13.86 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.375 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.417 ' CG2' HD23 ' A' ' 50' ' ' LEU . 11.3 t -131.43 110.96 18.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.283 -166.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -72.35 123.58 23.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.44 166.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 60.7 m -138.51 41.9 2.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.126 175.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.1 59.17 3.49 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.295 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -173.27 -24.58 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 114.137 -1.392 . . . . 0.0 109.467 -174.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.531 ' HB3' ' HA ' ' A' ' 12' ' ' PRO . 42.6 m-85 -58.98 162.82 6.45 Favored Pre-proline 0 C--O 1.24 0.571 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.605 167.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.531 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 31.6 Cg_endo -77.74 141.69 67.98 Favored 'Cis proline' 0 CA--C 1.517 -0.331 0 C-N-CA 122.947 -1.689 . . . . 0.0 109.325 0.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.44 ' HD2' ' CD2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -73.0 172.78 7.1 Favored Pre-proline 0 N--CA 1.455 -0.213 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.163 -178.604 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -53.91 -62.88 0.26 Allowed 'Trans proline' 0 C--N 1.361 1.202 0 C-N-CA 122.754 2.303 . . . . 0.0 110.585 172.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -114.87 116.12 28.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.262 -165.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.2 m -120.06 77.25 1.23 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.46 168.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.4 m -153.25 128.52 9.82 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.391 175.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.432 HD21 ' HA ' ' A' ' 19' ' ' GLU . 0.3 OUTLIER . . . . . 0 C--O 1.24 0.592 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.234 -173.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.432 ' HA ' HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.474 0.771 0 CA-C-O 121.658 0.742 . . . . 0.0 109.758 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.408 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 37.4 t80 -83.06 -52.66 6.44 Favored 'General case' 0 C--O 1.248 1.023 0 CA-C-O 117.576 -1.202 . . . . 0.0 109.054 165.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.411 ' NH1' ' HG3' ' A' ' 19' ' ' GLU . 4.0 ptp85 -53.9 138.07 54.7 Favored Pre-proline 0 CA--C 1.537 0.454 0 O-C-N 120.456 -1.402 . . . . 0.0 110.967 -145.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.408 ' HG3' ' CE2' ' A' ' 20' ' ' TYR . 63.4 Cg_endo -101.88 167.34 0.31 Allowed 'Trans proline' 0 N--CA 1.476 0.444 0 C-N-CA 123.978 3.119 . . . . 0.0 109.405 -148.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.88 -162.27 1.22 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 158.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.412 ' HB2' ' CA ' ' A' ' 56' ' ' CYS . 19.9 t -130.18 146.53 51.82 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.478 157.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.04 -167.65 41.69 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.069 -1.213 . . . . 0.0 110.069 175.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.22 27.04 4.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.457 0.646 . . . . 0.0 110.42 166.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.435 ' HB3' HD11 ' A' ' 48' ' ' LEU . 54.5 p-10 -122.48 11.81 9.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.869 -167.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 68.55 34.48 3.56 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.629 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.1 mttp -141.16 138.88 33.73 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.323 -178.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.3 m -76.89 145.94 37.96 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.281 163.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.425 ' CZ ' ' HB1' ' A' ' 40' ' ' ALA . 3.2 m-85 -121.81 133.69 54.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.434 -175.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.8 -73.11 0.54 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -169.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.406 ' ND2' ' HB3' ' A' ' 35' ' ' CYS . 1.0 OUTLIER -110.13 165.29 11.86 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.256 0.551 . . . . 0.0 110.56 175.464 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -62.84 -15.9 56.31 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.457 172.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.406 ' HB3' ' ND2' ' A' ' 33' ' ' ASN . 2.4 t -80.9 -18.23 47.91 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.463 178.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -103.89 -21.73 13.6 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.656 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.463 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 52.3 t80 -61.47 -64.92 0.79 Allowed 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.779 162.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 81.0 m -59.9 -26.64 66.07 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.228 -172.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.412 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 2.2 m-80 -73.29 -29.97 63.08 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.135 177.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.426 ' HB2' HD23 ' A' ' 48' ' ' LEU . . . -61.87 -39.24 91.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.309 165.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.418 ' CG2' HD22 ' A' ' 48' ' ' LEU . 86.4 t -70.48 -48.79 57.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.476 -174.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.43 HG12 ' HB2' ' A' ' 11' ' ' TYR . 12.8 m -73.49 -34.98 44.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.154 -172.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -31.82 72.75 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.291 -1.322 . . . . 0.0 110.57 170.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.7 t -68.56 -27.95 66.53 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.298 -177.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.8 m120 61.77 16.89 8.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.498 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.43 92.08 2.13 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 176.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.461 HG21 ' N ' ' A' ' 48' ' ' LEU . 5.3 t -175.21 -33.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.362 -0.419 . . . . 0.0 110.171 163.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.461 ' N ' HG21 ' A' ' 47' ' ' THR . 1.0 OUTLIER -67.53 -81.03 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.473 -164.16 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.44 153.1 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.293 178.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.466 ' HG ' ' N ' ' A' ' 51' ' ' SER . 2.7 tp -81.59 158.63 24.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.324 -164.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.466 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 35.8 t -109.11 -46.09 3.65 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.602 177.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.488 ' N ' ' CD2' ' A' ' 52' ' ' HIS . 0.8 OUTLIER -165.99 -178.8 4.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.47 173.055 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.447 ' CE1' ' CD2' ' A' ' 50' ' ' LEU . 1.8 m-85 -112.44 106.87 15.46 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.271 167.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -170.93 -105.6 0.18 Allowed Glycine 0 CA--C 1.53 1.028 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 164.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.5 64.95 0.88 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 123.121 1.438 . . . . 0.0 110.16 156.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.412 ' CA ' ' HB2' ' A' ' 24' ' ' CYS . 1.1 t . . . . . 0 N--CA 1.47 0.538 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.194 159.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 43.3 tp . . . . . 0 N--CA 1.474 0.746 0 CA-C-O 121.164 0.506 . . . . 0.0 109.811 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.49 79.3 0.26 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.367 -170.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -168.69 75.9 0.11 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.27 -168.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.6 p -62.54 83.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.358 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.91 -177.08 5.25 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 114.832 -1.077 . . . . 0.0 110.328 -177.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.457 HG21 ' CZ ' ' A' ' 53' ' ' PHE . 11.3 t -135.04 120.28 29.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.283 -166.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -72.84 80.65 1.16 Allowed 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.407 177.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.514 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 60.8 m -103.02 42.22 1.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.217 174.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.2 59.34 3.03 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.231 -178.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -173.66 -24.6 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 114.074 -1.421 . . . . 0.0 109.239 -173.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.604 ' HB3' ' HA ' ' A' ' 12' ' ' PRO . 47.9 m-85 -58.05 160.3 9.04 Favored Pre-proline 0 C--O 1.237 0.409 0 CA-C-N 113.98 -1.464 . . . . 0.0 110.714 164.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.604 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 33.6 Cg_endo -83.06 139.96 38.51 Favored 'Cis proline' 0 C--O 1.235 0.334 0 C-N-CA 122.894 -1.711 . . . . 0.0 109.409 8.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 1.9 tttp -78.83 149.97 74.78 Favored Pre-proline 0 C--O 1.237 0.421 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.937 164.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 13.6 Cg_endo -78.33 -21.48 10.35 Favored 'Trans proline' 0 C--O 1.238 0.516 0 C-N-CA 122.714 2.276 . . . . 0.0 110.794 -170.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -129.54 123.64 31.91 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 122.093 -0.38 . . . . 0.0 110.268 -161.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 21.8 m -80.07 -170.68 2.58 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.927 159.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.7 t -145.51 25.2 1.36 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.569 165.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.3 tt . . . . . 0 C--O 1.241 0.624 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.496 -174.799 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.459 ' HG2' ' N ' ' A' ' 20' ' ' TYR . 4.1 tt0 . . . . . 0 N--CA 1.475 0.803 0 CA-C-O 121.114 0.483 . . . . 0.0 109.715 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.467 ' CD1' ' HA ' ' A' ' 21' ' ' ARG . 11.2 t80 -71.63 144.62 49.37 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.165 -175.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.467 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 0.0 OUTLIER 177.3 133.49 0.21 Allowed Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.359 155.179 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 21' ' ' ARG . 57.9 Cg_endo -83.14 134.23 6.85 Favored 'Trans proline' 0 CA--C 1.515 -0.434 0 C-N-CA 123.729 2.953 . . . . 0.0 109.549 -159.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.94 -170.12 1.69 Allowed 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.874 166.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 18.5 t -133.81 102.9 5.62 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.416 158.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.93 155.49 45.34 Favored Glycine 0 N--CA 1.467 0.722 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 164.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.0 p -96.25 41.38 1.11 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.144 -0.528 . . . . 0.0 110.33 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.42 ' HB3' HD11 ' A' ' 48' ' ' LEU . 32.1 p-10 -108.08 21.85 16.79 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.862 0.839 . . . . 0.0 109.994 164.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . 0.399 0.0 OUTLIER 90.79 -17.55 0.18 Allowed 'General case' 0 C--O 1.239 0.53 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.948 -173.232 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.7 mttm -100.94 135.71 41.94 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 122.179 -0.326 . . . . 0.0 110.417 -159.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 67.3 m -79.46 130.03 35.03 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.852 157.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -102.21 123.59 46.31 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.449 -168.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.59 -42.21 99.72 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -169.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.432 ' HB3' ' HA ' ' A' ' 20' ' ' TYR . 1.0 OUTLIER -156.64 161.85 39.87 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 114.918 -0.641 . . . . 0.0 110.231 -175.614 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.82 -29.18 69.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.737 -163.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.2 p -66.54 -31.35 72.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.312 -175.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -92.65 -25.72 18.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.505 -175.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.463 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 37.2 t80 -62.72 -71.65 0.15 Allowed 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.642 166.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.514 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 71.1 m -61.45 -32.56 72.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.44 -165.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -67.25 -23.57 65.71 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.019 177.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.419 ' CB ' HD23 ' A' ' 48' ' ' LEU . . . -82.38 -22.31 35.48 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 114.351 -1.295 . . . . 0.0 110.377 175.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.42 ' HA ' HD21 ' A' ' 48' ' ' LEU . 90.2 t -72.27 -59.01 3.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.519 171.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.419 HG22 ' HG3' ' A' ' 12' ' ' PRO . 22.6 m -61.92 -27.28 42.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.07 -170.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.32 -47.42 64.52 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 113.697 -1.592 . . . . 0.0 110.584 174.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.42 ' HB2' ' CG2' ' A' ' 47' ' ' THR . 1.1 p -62.11 -17.79 58.82 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.697 -177.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 24.8 m120 62.16 16.61 8.47 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.319 -176.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.99 68.24 0.83 Allowed Glycine 0 CA--C 1.527 0.798 0 CA-C-N 114.618 -1.173 . . . . 0.0 110.475 -173.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.447 HG21 ' N ' ' A' ' 48' ' ' LEU . 1.4 t -136.29 -36.28 0.73 Allowed 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.373 0.606 . . . . 0.0 110.684 161.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.447 ' N ' HG21 ' A' ' 47' ' ' THR . 0.2 OUTLIER -75.24 -92.42 0.02 OUTLIER 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.529 -178.52 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 17.3 p 52.3 176.75 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 121.513 -0.742 . . . . 0.0 112.594 -172.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.463 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 3.3 tp -91.4 123.03 34.51 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.287 -159.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.9 t -60.64 -61.96 2.21 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.317 162.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.475 ' N ' ' CD2' ' A' ' 52' ' ' HIS . 2.5 p80 -158.97 163.11 36.76 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.112 173.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.457 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 36.2 m-85 -77.66 176.03 9.35 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.333 169.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.48 173.4 3.31 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -164.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.436 ' HG2' ' HB2' ' A' ' 22' ' ' PRO . 7.7 mmmt -61.56 171.89 1.37 Allowed 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.261 -0.469 . . . . 0.0 110.208 169.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.464 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 1.5 t . . . . . 0 C--O 1.24 0.599 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.932 -158.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.2 tt . . . . . 0 N--CA 1.473 0.721 0 CA-C-O 121.515 0.674 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.88 153.43 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.56 -175.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 61.78 98.39 0.03 OUTLIER 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.395 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.444 HG23 ' CZ ' ' A' ' 53' ' ' PHE . 13.2 p -80.39 -20.19 11.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.325 -168.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.3 t -59.99 165.87 3.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.683 -160.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.465 HG12 ' NZ ' ' A' ' 34' ' ' LYS . 6.5 t -107.48 129.84 60.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.976 -159.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -107.58 107.85 18.87 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.537 170.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.492 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 35.2 m -111.71 47.1 1.06 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.436 -177.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.6 m -96.24 39.12 1.16 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 114.196 -1.365 . . . . 0.0 110.374 166.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -129.91 25.48 5.29 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.977 161.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.514 ' HB3' ' HA ' ' A' ' 12' ' ' PRO . 85.1 m-85 -126.63 166.87 19.42 Favored Pre-proline 0 C--O 1.236 0.386 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.704 -170.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.514 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.2 Cg_endo -72.42 138.88 57.18 Favored 'Cis proline' 0 CA--C 1.518 -0.319 0 C-N-CA 122.064 -2.057 . . . . 0.0 108.98 -7.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.47 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -80.7 -178.07 1.08 Allowed Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.264 176.887 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -53.29 -62.75 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.131 0 C-N-CA 122.702 2.268 . . . . 0.0 110.792 174.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -175.49 -163.64 0.12 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.427 -165.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 t -158.3 172.23 18.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.846 -166.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.4 p -98.26 25.62 6.06 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.486 176.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.24 0.566 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.329 167.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 N--CA 1.473 0.678 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.469 ' CD1' ' N ' ' A' ' 21' ' ' ARG . 10.9 t80 -76.85 147.05 37.34 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.211 -169.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.469 ' N ' ' CD1' ' A' ' 20' ' ' TYR . 0.0 OUTLIER 177.73 135.61 0.22 Allowed Pre-proline 0 CA--C 1.536 0.413 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.531 155.848 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.426 ' HB2' ' HB3' ' A' ' 55' ' ' LYS . 47.7 Cg_endo -84.09 143.93 10.49 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.775 2.983 . . . . 0.0 109.593 -158.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.12 -165.52 1.69 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.055 158.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.419 ' HB3' ' NE2' ' A' ' 52' ' ' HIS . 21.1 t -132.6 148.53 52.37 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.293 158.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -81.87 -169.63 43.2 Favored Glycine 0 CA--C 1.531 1.093 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 174.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.4 m -97.62 19.9 12.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.98 -0.61 . . . . 0.0 110.454 161.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.422 ' HB3' HD11 ' A' ' 48' ' ' LEU . 34.1 p-10 -107.14 9.23 30.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.147 -175.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.9 m120 67.91 38.61 2.78 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.587 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.91 137.6 34.95 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 114.583 -1.189 . . . . 0.0 110.342 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.6 m -72.48 147.65 45.84 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.24 162.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -122.74 125.04 44.73 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.394 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.34 -50.27 68.6 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -167.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.434 ' HB3' ' HA ' ' A' ' 20' ' ' TYR . 1.7 p30 -125.04 175.38 7.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.203 -0.498 . . . . 0.0 110.482 170.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.465 ' NZ ' HG12 ' A' ' 6' ' ' VAL . 4.8 tttp -69.23 -17.57 63.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.414 169.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 22.8 m -60.99 -51.61 68.52 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.545 172.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -80.4 -21.33 42.37 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.859 -171.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.462 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 57.7 t80 -61.29 -67.64 0.39 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.967 165.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.492 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 96.8 m -65.05 -29.85 70.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.638 -163.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -65.37 -33.78 76.76 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.02 173.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.35 -24.22 63.87 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.324 174.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.413 HG23 ' CD2' ' A' ' 48' ' ' LEU . 59.3 t -87.9 -55.18 6.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.387 -172.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.424 HG13 ' HB2' ' A' ' 11' ' ' TYR . 6.6 m -62.33 -23.09 31.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.149 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.13 -37.99 52.95 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 113.774 -1.557 . . . . 0.0 110.621 173.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.424 ' HB2' HG21 ' A' ' 47' ' ' THR . 14.1 p -62.28 -19.99 63.82 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.628 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 69.27 41.61 1.33 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.274 -171.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.68 88.12 0.03 OUTLIER Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 172.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.424 HG21 ' HB2' ' A' ' 44' ' ' SER . 6.1 t -176.4 -42.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.262 -0.469 . . . . 0.0 110.322 -167.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.468 HD22 ' N ' ' A' ' 49' ' ' THR . 1.0 OUTLIER -61.71 -73.93 0.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.367 172.25 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.468 ' N ' HD22 ' A' ' 48' ' ' LEU . 0.2 OUTLIER 66.89 160.31 0.15 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.431 175.621 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.469 HD22 ' CE1' ' A' ' 53' ' ' PHE . 5.6 tp -82.7 162.05 21.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.286 -168.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.455 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 16.2 t -112.95 -41.44 3.75 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.671 173.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.426 ' N ' ' CD2' ' A' ' 52' ' ' HIS . 0.2 OUTLIER -177.79 167.63 2.12 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.371 -173.332 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.469 ' CE1' HD22 ' A' ' 50' ' ' LEU . 2.2 m-85 -108.25 30.81 6.07 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.347 -177.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.67 -140.25 6.6 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 168.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 22' ' ' PRO . 1.2 pttm -131.82 63.84 1.61 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 123.2 1.476 . . . . 0.0 110.29 161.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.24 0.57 0 O-C-N 121.345 -0.847 . . . . 0.0 110.187 158.983 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.474 0.753 0 CA-C-O 121.29 0.567 . . . . 0.0 109.791 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.48 24.59 14.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.417 171.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -174.38 44.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.305 169.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.429 HG22 ' HA ' ' A' ' 52' ' ' HIS . 4.4 p -89.66 83.59 2.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.345 -178.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -159.5 146.84 16.96 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.448 169.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.429 HG12 ' HD2' ' A' ' 34' ' ' LYS . 4.9 t -145.91 111.77 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.998 -177.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -67.81 114.22 6.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.408 167.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 57.8 m -133.39 37.16 3.36 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.036 177.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.1 m -91.23 58.7 3.75 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.221 -175.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -173.31 -24.19 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 114.081 -1.418 . . . . 0.0 109.488 -174.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.526 ' HB3' ' HA ' ' A' ' 12' ' ' PRO . 74.3 m-85 -58.69 160.38 10.55 Favored Pre-proline 0 C--O 1.238 0.459 0 CA-C-N 113.987 -1.461 . . . . 0.0 110.617 166.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.526 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 31.9 Cg_endo -78.32 139.99 58.33 Favored 'Cis proline' 0 C--O 1.233 0.261 0 C-N-CA 122.771 -1.762 . . . . 0.0 109.369 3.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.438 ' HG3' ' HD3' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -70.02 159.13 85.47 Favored Pre-proline 0 C--O 1.24 0.575 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.834 164.249 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.438 ' HD3' ' HG3' ' A' ' 13' ' ' LYS . 30.5 Cg_endo -78.62 -64.24 0.02 OUTLIER 'Trans proline' 0 CA--C 1.519 -0.264 0 C-N-CA 122.885 2.39 . . . . 0.0 109.257 -175.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -135.38 130.73 35.37 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.242 -167.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.2 t -117.03 157.91 25.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.367 -168.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -112.51 130.03 56.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.424 -169.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.24 0.57 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.372 -170.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.721 0 CA-C-O 121.592 0.71 . . . . 0.0 109.841 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.5 ' CD2' ' N ' ' A' ' 21' ' ' ARG . 93.7 t80 -61.62 167.0 3.75 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.026 -177.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.5 ' N ' ' CD2' ' A' ' 20' ' ' TYR . 1.7 ptm180 178.52 172.28 0.44 Allowed Pre-proline 0 C--O 1.248 0.983 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.406 151.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.438 ' HB2' ' HG2' ' A' ' 55' ' ' LYS 0.253 82.6 Cg_endo -110.15 92.52 0.02 OUTLIER 'Trans proline' 0 CA--C 1.515 -0.435 0 C-N-CA 122.252 1.968 . . . . 0.0 109.232 -178.7 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.443 ' CD2' ' CD2' ' A' ' 53' ' ' PHE . 0.2 OUTLIER -90.15 -171.22 3.04 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.855 162.439 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.432 ' HB3' ' NE2' ' A' ' 52' ' ' HIS . 21.6 t -146.06 135.93 23.45 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.221 156.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.27 -171.75 41.56 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 114.387 -1.278 . . . . 0.0 110.316 -177.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.25 26.62 5.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.42 0.629 . . . . 0.0 110.479 170.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.421 ' HB3' HD11 ' A' ' 48' ' ' LEU . 24.9 p-10 -126.9 13.09 7.33 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.827 -166.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.5 m120 69.24 32.51 3.58 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.289 -0.868 . . . . 0.0 110.59 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.73 137.9 38.78 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.285 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.441 HG22 ' HB2' ' A' ' 56' ' ' CYS . 1.3 m -77.73 148.95 34.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.337 164.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -121.55 129.99 53.23 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.455 -176.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.55 -93.01 0.01 OUTLIER Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 168.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.0 p-10 -99.9 157.6 16.41 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.998 -0.601 . . . . 0.0 110.577 -168.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.429 ' HD2' HG12 ' A' ' 6' ' ' VAL . 1.3 ttpt -61.59 -15.53 39.89 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.569 -178.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.1 m -66.13 -45.44 81.06 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.471 173.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -89.59 -23.33 21.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.373 -168.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.458 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 36.2 t80 -61.84 -69.11 0.26 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.877 162.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 85.2 m -61.79 -30.92 71.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.574 -168.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.415 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 90.0 m-20 -67.07 -31.44 71.95 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.942 175.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.17 -17.24 62.55 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.372 174.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.43 HG23 HD21 ' A' ' 48' ' ' LEU . 43.7 t -85.8 -52.5 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.501 177.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.429 HG12 ' HB2' ' A' ' 11' ' ' TYR . 4.4 m -70.1 -32.99 53.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.245 -170.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -70.51 -29.81 66.42 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.498 170.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.44 ' HB3' ' HB ' ' A' ' 47' ' ' THR . 0.5 OUTLIER -61.66 -30.61 70.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.548 175.937 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 70.22 51.93 0.38 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.301 -166.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.69 21.93 55.95 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.192 176.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.44 ' HB ' ' HB3' ' A' ' 44' ' ' SER . 40.5 m -66.9 -86.82 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 157.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.43 HD21 HG23 ' A' ' 41' ' ' VAL . 1.0 OUTLIER -61.3 148.66 40.49 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.302 -163.333 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 77.0 p -138.89 -172.43 3.32 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.921 165.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.458 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 5.8 tp -86.8 133.19 33.67 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.369 -173.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.6 t -82.82 -37.04 24.98 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 113.921 -1.49 . . . . 0.0 110.597 173.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.432 ' NE2' ' HB3' ' A' ' 24' ' ' CYS . 0.7 OUTLIER 173.47 162.66 0.15 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.334 -178.676 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.448 ' CE1' ' CD2' ' A' ' 50' ' ' LEU . 1.3 m-85 -98.78 74.9 2.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.894 160.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -152.39 21.79 0.84 Allowed Glycine 0 CA--C 1.523 0.57 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.811 -172.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.438 ' HG2' ' HB2' ' A' ' 22' ' ' PRO . 9.1 mttp 61.27 35.25 18.27 Favored 'General case' 0 C--O 1.239 0.506 0 O-C-N 122.753 -0.263 . . . . 0.0 110.307 164.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.441 ' HB2' HG22 ' A' ' 30' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.474 0.734 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.734 156.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.474 0.763 0 CA-C-O 121.181 0.515 . . . . 0.0 109.881 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.85 142.96 48.17 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.274 170.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -174.9 102.02 0.09 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.295 -176.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.3 p -74.35 97.53 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.279 166.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.7 p -164.72 -177.11 4.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.261 -167.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -136.79 -175.58 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.282 -167.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -153.94 65.86 0.72 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.342 -168.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.532 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 59.4 m -99.83 32.78 2.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.973 -174.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.72 60.5 5.59 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.196 -176.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -173.71 -24.98 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.326 -172.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.55 ' HB3' ' HA ' ' A' ' 12' ' ' PRO . 79.1 m-85 -58.33 160.29 9.82 Favored Pre-proline 0 C--O 1.236 0.374 0 CA-C-N 113.894 -1.503 . . . . 0.0 110.529 163.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.55 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 30.5 Cg_endo -78.69 135.83 38.53 Favored 'Cis proline' 0 CA--C 1.518 -0.277 0 C-N-CA 122.667 -1.806 . . . . 0.0 109.378 6.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.459 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.8 OUTLIER -67.91 162.1 61.74 Favored Pre-proline 0 C--O 1.238 0.459 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.065 179.205 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.419 ' CD ' ' HB3' ' A' ' 13' ' ' LYS . 30.3 Cg_endo -76.13 -57.57 0.05 OUTLIER 'Trans proline' 0 CA--C 1.516 -0.376 0 C-N-CA 122.615 2.21 . . . . 0.0 109.328 -178.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -130.73 112.14 12.81 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.272 -177.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.6 m -62.49 -165.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.98 164.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.6 t -155.17 49.3 0.56 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.411 169.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.457 HD21 ' ND2' ' A' ' 33' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--O 1.241 0.627 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.367 169.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.475 0.799 0 CA-C-O 121.465 0.65 . . . . 0.0 109.808 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.486 ' CD1' ' N ' ' A' ' 21' ' ' ARG . 10.5 t80 -108.87 146.86 33.04 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.288 -177.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.486 ' N ' ' CD1' ' A' ' 20' ' ' TYR . 0.0 OUTLIER 177.44 135.14 0.21 Allowed Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.712 155.586 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.434 ' HB2' ' HG2' ' A' ' 55' ' ' LYS . 59.5 Cg_endo -86.11 139.14 6.08 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.539 2.826 . . . . 0.0 109.368 -161.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.88 -165.09 1.3 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.999 161.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.447 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 15.9 t -134.58 118.09 16.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.874 165.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.54 -173.9 2.03 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.7 t -98.81 30.78 3.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.724 0.773 . . . . 0.0 110.356 165.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.415 ' HB3' ' CD1' ' A' ' 48' ' ' LEU . 32.2 p-10 -123.84 13.71 9.24 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.473 -166.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 66.74 31.97 7.17 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.532 178.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.37 141.96 19.83 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.81 173.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.47 HG21 ' N ' ' A' ' 31' ' ' TYR . 94.0 m -65.82 148.53 51.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.261 165.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.47 ' N ' HG21 ' A' ' 30' ' ' THR . 30.8 m-85 -106.85 138.41 43.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.353 166.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.02 -53.58 41.65 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.457 ' ND2' HD21 ' A' ' 18' ' ' LEU . 5.0 p-10 -128.08 169.78 13.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.418 -0.391 . . . . 0.0 110.301 -173.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.38 -31.88 73.26 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.497 174.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.2 t -74.73 -21.84 59.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.573 -173.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -97.75 -22.75 16.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.66 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -61.59 -68.09 0.35 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.762 164.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.532 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 64.4 m -61.0 -32.69 72.27 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.538 -167.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -73.45 -25.0 60.3 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.209 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.31 -43.0 92.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.183 165.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.8 t -61.82 -51.97 66.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.54 -175.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.426 HG12 ' HB2' ' A' ' 11' ' ' TYR . 18.8 m -74.3 -34.07 36.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.1 -168.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.48 -29.51 70.18 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.442 169.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.5 t -80.75 -17.26 51.55 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.332 -172.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 53.3 t30 71.33 50.72 0.28 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.568 167.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.88 -21.2 47.3 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 164.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 46.0 m -62.02 -85.71 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.238 -0.481 . . . . 0.0 110.002 177.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.415 ' CD1' ' HB3' ' A' ' 27' ' ' ASP . 1.4 tt -59.98 148.19 36.2 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.495 -157.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.435 HG21 ' N ' ' A' ' 50' ' ' LEU . 0.9 OUTLIER -146.81 -163.21 1.7 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.619 167.108 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.467 HD22 ' CE1' ' A' ' 53' ' ' PHE . 6.6 tp -94.45 118.68 32.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.15 -169.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.8 t -61.62 -42.16 98.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.493 167.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.459 ' CE1' ' HA ' ' A' ' 56' ' ' CYS . 1.8 p80 173.73 158.1 0.13 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.182 178.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.467 ' CE1' HD22 ' A' ' 50' ' ' LEU . 5.2 m-85 -84.51 170.97 12.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.217 168.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.59 32.08 10.67 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 168.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.434 ' HG2' ' HB2' ' A' ' 22' ' ' PRO . 4.9 mttp 61.14 167.7 0.09 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 114.541 -0.829 . . . . 0.0 110.455 -174.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.459 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 2.2 t . . . . . 0 C--O 1.24 0.594 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.034 -160.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.848 0.356 . . . . 0.0 110.348 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.662 HG13 ' CZ ' ' A' ' 53' ' ' PHE . 0.6 OUTLIER -146.11 -175.18 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.206 -165.551 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -145.97 63.87 1.23 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.037 -155.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.458 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 76.6 m -117.11 42.49 2.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.279 -165.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.8 m -89.76 61.57 5.45 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.343 172.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -173.01 -24.44 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.349 -175.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.709 ' O ' HG11 ' A' ' 42' ' ' VAL . 29.2 m-85 -58.18 158.12 14.79 Favored Pre-proline 0 C--O 1.236 0.382 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.636 163.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.481 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.3 Cg_endo -86.67 154.46 48.3 Favored 'Cis proline' 0 C--O 1.232 0.22 0 C-N-CA 122.914 -1.702 . . . . 0.0 109.449 10.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.531 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.894 166.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 . . . . . 0 N--CA 1.473 0.699 0 CA-C-O 121.267 0.556 . . . . 0.0 109.882 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -87.67 -51.61 5.78 Favored 'General case' 0 C--O 1.251 1.145 0 CA-C-O 117.581 -1.2 . . . . 0.0 109.368 171.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.402 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.4 ptp180 -54.13 131.05 59.96 Favored Pre-proline 0 CA--C 1.54 0.583 0 O-C-N 120.427 -1.421 . . . . 0.0 110.768 -145.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.452 ' HG2' ' HG3' ' A' ' 55' ' ' LYS . 72.5 Cg_endo -93.67 166.71 2.21 Favored 'Trans proline' 0 CA--C 1.517 -0.347 0 C-N-CA 124.293 3.329 . . . . 0.0 109.526 -150.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.674 HD12 ' HB2' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -126.33 -170.7 2.24 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.939 164.185 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.656 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 17.8 t -131.1 119.62 22.22 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.612 157.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.1 174.5 7.35 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 172.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.07 40.57 1.17 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.009 -0.596 . . . . 0.0 110.471 167.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.428 ' HB3' HD12 ' A' ' 48' ' ' LEU . 37.8 p-10 -131.4 13.76 5.04 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.595 -177.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 69.73 33.64 2.89 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.62 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -139.12 132.44 30.01 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.532 178.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 23' ' ' LEU . 84.9 m -78.71 154.22 30.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.316 165.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -127.17 126.73 43.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.454 -170.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.01 -9.18 86.89 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.224 -169.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -159.57 176.22 12.3 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.099 -0.551 . . . . 0.0 110.498 171.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.5 mttp -61.65 -22.36 65.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.398 166.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 95.5 m -75.72 -43.91 44.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.359 -169.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -82.13 -22.81 35.99 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.866 178.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.674 ' HB2' HD12 ' A' ' 23' ' ' LEU . 29.8 t80 -61.86 -67.94 0.37 Allowed 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.028 167.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.571 ' O ' HG22 ' A' ' 42' ' ' VAL . 71.9 m -69.56 -25.35 63.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.271 -167.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.419 ' HA ' HG22 ' A' ' 42' ' ' VAL . 96.2 m-20 -65.93 -31.07 71.79 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.118 171.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -69.68 -36.2 75.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.491 172.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.799 HG22 HD23 ' A' ' 48' ' ' LEU . 84.7 t -65.89 -53.93 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.511 -179.006 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.709 HG11 ' O ' ' A' ' 11' ' ' TYR . 5.1 m -62.3 -35.27 68.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.121 -172.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.654 ' OE1' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -62.2 -37.16 84.25 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 114.125 -1.398 . . . . 0.0 110.419 171.077 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.666 ' HB2' HG22 ' A' ' 47' ' ' THR . 10.8 p -72.15 -24.4 61.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.41 -170.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 69.12 36.73 2.33 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.41 -172.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.67 94.28 0.01 OUTLIER Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -170.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.666 HG22 ' HB2' ' A' ' 44' ' ' SER . 6.1 t -169.99 -35.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.437 -0.381 . . . . 0.0 110.183 173.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.799 HD23 HG22 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -61.47 -83.19 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.314 166.731 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.478 HG22 ' H ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER 61.85 171.69 0.12 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.45 179.41 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.679 HD11 ' C ' ' A' ' 52' ' ' HIS . 8.2 tp -91.84 120.28 32.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.111 -166.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.8 t -64.21 -41.91 96.84 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.595 166.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.679 ' C ' HD11 ' A' ' 50' ' ' LEU . 0.6 OUTLIER 174.25 146.17 0.06 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.156 -178.164 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.662 ' CZ ' HG13 ' A' ' 6' ' ' VAL . 20.4 m-85 -67.88 170.1 8.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.2 171.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.87 170.49 8.07 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -164.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.452 ' HG3' ' HG2' ' A' ' 22' ' ' PRO . 4.2 mttm -62.47 176.31 0.65 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.339 -0.431 . . . . 0.0 110.246 170.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.576 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.8 OUTLIER . . . . . 0 N--CA 1.472 0.628 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.732 -158.317 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.7 p . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.795 0.331 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.679 ' CG2' HD22 ' A' ' 50' ' ' LEU . 98.3 t -151.49 127.08 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.29 -164.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -87.77 114.75 24.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.358 -172.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.617 ' SG ' HG12 ' A' ' 6' ' ' VAL . 57.1 m -138.85 35.5 2.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.958 -166.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.3 t -89.83 59.92 4.79 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.389 -176.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.43 -25.56 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.264 -175.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.491 ' O ' HG11 ' A' ' 42' ' ' VAL . 97.5 m-85 -60.17 160.47 16.75 Favored Pre-proline 0 C--O 1.238 0.474 0 CA-C-N 113.904 -1.498 . . . . 0.0 110.375 168.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.541 ' CG ' HG21 ' A' ' 42' ' ' VAL . 56.5 Cg_endo -79.12 147.3 79.82 Favored 'Cis proline' 0 C--O 1.233 0.273 0 C-N-CA 122.58 -1.842 . . . . 0.0 109.371 4.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.561 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.849 162.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 . . . . . 0 N--CA 1.475 0.816 0 CA-C-O 121.548 0.69 . . . . 0.0 109.809 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -93.09 -50.04 5.71 Favored 'General case' 0 C--O 1.249 1.07 0 CA-C-O 117.468 -1.253 . . . . 0.0 108.918 168.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.5 ptp85 -53.75 140.77 48.39 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 120.47 -1.393 . . . . 0.0 111.152 -144.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.453 ' HG2' ' HG2' ' A' ' 55' ' ' LYS . 60.4 Cg_endo -99.11 153.47 0.62 Allowed 'Trans proline' 0 N--CA 1.475 0.387 0 C-N-CA 124.133 3.222 . . . . 0.0 109.253 -150.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.59 HD22 HD13 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -119.46 -166.88 1.32 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.956 160.831 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.471 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 18.7 t -121.4 116.68 25.23 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.464 159.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.465 ' HA3' ' CE2' ' A' ' 31' ' ' TYR . . . -61.67 152.61 41.97 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 167.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.38 39.73 1.23 Allowed 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 115.196 -0.502 . . . . 0.0 110.403 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.72 ' HB3' HD12 ' A' ' 48' ' ' LEU . 13.7 p-10 -113.53 -48.73 2.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.362 174.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -176.34 -26.82 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.128 178.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.28 158.07 21.91 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.304 -156.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.685 HG21 ' HD2' ' A' ' 55' ' ' LYS . 60.1 m -77.03 133.29 39.16 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.901 157.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.565 ' HE2' HD11 ' A' ' 48' ' ' LEU . 18.1 m-85 -96.88 138.07 35.0 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.445 176.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.05 -69.76 1.22 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -177.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -131.92 167.32 19.82 Favored 'General case' 0 C--O 1.232 0.163 0 O-C-N 121.794 -0.827 . . . . 0.0 110.597 -178.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.98 -14.06 20.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.705 -169.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.8 m -72.35 -60.14 2.38 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.453 176.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -61.31 -25.6 67.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.798 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.455 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 53.5 t80 -62.12 -66.22 0.57 Allowed 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.872 170.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.546 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 96.7 m -66.21 -31.57 72.48 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.671 -160.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.54 ' HA ' HG22 ' A' ' 42' ' ' VAL . 5.1 p30 -72.16 -23.79 61.34 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.119 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.468 ' C ' HD22 ' A' ' 48' ' ' LEU . . . -69.33 -27.98 65.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.294 166.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.883 HG22 HD23 ' A' ' 48' ' ' LEU . 89.8 t -75.89 -45.62 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.578 -178.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.541 HG21 ' CG ' ' A' ' 12' ' ' PRO . 20.3 m -70.71 -35.32 60.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.084 -172.119 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.51 ' OE1' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -60.88 -33.8 73.66 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.335 168.413 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.55 ' OG ' HG22 ' A' ' 47' ' ' THR . 0.1 OUTLIER -70.98 -39.42 72.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.291 -169.41 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 69.09 24.16 6.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.223 -163.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.462 ' H ' ' HB3' ' A' ' 44' ' ' SER . . . 86.16 40.82 7.31 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 166.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.55 HG22 ' OG ' ' A' ' 44' ' ' SER . 6.1 t -100.88 -39.06 7.96 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.199 0.524 . . . . 0.0 110.268 165.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.883 HD23 HG22 ' A' ' 41' ' ' VAL . 0.3 OUTLIER -62.14 -86.99 0.01 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.408 -179.326 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.404 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER 67.17 164.13 0.2 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.488 174.234 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.761 HD21 ' CE1' ' A' ' 53' ' ' PHE . 5.0 tp -86.6 137.13 32.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.276 -168.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.7 t -92.4 -43.48 9.2 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.409 177.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.471 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.6 p80 -177.51 150.09 0.67 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.217 177.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.761 ' CE1' HD21 ' A' ' 50' ' ' LEU . 9.1 m-85 -76.78 157.17 31.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.303 175.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.6 166.29 23.47 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 -163.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.685 ' HD2' HG21 ' A' ' 30' ' ' THR . 4.4 mtmm -63.22 -179.0 0.28 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.419 -0.39 . . . . 0.0 110.267 177.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.453 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.8 OUTLIER . . . . . 0 N--CA 1.473 0.689 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.819 -155.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.507 ' O ' HG13 ' A' ' 6' ' ' VAL . 24.1 p . . . . . 0 C--O 1.233 0.2 0 CA-C-O 120.71 0.29 . . . . 0.0 110.33 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.519 HG21 ' CE2' ' A' ' 37' ' ' PHE . 0.4 OUTLIER -156.36 -176.01 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.25 -167.633 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -146.24 80.74 1.57 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.939 -156.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.445 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 62.4 m -125.49 48.03 2.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.22 -165.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.5 p -96.13 55.69 1.57 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.191 -175.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -173.2 -23.76 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.181 -1.372 . . . . 0.0 109.648 -174.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.533 ' O ' HG11 ' A' ' 42' ' ' VAL . 67.3 m-85 -59.83 161.63 11.4 Favored Pre-proline 0 C--O 1.239 0.52 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.505 170.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.409 ' CG ' HG21 ' A' ' 42' ' ' VAL . 35.9 Cg_endo -77.09 156.63 97.25 Favored 'Cis proline' 0 C--O 1.233 0.26 0 C-N-CA 122.676 -1.802 . . . . 0.0 109.14 -0.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.45 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 2.1 mtpm? . . . . . 0 C--O 1.234 0.263 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.135 -164.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 . . . . . 0 N--CA 1.474 0.733 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.462 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 31.5 t80 -63.19 -52.82 60.77 Favored 'General case' 0 C--O 1.247 0.943 0 CA-C-O 118.114 -0.946 . . . . 0.0 109.279 -166.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.459 ' HB3' ' NH1' ' A' ' 21' ' ' ARG . 2.0 ptp180 -54.4 142.75 49.24 Favored Pre-proline 0 CA--C 1.539 0.527 0 O-C-N 120.734 -1.229 . . . . 0.0 110.941 -146.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.462 ' HG3' ' CE2' ' A' ' 20' ' ' TYR 0.259 91.4 Cg_endo -119.47 -179.34 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 123.314 2.676 . . . . 0.0 108.907 -142.676 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.668 HD21 ' HZ3' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -142.2 -164.17 1.75 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.968 162.354 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.663 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 34.3 t -125.37 126.89 45.74 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 158.121 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.55 -171.95 48.52 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.3 p -97.74 34.43 1.87 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.001 -0.6 . . . . 0.0 110.312 163.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.406 ' HB3' ' CD1' ' A' ' 48' ' ' LEU . 24.2 p-10 -96.4 11.09 36.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.485 170.109 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.5 m120 62.76 42.95 7.57 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.594 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.69 168.51 9.01 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.846 173.192 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.5 m -67.53 138.13 56.29 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.997 164.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.482 ' HE2' HD11 ' A' ' 48' ' ' LEU . 3.8 m-85 -93.76 143.32 26.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.358 167.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.94 -56.48 22.31 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -174.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 39.6 p-10 -142.72 179.14 7.17 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 114.636 -0.782 . . . . 0.0 110.624 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.668 ' HZ3' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -61.71 -38.84 89.36 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.524 -178.553 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.6 m -70.99 -39.34 72.5 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.177 -169.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -74.32 -24.08 59.15 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.054 174.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.533 ' O ' HG23 ' A' ' 41' ' ' VAL . 73.2 t80 -62.21 -64.37 0.95 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.057 169.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.652 ' O ' HG13 ' A' ' 42' ' ' VAL . 74.1 m -60.25 -29.32 68.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.99 -171.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.705 ' HA ' HG22 ' A' ' 42' ' ' VAL . 31.6 m-20 -73.24 -31.38 64.08 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.173 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -61.67 -29.23 69.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.377 168.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 1.016 HG22 HD23 ' A' ' 48' ' ' LEU . 35.6 t -82.12 -42.58 18.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.524 -176.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.705 HG22 ' HA ' ' A' ' 39' ' ' ASN . 18.8 m -78.37 -34.29 18.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.209 -171.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.476 ' OE1' HG23 ' A' ' 42' ' ' VAL . 1.5 mp0 -64.09 -32.25 73.74 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.238 167.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.96 -21.79 63.82 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.734 -172.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.9 m120 69.17 25.53 5.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.131 -168.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.5 85.96 0.09 OUTLIER Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 -170.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.9 t -151.77 -36.67 0.12 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.083 0.468 . . . . 0.0 110.514 166.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.016 HD23 HG22 ' A' ' 41' ' ' VAL . 0.8 OUTLIER -79.87 160.27 26.12 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.584 175.832 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.441 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 2.7 t -174.18 164.19 3.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.991 -174.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.686 HD21 ' CE1' ' A' ' 53' ' ' PHE . 5.8 tp -76.29 129.02 36.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.131 -164.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.6 t -77.23 -42.24 38.08 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.454 171.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.663 ' CE1' ' HB3' ' A' ' 24' ' ' CYS . 1.7 p-80 -174.06 167.42 4.22 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.267 175.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.686 ' CE1' HD21 ' A' ' 50' ' ' LEU . 20.3 m-85 -94.72 89.23 5.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.248 168.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -155.96 -139.24 2.72 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.496 -1.041 . . . . 0.0 110.496 -175.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.431 ' HG2' ' HG2' ' A' ' 22' ' ' PRO . 6.8 mtpp -139.82 41.11 2.0 Allowed 'General case' 0 C--O 1.24 0.602 0 CA-C-N 115.26 -0.47 . . . . 0.0 109.874 170.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 C--O 1.241 0.647 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.022 161.915 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.3 p . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.844 0.354 . . . . 0.0 110.427 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.802 ' CG2' HD22 ' A' ' 50' ' ' LEU . 11.7 t -145.34 117.02 2.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.118 -164.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -73.27 117.74 15.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.466 169.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.516 ' SG ' HG12 ' A' ' 6' ' ' VAL . 59.8 m -138.08 44.38 2.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.115 177.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.66 58.56 3.12 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.373 -177.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -172.81 -24.33 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.539 -177.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.478 ' CD2' ' HB2' ' A' ' 38' ' ' CYS . 71.2 m-85 -60.69 159.73 23.66 Favored Pre-proline 0 C--O 1.236 0.345 0 CA-C-N 114.024 -1.443 . . . . 0.0 110.414 172.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.586 ' N ' HG21 ' A' ' 42' ' ' VAL . 56.2 Cg_endo -78.63 163.98 85.26 Favored 'Cis proline' 0 CA--C 1.519 -0.23 0 C-N-CA 122.511 -1.87 . . . . 0.0 109.337 5.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.258 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.736 -166.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.492 ' HG3' ' N ' ' A' ' 20' ' ' TYR . 2.2 tp10 . . . . . 0 N--CA 1.475 0.823 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.492 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 10.0 t80 -105.92 142.43 35.63 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.072 164.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.466 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 1.0 OUTLIER 177.36 133.77 0.21 Allowed Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.582 154.117 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 21' ' ' ARG . 71.9 Cg_endo -88.25 139.52 4.35 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.53 2.82 . . . . 0.0 109.413 -160.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.682 HD23 ' CD2' ' A' ' 53' ' ' PHE . 0.2 OUTLIER -121.92 -163.84 1.1 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.884 160.051 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.584 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 17.5 t -127.24 142.94 51.35 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.702 159.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -78.08 179.38 51.62 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 169.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 60.0 p -98.28 26.59 5.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.434 0.635 . . . . 0.0 110.404 169.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.743 ' HB3' HD12 ' A' ' 48' ' ' LEU . 42.4 p-10 -123.1 13.49 9.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.615 -168.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 69.66 32.35 3.33 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.519 -176.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.1 mtpt -141.51 127.7 19.71 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.205 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.416 HG22 ' N ' ' A' ' 31' ' ' TYR . 84.5 m -62.03 163.39 7.96 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.179 162.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.416 ' N ' HG22 ' A' ' 30' ' ' THR . 25.4 m-85 -138.04 123.72 19.82 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.403 178.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.48 -43.54 99.18 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -167.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.408 ' HB3' ' HA ' ' A' ' 20' ' ' TYR . 0.9 OUTLIER -149.54 166.88 27.86 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 114.755 -0.723 . . . . 0.0 110.399 178.526 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -61.37 -28.46 69.25 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.522 -164.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.0 p -71.12 -39.43 72.03 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.366 -176.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 -75.96 -24.0 55.41 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.42 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.433 ' O ' HG23 ' A' ' 41' ' ' VAL . 57.4 t80 -61.37 -63.36 1.31 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.803 164.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.665 ' O ' HG13 ' A' ' 42' ' ' VAL . 86.1 m -62.19 -32.82 73.51 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.538 -161.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.789 ' HA ' HG22 ' A' ' 42' ' ' VAL . 6.3 p30 -78.13 -22.17 49.23 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 114.607 -1.178 . . . . 0.0 110.172 -176.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -66.36 -26.07 67.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.247 164.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.834 HG22 ' CD2' ' A' ' 48' ' ' LEU . 62.1 t -80.44 -46.74 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.094 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.474 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.789 HG22 ' HA ' ' A' ' 39' ' ' ASN . 15.6 m -74.78 -35.44 36.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.174 -169.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.444 ' OE1' HG23 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -60.73 -32.47 71.75 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.348 167.024 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.24 -32.64 72.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.404 -173.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 69.57 50.96 0.49 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.437 176.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.87 24.34 55.7 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 176.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 97.8 m -96.12 -87.84 0.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.378 -0.411 . . . . 0.0 110.169 169.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.834 ' CD2' HG22 ' A' ' 41' ' ' VAL . 1.0 OUTLIER -68.25 151.24 47.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.29 -161.917 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 31.9 p -151.34 -178.87 6.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.188 168.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.802 HD22 ' CG2' ' A' ' 6' ' ' VAL . 3.6 tp -79.55 140.84 37.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.158 -166.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.5 t -96.39 -35.02 11.33 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.451 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.584 ' CE1' ' HB3' ' A' ' 24' ' ' CYS . 1.0 OUTLIER 174.73 157.49 0.16 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.335 178.649 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.774 ' CE1' HD21 ' A' ' 50' ' ' LEU . 20.7 m-85 -91.37 141.32 28.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.345 173.003 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 113.11 40.67 1.04 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 166.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.419 ' CE ' ' HB2' ' A' ' 22' ' ' PRO . 0.2 OUTLIER 60.73 171.44 0.1 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.441 -0.88 . . . . 0.0 110.553 -174.757 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.523 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 1.8 t . . . . . 0 C--O 1.241 0.621 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.032 -157.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.5 p . . . . . 0 C--O 1.233 0.188 0 CA-C-O 120.84 0.352 . . . . 0.0 110.349 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.726 ' CG2' HD22 ' A' ' 50' ' ' LEU . 9.0 t -129.44 140.32 49.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.848 -172.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.83 90.53 3.17 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.736 -156.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.536 ' SG ' HG12 ' A' ' 6' ' ' VAL . 66.4 m -138.58 39.41 2.22 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.089 -158.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.4 t -90.81 61.51 4.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.213 169.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.38 -23.75 0.01 OUTLIER 'General case' 0 C--O 1.235 0.315 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.794 -175.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.532 ' O ' HG11 ' A' ' 42' ' ' VAL . 41.2 m-85 -59.25 161.43 9.87 Favored Pre-proline 0 C--O 1.239 0.543 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.541 167.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.41 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 35.0 Cg_endo -77.93 150.16 88.94 Favored 'Cis proline' 0 CA--C 1.517 -0.339 0 C-N-CA 122.779 -1.759 . . . . 0.0 109.304 1.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.476 ' HG2' ' CD2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.237 0.411 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.225 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 . . . . . 0 N--CA 1.475 0.78 0 CA-C-O 121.076 0.465 . . . . 0.0 109.783 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.497 ' CD1' ' N ' ' A' ' 21' ' ' ARG . 27.9 t80 -61.79 154.2 26.43 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.157 174.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.497 ' N ' ' CD1' ' A' ' 20' ' ' TYR . 6.2 ptp180 176.72 154.98 0.42 Allowed Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.671 154.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.454 ' HB2' ' HG3' ' A' ' 55' ' ' LYS . 61.6 Cg_endo -90.55 100.45 0.27 Allowed 'Trans proline' 0 C--O 1.237 0.43 0 C-N-CA 123.776 2.984 . . . . 0.0 109.278 -162.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.582 ' O ' HG22 ' A' ' 30' ' ' THR . 0.1 OUTLIER -110.67 178.61 4.31 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 121.971 -0.455 . . . . 0.0 109.924 157.089 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.669 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 36.7 t -132.03 124.38 29.14 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 154.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.28 -165.49 1.89 Allowed Glycine 0 CA--C 1.529 0.968 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 173.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.8 t -98.26 39.13 1.26 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.591 0.71 . . . . 0.0 110.387 165.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.696 ' HB3' HD12 ' A' ' 48' ' ' LEU . 31.4 p-10 -123.24 13.58 9.63 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.672 -171.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 66.17 32.27 8.17 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.663 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.12 159.89 18.15 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 114.691 -1.141 . . . . 0.0 110.767 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.582 HG22 ' O ' ' A' ' 23' ' ' LEU . 1.0 OUTLIER -71.71 165.28 24.34 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.347 178.247 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.5 ' O ' HD12 ' A' ' 23' ' ' LEU . 62.1 m-85 -126.66 141.76 51.75 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.067 162.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.3 -85.82 0.31 Allowed Glycine 0 CA--C 1.525 0.658 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.551 177.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.412 ' ND2' ' HB2' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -78.0 158.0 29.43 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.932 -0.634 . . . . 0.0 109.755 -178.865 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.538 ' HD2' HG13 ' A' ' 6' ' ' VAL . 6.6 ttpm? -61.06 -27.68 68.52 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.859 172.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 25.6 p -90.12 -26.13 20.36 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.722 -169.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.412 ' HB2' ' ND2' ' A' ' 33' ' ' ASN . 1.3 m120 -79.34 -24.91 42.43 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.326 168.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.623 ' CE1' HD21 ' A' ' 48' ' ' LEU . 30.4 t80 -62.18 -69.96 0.22 Allowed 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.628 164.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.592 ' O ' HG22 ' A' ' 42' ' ' VAL . 96.6 m -67.77 -25.7 65.74 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.366 -164.059 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -65.08 -28.86 69.75 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.766 171.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.525 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -74.94 -33.22 61.92 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.425 174.033 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.665 HG22 ' CD2' ' A' ' 48' ' ' LEU . 97.2 t -62.98 -60.19 3.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.251 175.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.748 HG23 ' OE1' ' A' ' 43' ' ' GLU . 5.9 m -63.56 -34.08 65.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.19 -169.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.748 ' OE1' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -64.5 -36.57 84.63 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.43 174.893 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.723 ' HB2' HG22 ' A' ' 47' ' ' THR . 20.5 p -71.99 -19.28 61.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.438 -174.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 69.69 30.36 3.91 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.378 177.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.64 44.65 4.83 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 167.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.723 HG22 ' HB2' ' A' ' 44' ' ' SER . 3.5 t -115.8 -37.55 3.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.281 -0.459 . . . . 0.0 110.51 171.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.696 HD12 ' HB3' ' A' ' 27' ' ' ASP . 1.4 tt -74.21 -82.61 0.06 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.507 -164.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.684 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.2 OUTLIER 61.96 161.84 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.326 -179.769 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.726 HD22 ' CG2' ' A' ' 6' ' ' VAL . 3.3 tp -83.47 132.8 34.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.125 -165.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.2 t -78.23 -39.92 38.87 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 114.302 -1.317 . . . . 0.0 110.509 175.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.669 ' CE1' ' HB3' ' A' ' 24' ' ' CYS . 2.0 p-80 -176.57 174.51 1.86 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.137 176.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.659 ' CZ ' HG22 ' A' ' 6' ' ' VAL . 19.2 m-85 -98.39 71.6 2.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.078 163.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -142.56 -156.97 6.97 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 178.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.454 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 14.9 mtpp -119.17 40.61 3.28 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 114.931 -0.635 . . . . 0.0 109.942 -178.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.49 ' HB2' HG23 ' A' ' 30' ' ' THR . 2.0 t . . . . . 0 C--O 1.241 0.611 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.137 156.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 C--O 1.233 0.204 0 CA-C-O 120.712 0.292 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.816 ' CG2' HD22 ' A' ' 50' ' ' LEU . 8.7 t -145.62 134.76 17.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.247 -166.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -99.71 97.42 8.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.485 -174.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.504 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 58.6 m -125.8 31.08 5.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.922 -171.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.6 t -87.46 60.87 6.28 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.192 -176.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -173.81 -25.17 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.064 -1.426 . . . . 0.0 109.214 -172.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.689 ' O ' HG11 ' A' ' 42' ' ' VAL . 63.1 m-85 -58.27 162.39 6.02 Favored Pre-proline 0 C--O 1.238 0.496 0 CA-C-N 113.948 -1.478 . . . . 0.0 110.636 163.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.44 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.3 Cg_endo -78.72 138.28 49.03 Favored 'Cis proline' 0 CA--C 1.516 -0.377 0 C-N-CA 122.838 -1.734 . . . . 0.0 109.239 1.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.3 mttp . . . . . 0 C--O 1.24 0.596 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.986 172.939 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' A' ' 21' ' ' ARG . 10.2 t80 -78.93 147.67 32.94 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.055 -165.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.481 ' N ' ' CD1' ' A' ' 20' ' ' TYR . 0.0 OUTLIER 177.73 134.86 0.22 Allowed Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.535 155.915 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.455 ' HB2' ' HG3' ' A' ' 55' ' ' LYS . 55.3 Cg_endo -83.45 127.74 4.53 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 123.684 2.922 . . . . 0.0 109.457 -160.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.422 HD23 ' CD2' ' A' ' 53' ' ' PHE . 0.2 OUTLIER -111.43 -170.12 1.59 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.903 160.304 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.634 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 17.4 t -124.16 145.32 49.38 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.643 158.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -78.97 176.13 54.82 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 166.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -98.09 43.73 1.06 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.357 -0.422 . . . . 0.0 110.319 164.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.523 ' HB3' HD12 ' A' ' 48' ' ' LEU . 26.8 p-10 -129.96 12.45 5.69 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.701 178.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.7 m120 69.68 34.05 2.8 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.581 -177.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -137.53 127.12 25.16 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.273 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 57.8 m -66.73 155.51 37.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.245 163.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.502 ' OH ' ' HB1' ' A' ' 40' ' ' ALA . 8.1 m-85 -135.31 128.69 32.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.439 -172.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.17 -49.34 79.11 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 -165.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.4 ' HB2' ' H ' ' A' ' 35' ' ' CYS . 0.1 OUTLIER -126.17 -169.4 2.01 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.269 -0.465 . . . . 0.0 109.825 -179.019 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.9 tptp -68.21 -33.35 74.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.277 160.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.4 ' H ' ' HB2' ' A' ' 33' ' ' ASN . 15.3 m -81.75 -21.11 38.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.223 -168.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -89.65 -25.37 21.29 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.313 174.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.619 ' O ' HG23 ' A' ' 41' ' ' VAL . 49.1 t80 -61.28 -66.4 0.54 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.109 166.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.504 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 72.9 m -61.12 -33.68 73.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.516 -164.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.458 ' HA ' HG22 ' A' ' 42' ' ' VAL . 79.4 m-20 -71.43 -30.37 65.98 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.106 179.008 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -61.54 -33.58 74.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.333 168.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.919 HG22 HD22 ' A' ' 48' ' ' LEU . 66.7 t -76.37 -52.76 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.515 -172.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.772 HG23 ' OE1' ' A' ' 43' ' ' GLU . 10.5 m -62.14 -29.22 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.205 -178.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.772 ' OE1' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -70.3 -39.42 74.84 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 113.804 -1.544 . . . . 0.0 110.499 173.267 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.2 p -61.98 -16.6 52.62 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.5 -175.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 67.86 35.31 3.91 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.393 176.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.62 80.67 0.66 Allowed Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 173.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.9 t -171.47 -39.89 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.973 -0.613 . . . . 0.0 110.566 -170.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.919 HD22 HG22 ' A' ' 41' ' ' VAL . 4.9 tt -75.82 -83.02 0.07 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.379 -168.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.846 ' N ' HD23 ' A' ' 48' ' ' LEU . 6.7 p 59.09 163.47 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.072 -178.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.816 HD22 ' CG2' ' A' ' 6' ' ' VAL . 2.9 tp -81.1 159.84 24.61 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.303 -159.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.481 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 41.3 t -113.07 -39.84 4.1 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 114.482 -1.236 . . . . 0.0 110.63 174.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.634 ' CE1' ' HB3' ' A' ' 24' ' ' CYS . 1.9 p-80 -175.92 160.49 2.34 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.327 -176.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.546 ' CD1' HD21 ' A' ' 50' ' ' LEU . 29.8 m-85 -100.54 22.89 11.08 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.564 -165.264 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -119.07 -174.69 15.95 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 164.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.455 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -61.38 170.12 1.93 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.137 -0.531 . . . . 0.0 109.977 163.077 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.495 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 1.2 t . . . . . 0 N--CA 1.471 0.604 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.879 -155.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.454 -0.258 0 CA-C-O 120.643 0.259 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.802 ' CG2' HD22 ' A' ' 50' ' ' LEU . 97.2 t -139.3 145.47 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.054 -171.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -132.4 94.75 3.49 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.993 -156.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.494 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 61.1 m -133.43 35.23 3.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.195 -161.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.34 61.45 6.65 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.272 174.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.03 -24.81 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.159 -1.382 . . . . 0.0 109.356 -175.097 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.659 ' C ' HG11 ' A' ' 42' ' ' VAL . 41.2 m-85 -57.92 160.66 8.02 Favored Pre-proline 0 C--O 1.237 0.413 0 CA-C-N 114.083 -1.417 . . . . 0.0 110.544 161.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.699 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.0 Cg_endo -88.17 165.22 42.38 Favored 'Cis proline' 0 CA--C 1.519 -0.264 0 C-N-CA 123.185 -1.59 . . . . 0.0 109.364 9.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.2 mttt . . . . . 0 C--O 1.237 0.4 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.266 -170.857 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.6 pm0 . . . . . 0 N--CA 1.474 0.73 0 CA-C-O 121.124 0.487 . . . . 0.0 109.754 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.463 ' CD1' ' HA ' ' A' ' 21' ' ' ARG . 10.6 t80 -91.76 144.42 25.52 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.161 171.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.463 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 1.1 ptm180 177.37 131.91 0.2 Allowed Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.531 154.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 21' ' ' ARG . 66.8 Cg_endo -85.48 139.21 6.71 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 123.684 2.923 . . . . 0.0 109.512 -159.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.793 ' O ' HG23 ' A' ' 30' ' ' THR . 0.2 OUTLIER -117.2 -168.92 1.56 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.88 159.485 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.552 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 21.8 t -119.78 118.61 31.3 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.413 158.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.434 ' HA3' ' CE2' ' A' ' 31' ' ' TYR . . . -86.53 144.11 19.6 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 168.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.72 40.08 1.15 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.379 -0.41 . . . . 0.0 110.314 -164.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.918 ' HB3' HD12 ' A' ' 48' ' ' LEU . 22.1 p-10 -99.49 -45.71 5.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.013 167.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -175.03 -30.1 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.043 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -119.66 154.4 34.1 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.446 -155.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.793 HG23 ' O ' ' A' ' 23' ' ' LEU . 69.9 m -75.71 146.82 39.85 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.047 159.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.459 ' CE1' ' HB2' ' A' ' 40' ' ' ALA . 19.9 m-85 -114.66 127.35 55.72 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.445 -173.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.49 -47.29 91.48 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -167.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -137.64 171.77 13.95 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-O 121.416 0.627 . . . . 0.0 110.438 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.4 ' CE ' HG13 ' A' ' 6' ' ' VAL . 6.8 tttm -70.68 -27.44 64.02 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.531 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.5 t -73.45 -20.66 60.66 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.074 -0.967 . . . . 0.0 110.635 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -102.13 -22.12 14.28 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.833 -178.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.776 ' O ' HG23 ' A' ' 41' ' ' VAL . 75.9 t80 -62.21 -60.04 4.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.952 164.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.525 ' O ' HG22 ' A' ' 42' ' ' VAL . 72.1 m -60.19 -28.87 68.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.946 -173.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.508 ' HA ' HG22 ' A' ' 42' ' ' VAL . 3.1 m120 -73.98 -31.27 62.91 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.215 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -61.33 -28.59 69.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.326 168.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.895 HG22 ' CD2' ' A' ' 48' ' ' LEU . 28.7 t -88.4 -46.66 15.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.525 -168.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.726 HG23 ' OE1' ' A' ' 43' ' ' GLU . 8.7 m -61.94 -35.36 67.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.346 174.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.726 ' OE1' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -63.11 -46.58 86.67 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.373 178.938 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.422 ' CB ' HG22 ' A' ' 47' ' ' THR . 5.7 p -76.72 -10.12 59.16 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.847 -168.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.294 0.1 OUTLIER 75.29 27.52 1.08 Allowed 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.209 -1.36 . . . . 0.0 109.626 173.113 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.58 40.32 4.76 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 166.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.422 HG22 ' CB ' ' A' ' 44' ' ' SER . 14.6 t -126.67 -37.47 2.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.981 0.42 . . . . 0.0 110.329 -171.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.918 HD12 ' HB3' ' A' ' 27' ' ' ASP . 1.3 tt -78.94 148.58 32.61 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.171 168.069 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.503 HG22 ' H ' ' A' ' 50' ' ' LEU . 3.8 m -157.14 167.85 29.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.327 174.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.802 HD22 ' CG2' ' A' ' 6' ' ' VAL . 7.6 tp -74.65 130.95 40.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.157 -169.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.5 t -84.64 -37.28 21.25 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.535 174.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.552 ' CE1' ' HB3' ' A' ' 24' ' ' CYS . 1.2 p-80 176.96 151.16 0.17 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.204 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.702 ' CE1' HD21 ' A' ' 50' ' ' LEU . 45.4 m-85 -78.16 166.1 23.16 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.318 177.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 62.71 -179.41 5.06 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.331 -1.107 . . . . 0.0 110.331 -162.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.57 -175.62 1.69 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 114.93 -0.635 . . . . 0.0 110.333 -174.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.504 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 3.0 t . . . . . 0 C--O 1.241 0.632 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.215 -155.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.1 p . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.645 0.26 . . . . 0.0 110.375 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.847 ' CG2' HD22 ' A' ' 50' ' ' LEU . 11.3 t -131.43 110.96 18.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.283 -166.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -72.35 123.58 23.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.44 166.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.548 ' SG ' HG12 ' A' ' 6' ' ' VAL . 60.7 m -138.51 41.9 2.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.126 175.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.1 59.17 3.49 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.295 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -173.27 -24.58 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 114.137 -1.392 . . . . 0.0 109.467 -174.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.538 ' O ' HG11 ' A' ' 42' ' ' VAL . 42.6 m-85 -58.98 162.82 6.45 Favored Pre-proline 0 C--O 1.24 0.571 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.605 167.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.426 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 31.6 Cg_endo -77.74 141.69 67.98 Favored 'Cis proline' 0 CA--C 1.517 -0.331 0 C-N-CA 122.947 -1.689 . . . . 0.0 109.325 0.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.426 ' HE3' ' HA ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.213 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.163 -178.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.474 0.771 0 CA-C-O 121.658 0.742 . . . . 0.0 109.758 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -83.06 -52.66 6.44 Favored 'General case' 0 C--O 1.248 1.023 0 CA-C-O 117.576 -1.202 . . . . 0.0 109.054 165.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.0 ptp85 -53.9 138.07 54.7 Favored Pre-proline 0 CA--C 1.537 0.454 0 O-C-N 120.456 -1.402 . . . . 0.0 110.967 -145.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -101.88 167.34 0.31 Allowed 'Trans proline' 0 N--CA 1.476 0.444 0 C-N-CA 123.978 3.119 . . . . 0.0 109.405 -148.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.632 HD23 ' CD2' ' A' ' 53' ' ' PHE . 0.2 OUTLIER -132.88 -162.27 1.22 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 158.404 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.527 ' O ' HD12 ' A' ' 50' ' ' LEU . 19.9 t -130.18 146.53 51.82 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.478 157.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.04 -167.65 41.69 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.069 -1.213 . . . . 0.0 110.069 175.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.22 27.04 4.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.457 0.646 . . . . 0.0 110.42 166.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.704 ' HB3' HD12 ' A' ' 48' ' ' LEU . 54.5 p-10 -122.48 11.81 9.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.869 -167.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.6 m120 68.55 34.48 3.56 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.629 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.1 mttp -141.16 138.88 33.73 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.323 -178.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.3 m -76.89 145.94 37.96 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.281 163.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.539 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 3.2 m-85 -121.81 133.69 54.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.434 -175.019 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.8 -73.11 0.54 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -169.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.417 ' ND2' ' HB3' ' A' ' 35' ' ' CYS . 1.0 OUTLIER -110.13 165.29 11.86 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.256 0.551 . . . . 0.0 110.56 175.464 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -62.84 -15.9 56.31 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.457 172.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.417 ' HB3' ' ND2' ' A' ' 33' ' ' ASN . 2.4 t -80.9 -18.23 47.91 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.463 178.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -103.89 -21.73 13.6 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.656 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.543 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 52.3 t80 -61.47 -64.92 0.79 Allowed 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.779 162.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.603 ' O ' HG22 ' A' ' 42' ' ' VAL . 81.0 m -59.9 -26.64 66.07 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.228 -172.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.566 ' HA ' HG22 ' A' ' 42' ' ' VAL . 3.0 m120 -73.29 -29.97 63.08 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.135 177.313 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -61.87 -39.24 91.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.309 165.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.914 HG22 HD23 ' A' ' 48' ' ' LEU . 86.4 t -70.48 -48.79 57.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.476 -174.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.781 HG23 ' OE1' ' A' ' 43' ' ' GLU . 12.8 m -73.49 -34.98 44.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.154 -172.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.781 ' OE1' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -66.66 -31.82 72.75 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.291 -1.322 . . . . 0.0 110.57 170.291 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.809 ' OG ' HG22 ' A' ' 47' ' ' THR . 12.7 t -68.56 -27.95 66.53 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.298 -177.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 61.77 16.89 8.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.498 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.43 92.08 2.13 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 176.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.809 HG22 ' OG ' ' A' ' 44' ' ' SER . 5.3 t -175.21 -33.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.362 -0.419 . . . . 0.0 110.171 163.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.914 HD23 HG22 ' A' ' 41' ' ' VAL . 1.0 OUTLIER -67.53 -81.03 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.473 -164.16 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.44 153.1 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.293 178.08 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.847 HD22 ' CG2' ' A' ' 6' ' ' VAL . 2.7 tp -81.59 158.63 24.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.324 -164.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.469 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 35.8 t -109.11 -46.09 3.65 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.602 177.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.543 ' CE1' ' HA ' ' A' ' 56' ' ' CYS . 1.7 p-80 -165.99 -178.8 4.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.47 173.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.67 ' CE1' HD21 ' A' ' 50' ' ' LEU . 1.8 m-85 -112.44 106.87 15.46 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.271 167.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -170.93 -105.6 0.18 Allowed Glycine 0 CA--C 1.53 1.028 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 164.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.5 64.95 0.88 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 123.121 1.438 . . . . 0.0 110.16 156.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.543 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 1.1 t . . . . . 0 N--CA 1.47 0.538 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.194 159.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.16 0 CA-C-O 120.715 0.293 . . . . 0.0 110.328 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.863 ' CG2' HD22 ' A' ' 50' ' ' LEU . 11.3 t -135.04 120.28 29.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.283 -166.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -72.84 80.65 1.16 Allowed 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.407 177.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 60.8 m -103.02 42.22 1.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.217 174.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.2 59.34 3.03 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.231 -178.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -173.66 -24.6 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 114.074 -1.421 . . . . 0.0 109.239 -173.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.537 ' HB3' ' HA ' ' A' ' 12' ' ' PRO . 47.9 m-85 -58.05 160.3 9.04 Favored Pre-proline 0 C--O 1.237 0.409 0 CA-C-N 113.98 -1.464 . . . . 0.0 110.714 164.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.537 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 33.6 Cg_endo -83.06 139.96 38.51 Favored 'Cis proline' 0 C--O 1.235 0.334 0 C-N-CA 122.894 -1.711 . . . . 0.0 109.409 8.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.9 tttp . . . . . 0 C--O 1.237 0.421 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.937 164.932 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.453 ' HG2' ' N ' ' A' ' 20' ' ' TYR . 4.1 tt0 . . . . . 0 N--CA 1.475 0.803 0 CA-C-O 121.114 0.483 . . . . 0.0 109.715 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.466 ' CD1' ' HA ' ' A' ' 21' ' ' ARG . 11.2 t80 -71.63 144.62 49.37 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.165 -175.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.466 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 0.0 OUTLIER 177.3 133.49 0.21 Allowed Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.359 155.179 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.428 ' HB2' ' CD ' ' A' ' 55' ' ' LYS . 57.9 Cg_endo -83.14 134.23 6.85 Favored 'Trans proline' 0 CA--C 1.515 -0.434 0 C-N-CA 123.729 2.953 . . . . 0.0 109.549 -159.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.569 ' O ' HG23 ' A' ' 30' ' ' THR . 0.2 OUTLIER -114.94 -170.12 1.69 Allowed 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.874 166.16 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 18.5 t -133.81 102.9 5.62 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.416 158.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.422 ' H ' ' HD2' ' A' ' 31' ' ' TYR . . . -63.93 155.49 45.34 Favored Glycine 0 N--CA 1.467 0.722 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 164.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.0 p -96.25 41.38 1.11 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.144 -0.528 . . . . 0.0 110.33 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.544 ' HB3' HD12 ' A' ' 48' ' ' LEU . 32.1 p-10 -108.08 21.85 16.79 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.862 0.839 . . . . 0.0 109.994 164.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . 0.399 0.1 OUTLIER 90.79 -17.55 0.18 Allowed 'General case' 0 C--O 1.239 0.53 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.948 -173.232 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.7 mttm -100.94 135.71 41.94 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 122.179 -0.326 . . . . 0.0 110.417 -159.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.569 HG23 ' O ' ' A' ' 23' ' ' LEU . 67.3 m -79.46 130.03 35.03 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.852 157.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.472 ' HE2' HD11 ' A' ' 48' ' ' LEU . 11.0 m-85 -102.21 123.59 46.31 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.449 -168.115 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.59 -42.21 99.72 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -169.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.425 ' HB3' ' HA ' ' A' ' 20' ' ' TYR . 1.0 OUTLIER -156.64 161.85 39.87 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 114.918 -0.641 . . . . 0.0 110.231 -175.614 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.82 -29.18 69.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.737 -163.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.2 p -66.54 -31.35 72.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.312 -175.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -92.65 -25.72 18.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.505 -175.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.461 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 37.2 t80 -62.72 -71.65 0.15 Allowed 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.642 166.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 71.1 m -61.45 -32.56 72.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.44 -165.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.563 ' HA ' HG22 ' A' ' 42' ' ' VAL . 2.4 m-80 -67.25 -23.57 65.71 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.019 177.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.611 ' C ' HD22 ' A' ' 48' ' ' LEU . . . -82.38 -22.31 35.48 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 114.351 -1.295 . . . . 0.0 110.377 175.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.823 HG22 HD23 ' A' ' 48' ' ' LEU . 90.2 t -72.27 -59.01 3.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.519 171.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.732 HG23 ' OE1' ' A' ' 43' ' ' GLU . 22.6 m -61.92 -27.28 42.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.07 -170.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.732 ' OE1' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -69.32 -47.42 64.52 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 113.697 -1.592 . . . . 0.0 110.584 174.956 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.938 ' CB ' HG22 ' A' ' 47' ' ' THR . 1.1 p -62.11 -17.79 58.82 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.697 -177.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 24.8 m120 62.16 16.61 8.47 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.319 -176.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.99 68.24 0.83 Allowed Glycine 0 CA--C 1.527 0.798 0 CA-C-N 114.618 -1.173 . . . . 0.0 110.475 -173.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.938 HG22 ' CB ' ' A' ' 44' ' ' SER . 1.4 t -136.29 -36.28 0.73 Allowed 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.373 0.606 . . . . 0.0 110.684 161.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.823 HD23 HG22 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -75.24 -92.42 0.02 OUTLIER 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.529 -178.52 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 17.3 p 52.3 176.75 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 121.513 -0.742 . . . . 0.0 112.594 -172.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.863 HD22 ' CG2' ' A' ' 6' ' ' VAL . 3.3 tp -91.4 123.03 34.51 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.287 -159.084 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.9 t -60.64 -61.96 2.21 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.317 162.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.65 ' C ' HD11 ' A' ' 50' ' ' LEU . 1.6 p-80 -158.97 163.11 36.76 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.112 173.068 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.824 ' CZ ' HG22 ' A' ' 6' ' ' VAL . 36.2 m-85 -77.66 176.03 9.35 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.333 169.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.48 173.4 3.31 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -164.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.428 ' CD ' ' HB2' ' A' ' 22' ' ' PRO . 7.7 mmmt -61.56 171.89 1.37 Allowed 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.261 -0.469 . . . . 0.0 110.208 169.028 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.481 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 1.5 t . . . . . 0 C--O 1.24 0.599 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.932 -158.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.3 t . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.836 0.35 . . . . 0.0 110.683 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.838 HG23 HD22 ' A' ' 50' ' ' LEU . 6.5 t -107.48 129.84 60.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.976 -159.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -107.58 107.85 18.87 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.537 170.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 35.2 m -111.71 47.1 1.06 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.436 -177.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.6 m -96.24 39.12 1.16 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 114.196 -1.365 . . . . 0.0 110.374 166.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -129.91 25.48 5.29 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.977 161.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.541 ' HB2' HG11 ' A' ' 42' ' ' VAL . 85.1 m-85 -126.63 166.87 19.42 Favored Pre-proline 0 C--O 1.236 0.386 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.704 -170.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.414 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.2 Cg_endo -72.42 138.88 57.18 Favored 'Cis proline' 0 CA--C 1.518 -0.319 0 C-N-CA 122.064 -2.057 . . . . 0.0 108.98 -7.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.476 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.184 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.264 176.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 N--CA 1.473 0.678 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.469 ' CD1' ' N ' ' A' ' 21' ' ' ARG . 10.9 t80 -76.85 147.05 37.34 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.211 -169.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.469 ' N ' ' CD1' ' A' ' 20' ' ' TYR . 0.0 OUTLIER 177.73 135.61 0.22 Allowed Pre-proline 0 CA--C 1.536 0.413 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.531 155.848 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.421 ' HB2' ' HB3' ' A' ' 55' ' ' LYS . 47.7 Cg_endo -84.09 143.93 10.49 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.775 2.983 . . . . 0.0 109.593 -158.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.12 -165.52 1.69 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.055 158.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.623 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 21.1 t -132.6 148.53 52.37 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.293 158.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -81.87 -169.63 43.2 Favored Glycine 0 CA--C 1.531 1.093 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 174.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.4 m -97.62 19.9 12.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.98 -0.61 . . . . 0.0 110.454 161.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.705 ' HB3' HD12 ' A' ' 48' ' ' LEU . 34.1 p-10 -107.14 9.23 30.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.147 -175.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 67.91 38.61 2.78 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.587 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.91 137.6 34.95 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 114.583 -1.189 . . . . 0.0 110.342 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.6 m -72.48 147.65 45.84 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.24 162.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -122.74 125.04 44.73 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.394 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.34 -50.27 68.6 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -167.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.421 ' HB3' ' HA ' ' A' ' 20' ' ' TYR . 1.7 p30 -125.04 175.38 7.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.203 -0.498 . . . . 0.0 110.482 170.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.421 ' HE3' ' CG1' ' A' ' 6' ' ' VAL . 4.8 tttp -69.23 -17.57 63.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.414 169.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 22.8 m -60.99 -51.61 68.52 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.545 172.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -80.4 -21.33 42.37 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.859 -171.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.683 ' O ' HG23 ' A' ' 41' ' ' VAL . 57.7 t80 -61.29 -67.64 0.39 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.967 165.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.84 ' O ' HG22 ' A' ' 42' ' ' VAL . 96.8 m -65.05 -29.85 70.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.638 -163.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -65.37 -33.78 76.76 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.02 173.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -69.35 -24.22 63.87 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.324 174.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.936 HG22 HD22 ' A' ' 48' ' ' LEU . 59.3 t -87.9 -55.18 6.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.387 -172.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.84 HG22 ' O ' ' A' ' 38' ' ' CYS . 6.6 m -62.33 -23.09 31.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.149 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.76 ' OE1' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -77.13 -37.99 52.95 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 113.774 -1.557 . . . . 0.0 110.621 173.003 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.1 p -62.28 -19.99 63.82 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.628 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 69.27 41.61 1.33 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.274 -171.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.68 88.12 0.03 OUTLIER Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 172.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.1 t -176.4 -42.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.262 -0.469 . . . . 0.0 110.322 -167.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.936 HD22 HG22 ' A' ' 41' ' ' VAL . 1.0 OUTLIER -61.71 -73.93 0.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.367 172.25 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.858 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.2 OUTLIER 66.89 160.31 0.15 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.431 175.621 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.838 HD22 HG23 ' A' ' 6' ' ' VAL . 5.6 tp -82.7 162.05 21.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.286 -168.046 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.462 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 16.2 t -112.95 -41.44 3.75 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.671 173.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.623 ' CE1' ' HB3' ' A' ' 24' ' ' CYS . 1.6 p-80 -177.79 167.63 2.12 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.371 -173.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.756 ' CE1' HD21 ' A' ' 50' ' ' LEU . 2.2 m-85 -108.25 30.81 6.07 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.347 -177.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.67 -140.25 6.6 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 168.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 22' ' ' PRO . 1.2 pttm -131.82 63.84 1.61 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 123.2 1.476 . . . . 0.0 110.29 161.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.457 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 1.5 t . . . . . 0 C--O 1.24 0.57 0 O-C-N 121.345 -0.847 . . . . 0.0 110.187 158.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.455 -0.198 0 CA-C-O 121.329 0.585 . . . . 0.0 110.448 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.797 ' CG2' HD22 ' A' ' 50' ' ' LEU . 4.9 t -145.91 111.77 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.998 -177.165 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -67.81 114.22 6.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.408 167.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.476 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 57.8 m -133.39 37.16 3.36 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.036 177.105 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.1 m -91.23 58.7 3.75 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.221 -175.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -173.31 -24.19 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 114.081 -1.418 . . . . 0.0 109.488 -174.126 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.595 ' O ' HG11 ' A' ' 42' ' ' VAL . 74.3 m-85 -58.69 160.38 10.55 Favored Pre-proline 0 C--O 1.238 0.459 0 CA-C-N 113.987 -1.461 . . . . 0.0 110.617 166.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.48 ' HB3' HG21 ' A' ' 42' ' ' VAL . 31.9 Cg_endo -78.32 139.99 58.33 Favored 'Cis proline' 0 C--O 1.233 0.261 0 C-N-CA 122.771 -1.762 . . . . 0.0 109.369 3.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.24 0.575 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.834 164.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.721 0 CA-C-O 121.592 0.71 . . . . 0.0 109.841 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.5 ' CD2' ' N ' ' A' ' 21' ' ' ARG . 93.7 t80 -61.62 167.0 3.75 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.026 -177.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.5 ' N ' ' CD2' ' A' ' 20' ' ' TYR . 1.7 ptm180 178.52 172.28 0.44 Allowed Pre-proline 0 C--O 1.248 0.983 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.406 151.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.431 ' HG2' ' CE ' ' A' ' 55' ' ' LYS 0.253 82.6 Cg_endo -110.15 92.52 0.02 OUTLIER 'Trans proline' 0 CA--C 1.515 -0.435 0 C-N-CA 122.252 1.968 . . . . 0.0 109.232 -178.7 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.594 HD23 ' CD2' ' A' ' 53' ' ' PHE . 0.2 OUTLIER -90.15 -171.22 3.04 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.855 162.439 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.639 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 21.6 t -146.06 135.93 23.45 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.221 156.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.27 -171.75 41.56 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 114.387 -1.278 . . . . 0.0 110.316 -177.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.25 26.62 5.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.42 0.629 . . . . 0.0 110.479 170.205 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.89 ' HB3' HD12 ' A' ' 48' ' ' LEU . 24.9 p-10 -126.9 13.09 7.33 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.827 -166.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 69.24 32.51 3.58 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.289 -0.868 . . . . 0.0 110.59 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.73 137.9 38.78 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.285 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 23' ' ' LEU . 1.3 m -77.73 148.95 34.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.337 164.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -121.55 129.99 53.23 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.455 -176.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.55 -93.01 0.01 OUTLIER Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 168.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.0 p-10 -99.9 157.6 16.41 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.998 -0.601 . . . . 0.0 110.577 -168.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -61.59 -15.53 39.89 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.569 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.1 m -66.13 -45.44 81.06 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.471 173.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -89.59 -23.33 21.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.373 -168.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.492 ' O ' HG23 ' A' ' 41' ' ' VAL . 36.2 t80 -61.84 -69.11 0.26 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.877 162.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.551 ' O ' HG22 ' A' ' 42' ' ' VAL . 85.2 m -61.79 -30.92 71.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.574 -168.443 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.521 ' HA ' HG22 ' A' ' 42' ' ' VAL . 90.0 m-20 -67.07 -31.44 71.95 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.942 175.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -71.17 -17.24 62.55 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.372 174.236 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.824 HG22 ' CD2' ' A' ' 48' ' ' LEU . 43.7 t -85.8 -52.5 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.501 177.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.748 HG23 ' OE1' ' A' ' 43' ' ' GLU . 4.4 m -70.1 -32.99 53.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.245 -170.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.748 ' OE1' HG23 ' A' ' 42' ' ' VAL . 2.0 mp0 -70.51 -29.81 66.42 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.498 170.41 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.66 -30.61 70.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.548 175.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 70.22 51.93 0.38 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.301 -166.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.69 21.93 55.95 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.192 176.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 40.5 m -66.9 -86.82 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 157.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.89 HD12 ' HB3' ' A' ' 27' ' ' ASP . 1.0 OUTLIER -61.3 148.66 40.49 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.302 -163.333 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 77.0 p -138.89 -172.43 3.32 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.921 165.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.797 HD22 ' CG2' ' A' ' 6' ' ' VAL . 5.8 tp -86.8 133.19 33.67 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.369 -173.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.6 t -82.82 -37.04 24.98 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 113.921 -1.49 . . . . 0.0 110.597 173.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.639 ' CE1' ' HB3' ' A' ' 24' ' ' CYS . 1.1 p-80 173.47 162.66 0.15 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.334 -178.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.697 ' CE1' HD21 ' A' ' 50' ' ' LEU . 1.3 m-85 -98.78 74.9 2.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.894 160.255 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -152.39 21.79 0.84 Allowed Glycine 0 CA--C 1.523 0.57 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.811 -172.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.431 ' CE ' ' HG2' ' A' ' 22' ' ' PRO . 9.1 mttp 61.27 35.25 18.27 Favored 'General case' 0 C--O 1.239 0.506 0 O-C-N 122.753 -0.263 . . . . 0.0 110.307 164.334 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.474 0.734 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.734 156.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.7 p . . . . . 0 C--O 1.231 0.103 0 CA-C-O 121.043 0.449 . . . . 0.0 110.261 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.645 HG13 ' CZ ' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -136.79 -175.58 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.282 -167.248 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -153.94 65.86 0.72 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.342 -168.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.527 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 59.4 m -99.83 32.78 2.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.973 -174.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.72 60.5 5.59 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.196 -176.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -173.71 -24.98 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.326 -172.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.474 ' CE2' ' HD2' ' A' ' 13' ' ' LYS . 79.1 m-85 -58.33 160.29 9.82 Favored Pre-proline 0 C--O 1.236 0.374 0 CA-C-N 113.894 -1.503 . . . . 0.0 110.529 163.268 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.499 ' HB3' HG21 ' A' ' 42' ' ' VAL . 30.5 Cg_endo -78.69 135.83 38.53 Favored 'Cis proline' 0 CA--C 1.518 -0.277 0 C-N-CA 122.667 -1.806 . . . . 0.0 109.378 6.022 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.474 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.8 OUTLIER . . . . . 0 C--O 1.238 0.459 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.065 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.475 0.799 0 CA-C-O 121.465 0.65 . . . . 0.0 109.808 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.486 ' CD1' ' N ' ' A' ' 21' ' ' ARG . 10.5 t80 -108.87 146.86 33.04 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.288 -177.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.486 ' N ' ' CD1' ' A' ' 20' ' ' TYR . 0.0 OUTLIER 177.44 135.14 0.21 Allowed Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.712 155.586 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 21' ' ' ARG . 59.5 Cg_endo -86.11 139.14 6.08 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.539 2.826 . . . . 0.0 109.368 -161.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.758 ' O ' HG23 ' A' ' 30' ' ' THR . 0.3 OUTLIER -123.88 -165.09 1.3 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.999 161.57 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.58 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 15.9 t -134.58 118.09 16.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.874 165.334 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.54 -173.9 2.03 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.7 t -98.81 30.78 3.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.724 0.773 . . . . 0.0 110.356 165.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.832 ' HB3' HD12 ' A' ' 48' ' ' LEU . 32.2 p-10 -123.84 13.71 9.24 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.473 -166.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 66.74 31.97 7.17 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.532 178.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.37 141.96 19.83 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.81 173.441 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.758 HG23 ' O ' ' A' ' 23' ' ' LEU . 94.0 m -65.82 148.53 51.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.261 165.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -106.85 138.41 43.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.353 166.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.02 -53.58 41.65 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.434 ' HB3' ' HA ' ' A' ' 20' ' ' TYR . 5.0 p-10 -128.08 169.78 13.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.418 -0.391 . . . . 0.0 110.301 -173.303 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.38 -31.88 73.26 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.497 174.401 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.2 t -74.73 -21.84 59.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.573 -173.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -97.75 -22.75 16.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.66 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.502 ' O ' HG23 ' A' ' 41' ' ' VAL . 59.5 t80 -61.59 -68.09 0.35 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.762 164.202 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.527 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 64.4 m -61.0 -32.69 72.27 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.538 -167.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.429 ' HA ' HG22 ' A' ' 42' ' ' VAL . 5.6 m120 -73.45 -25.0 60.3 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.209 -178.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -65.31 -43.0 92.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.183 165.609 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.842 HG22 ' CD2' ' A' ' 48' ' ' LEU . 60.8 t -61.82 -51.97 66.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.54 -175.413 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.718 HG23 ' OE1' ' A' ' 43' ' ' GLU . 18.8 m -74.3 -34.07 36.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.1 -168.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.718 ' OE1' HG23 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -65.48 -29.51 70.18 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.442 169.748 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.5 t -80.75 -17.26 51.55 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.332 -172.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 53.3 t30 71.33 50.72 0.28 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.568 167.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.88 -21.2 47.3 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 164.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 46.0 m -62.02 -85.71 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.238 -0.481 . . . . 0.0 110.002 177.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.842 ' CD2' HG22 ' A' ' 41' ' ' VAL . 1.4 tt -59.98 148.19 36.2 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.495 -157.383 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.417 HG23 ' N ' ' A' ' 50' ' ' LEU . 0.9 OUTLIER -146.81 -163.21 1.7 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.619 167.108 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.66 HD11 ' C ' ' A' ' 52' ' ' HIS . 6.6 tp -94.45 118.68 32.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.15 -169.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.8 t -61.62 -42.16 98.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.493 167.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.66 ' C ' HD11 ' A' ' 50' ' ' LEU . 0.9 OUTLIER 173.73 158.1 0.13 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.182 178.967 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.652 ' CE1' HD21 ' A' ' 50' ' ' LEU . 5.2 m-85 -84.51 170.97 12.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.217 168.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.59 32.08 10.67 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 168.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.447 ' HG2' ' HG2' ' A' ' 22' ' ' PRO . 4.9 mttp 61.14 167.7 0.09 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 114.541 -0.829 . . . . 0.0 110.455 -174.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.582 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 2.2 t . . . . . 0 C--O 1.24 0.594 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.034 -160.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 8.2 tt . . . . . 0 N--CA 1.473 0.708 0 CA-C-O 121.308 0.575 . . . . 0.0 109.982 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.07 129.83 42.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.311 -171.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -154.49 103.33 2.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.17 172.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.619 HG13 ' HD1' ' A' ' 53' ' ' PHE . 11.6 t -126.68 68.89 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.244 -165.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.24 -175.55 4.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.348 170.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.662 HG13 ' CZ ' ' A' ' 53' ' ' PHE . 0.6 OUTLIER -146.11 -175.18 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.206 -165.551 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -145.97 63.87 1.23 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.037 -155.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.458 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 76.6 m -117.11 42.49 2.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.279 -165.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.8 m -89.76 61.57 5.45 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.343 172.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -173.01 -24.44 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.349 -175.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.709 ' O ' HG11 ' A' ' 42' ' ' VAL . 29.2 m-85 -58.18 158.12 14.79 Favored Pre-proline 0 C--O 1.236 0.382 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.636 163.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.481 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.3 Cg_endo -86.67 154.46 48.3 Favored 'Cis proline' 0 C--O 1.232 0.22 0 C-N-CA 122.914 -1.702 . . . . 0.0 109.449 10.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.458 ' HG3' ' HD3' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -88.45 158.73 48.36 Favored Pre-proline 0 C--O 1.239 0.531 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.894 166.846 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.458 ' HD3' ' HG3' ' A' ' 13' ' ' LYS . 11.7 Cg_endo -76.71 -22.66 11.74 Favored 'Trans proline' 0 CA--C 1.514 -0.494 0 C-N-CA 122.672 2.248 . . . . 0.0 110.695 -171.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -171.04 172.9 5.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.345 -168.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.5 t -172.31 159.94 4.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.981 -166.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.7 p -100.26 44.24 1.03 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.334 -164.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.241 0.622 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.377 168.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 . . . . . 0 N--CA 1.473 0.699 0 CA-C-O 121.267 0.556 . . . . 0.0 109.882 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -87.67 -51.61 5.78 Favored 'General case' 0 C--O 1.251 1.145 0 CA-C-O 117.581 -1.2 . . . . 0.0 109.368 171.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.402 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.4 ptp180 -54.13 131.05 59.96 Favored Pre-proline 0 CA--C 1.54 0.583 0 O-C-N 120.427 -1.421 . . . . 0.0 110.768 -145.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.452 ' HG2' ' HG3' ' A' ' 55' ' ' LYS . 72.5 Cg_endo -93.67 166.71 2.21 Favored 'Trans proline' 0 CA--C 1.517 -0.347 0 C-N-CA 124.293 3.329 . . . . 0.0 109.526 -150.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.674 HD12 ' HB2' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -126.33 -170.7 2.24 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.939 164.185 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.656 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 17.8 t -131.1 119.62 22.22 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.612 157.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.1 174.5 7.35 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 172.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.07 40.57 1.17 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.009 -0.596 . . . . 0.0 110.471 167.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.428 ' HB3' HD12 ' A' ' 48' ' ' LEU . 37.8 p-10 -131.4 13.76 5.04 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.595 -177.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 69.73 33.64 2.89 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.62 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -139.12 132.44 30.01 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.532 178.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 23' ' ' LEU . 84.9 m -78.71 154.22 30.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.316 165.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -127.17 126.73 43.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.454 -170.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.01 -9.18 86.89 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.224 -169.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -159.57 176.22 12.3 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.099 -0.551 . . . . 0.0 110.498 171.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.5 mttp -61.65 -22.36 65.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.398 166.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 95.5 m -75.72 -43.91 44.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.359 -169.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -82.13 -22.81 35.99 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.866 178.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.674 ' HB2' HD12 ' A' ' 23' ' ' LEU . 29.8 t80 -61.86 -67.94 0.37 Allowed 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.028 167.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.571 ' O ' HG22 ' A' ' 42' ' ' VAL . 71.9 m -69.56 -25.35 63.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.271 -167.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.419 ' HA ' HG22 ' A' ' 42' ' ' VAL . 96.2 m-20 -65.93 -31.07 71.79 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.118 171.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -69.68 -36.2 75.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.491 172.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.799 HG22 HD23 ' A' ' 48' ' ' LEU . 84.7 t -65.89 -53.93 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.511 -179.006 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.709 HG11 ' O ' ' A' ' 11' ' ' TYR . 5.1 m -62.3 -35.27 68.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.121 -172.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.654 ' OE1' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -62.2 -37.16 84.25 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 114.125 -1.398 . . . . 0.0 110.419 171.077 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.666 ' HB2' HG22 ' A' ' 47' ' ' THR . 10.8 p -72.15 -24.4 61.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.41 -170.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 69.12 36.73 2.33 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.41 -172.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.67 94.28 0.01 OUTLIER Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -170.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.666 HG22 ' HB2' ' A' ' 44' ' ' SER . 6.1 t -169.99 -35.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.437 -0.381 . . . . 0.0 110.183 173.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.799 HD23 HG22 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -61.47 -83.19 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.314 166.731 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.478 HG22 ' H ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER 61.85 171.69 0.12 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.45 179.41 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.679 HD11 ' C ' ' A' ' 52' ' ' HIS . 8.2 tp -91.84 120.28 32.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.111 -166.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.8 t -64.21 -41.91 96.84 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.595 166.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.679 ' C ' HD11 ' A' ' 50' ' ' LEU . 0.6 OUTLIER 174.25 146.17 0.06 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.156 -178.164 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.662 ' CZ ' HG13 ' A' ' 6' ' ' VAL . 20.4 m-85 -67.88 170.1 8.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.2 171.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.87 170.49 8.07 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -164.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.452 ' HG3' ' HG2' ' A' ' 22' ' ' PRO . 4.2 mttm -62.47 176.31 0.65 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.339 -0.431 . . . . 0.0 110.246 170.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.576 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.8 OUTLIER . . . . . 0 N--CA 1.472 0.628 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.732 -158.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.7 mp . . . . . 0 N--CA 1.473 0.705 0 CA-C-O 121.211 0.529 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.34 -24.37 66.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.421 -170.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -115.7 97.63 6.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.373 172.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.789 ' O ' HD23 ' A' ' 50' ' ' LEU . 30.4 m -112.73 94.46 3.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.012 164.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.7 p -117.58 177.94 4.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.357 -164.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.679 ' CG2' HD22 ' A' ' 50' ' ' LEU . 98.3 t -151.49 127.08 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.29 -164.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -87.77 114.75 24.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.358 -172.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.617 ' SG ' HG12 ' A' ' 6' ' ' VAL . 57.1 m -138.85 35.5 2.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.958 -166.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.3 t -89.83 59.92 4.79 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.389 -176.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.43 -25.56 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.264 -175.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.491 ' O ' HG11 ' A' ' 42' ' ' VAL . 97.5 m-85 -60.17 160.47 16.75 Favored Pre-proline 0 C--O 1.238 0.474 0 CA-C-N 113.904 -1.498 . . . . 0.0 110.375 168.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.541 ' CG ' HG21 ' A' ' 42' ' ' VAL . 56.5 Cg_endo -79.12 147.3 79.82 Favored 'Cis proline' 0 C--O 1.233 0.273 0 C-N-CA 122.58 -1.842 . . . . 0.0 109.371 4.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.4 ' HB3' ' CD ' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -74.33 178.11 1.84 Allowed Pre-proline 0 C--O 1.24 0.561 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.849 162.601 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.4 ' CD ' ' HB3' ' A' ' 13' ' ' LYS . 17.8 Cg_endo -90.63 -54.2 0.02 OUTLIER 'Trans proline' 0 CA--C 1.517 -0.336 0 C-N-CA 122.576 2.184 . . . . 0.0 109.533 170.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -148.5 138.01 22.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.29 -171.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.6 m -130.7 168.69 16.75 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.398 172.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 86.4 m -158.34 -40.2 0.06 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.268 167.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.54 HD23 ' HA ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER . . . . . 0 C--O 1.24 0.572 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.319 167.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.54 ' HA ' HD23 ' A' ' 18' ' ' LEU . 2.3 mt-10 . . . . . 0 N--CA 1.475 0.816 0 CA-C-O 121.548 0.69 . . . . 0.0 109.809 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -93.09 -50.04 5.71 Favored 'General case' 0 C--O 1.249 1.07 0 CA-C-O 117.468 -1.253 . . . . 0.0 108.918 168.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.5 ptp85 -53.75 140.77 48.39 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 120.47 -1.393 . . . . 0.0 111.152 -144.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.453 ' HG2' ' HG2' ' A' ' 55' ' ' LYS . 60.4 Cg_endo -99.11 153.47 0.62 Allowed 'Trans proline' 0 N--CA 1.475 0.387 0 C-N-CA 124.133 3.222 . . . . 0.0 109.253 -150.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.59 HD22 HD13 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -119.46 -166.88 1.32 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.956 160.831 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.471 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 18.7 t -121.4 116.68 25.23 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.464 159.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.465 ' HA3' ' CE2' ' A' ' 31' ' ' TYR . . . -61.67 152.61 41.97 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 167.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.38 39.73 1.23 Allowed 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 115.196 -0.502 . . . . 0.0 110.403 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.72 ' HB3' HD12 ' A' ' 48' ' ' LEU . 13.7 p-10 -113.53 -48.73 2.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.362 174.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -176.34 -26.82 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.128 178.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.28 158.07 21.91 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.304 -156.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.685 HG21 ' HD2' ' A' ' 55' ' ' LYS . 60.1 m -77.03 133.29 39.16 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.901 157.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.565 ' HE2' HD11 ' A' ' 48' ' ' LEU . 18.1 m-85 -96.88 138.07 35.0 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.445 176.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.05 -69.76 1.22 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -177.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -131.92 167.32 19.82 Favored 'General case' 0 C--O 1.232 0.163 0 O-C-N 121.794 -0.827 . . . . 0.0 110.597 -178.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.98 -14.06 20.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.705 -169.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.8 m -72.35 -60.14 2.38 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.453 176.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -61.31 -25.6 67.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.798 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.455 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 53.5 t80 -62.12 -66.22 0.57 Allowed 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.872 170.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.546 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 96.7 m -66.21 -31.57 72.48 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.671 -160.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.54 ' HA ' HG22 ' A' ' 42' ' ' VAL . 5.1 p30 -72.16 -23.79 61.34 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.119 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.468 ' C ' HD22 ' A' ' 48' ' ' LEU . . . -69.33 -27.98 65.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.294 166.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.883 HG22 HD23 ' A' ' 48' ' ' LEU . 89.8 t -75.89 -45.62 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.578 -178.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.541 HG21 ' CG ' ' A' ' 12' ' ' PRO . 20.3 m -70.71 -35.32 60.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.084 -172.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.51 ' OE1' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -60.88 -33.8 73.66 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.335 168.413 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.55 ' OG ' HG22 ' A' ' 47' ' ' THR . 0.1 OUTLIER -70.98 -39.42 72.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.291 -169.41 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 69.09 24.16 6.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.223 -163.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.462 ' H ' ' HB3' ' A' ' 44' ' ' SER . . . 86.16 40.82 7.31 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 166.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.55 HG22 ' OG ' ' A' ' 44' ' ' SER . 6.1 t -100.88 -39.06 7.96 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.199 0.524 . . . . 0.0 110.268 165.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.883 HD23 HG22 ' A' ' 41' ' ' VAL . 0.3 OUTLIER -62.14 -86.99 0.01 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.408 -179.326 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.404 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER 67.17 164.13 0.2 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.488 174.234 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.789 HD23 ' O ' ' A' ' 4' ' ' VAL . 5.0 tp -86.6 137.13 32.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.276 -168.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.7 t -92.4 -43.48 9.2 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.409 177.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.471 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.6 p80 -177.51 150.09 0.67 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.217 177.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.761 ' CE1' HD21 ' A' ' 50' ' ' LEU . 9.1 m-85 -76.78 157.17 31.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.303 175.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.6 166.29 23.47 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 -163.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.685 ' HD2' HG21 ' A' ' 30' ' ' THR . 4.4 mtmm -63.22 -179.0 0.28 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.419 -0.39 . . . . 0.0 110.267 177.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.453 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.8 OUTLIER . . . . . 0 N--CA 1.473 0.689 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.819 -155.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 33.4 tp . . . . . 0 N--CA 1.474 0.737 0 CA-C-O 121.265 0.555 . . . . 0.0 109.827 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.24 -79.77 0.05 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.306 175.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 61.69 -164.49 0.24 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.308 171.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.63 ' O ' HD23 ' A' ' 50' ' ' LEU . 17.7 m -113.16 63.69 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.318 -167.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.507 ' O ' HG13 ' A' ' 6' ' ' VAL . 24.1 p -121.77 -175.96 3.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.33 169.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.519 HG21 ' CE2' ' A' ' 37' ' ' PHE . 0.4 OUTLIER -156.36 -176.01 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.25 -167.633 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -146.24 80.74 1.57 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.939 -156.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.445 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 62.4 m -125.49 48.03 2.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.22 -165.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.5 p -96.13 55.69 1.57 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.191 -175.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -173.2 -23.76 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.181 -1.372 . . . . 0.0 109.648 -174.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.533 ' O ' HG11 ' A' ' 42' ' ' VAL . 67.3 m-85 -59.83 161.63 11.4 Favored Pre-proline 0 C--O 1.239 0.52 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.505 170.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.409 ' CG ' HG21 ' A' ' 42' ' ' VAL . 35.9 Cg_endo -77.09 156.63 97.25 Favored 'Cis proline' 0 C--O 1.233 0.26 0 C-N-CA 122.676 -1.802 . . . . 0.0 109.14 -0.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.45 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 2.1 mtpm? -109.77 163.8 16.27 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.135 -164.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -55.86 -69.71 0.05 OUTLIER 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 122.306 2.004 . . . . 0.0 110.061 175.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -108.09 107.44 18.09 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.361 -153.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.4 m -149.67 128.34 12.41 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.427 156.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.508 ' C ' HD23 ' A' ' 18' ' ' LEU . 0.6 OUTLIER -102.58 127.7 49.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.437 -165.188 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.508 HD23 ' C ' ' A' ' 17' ' ' THR . 4.6 mt . . . . . 0 C--O 1.241 0.631 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.324 -168.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 . . . . . 0 N--CA 1.474 0.733 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.462 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 31.5 t80 -63.19 -52.82 60.77 Favored 'General case' 0 C--O 1.247 0.943 0 CA-C-O 118.114 -0.946 . . . . 0.0 109.279 -166.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.459 ' HB3' ' NH1' ' A' ' 21' ' ' ARG . 2.0 ptp180 -54.4 142.75 49.24 Favored Pre-proline 0 CA--C 1.539 0.527 0 O-C-N 120.734 -1.229 . . . . 0.0 110.941 -146.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.462 ' HG3' ' CE2' ' A' ' 20' ' ' TYR 0.259 91.4 Cg_endo -119.47 -179.34 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 123.314 2.676 . . . . 0.0 108.907 -142.676 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.668 HD21 ' HZ3' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -142.2 -164.17 1.75 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.968 162.354 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.663 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 34.3 t -125.37 126.89 45.74 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 158.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.55 -171.95 48.52 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.3 p -97.74 34.43 1.87 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.001 -0.6 . . . . 0.0 110.312 163.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.406 ' HB3' ' CD1' ' A' ' 48' ' ' LEU . 24.2 p-10 -96.4 11.09 36.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.485 170.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.5 m120 62.76 42.95 7.57 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.594 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.69 168.51 9.01 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.846 173.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.5 m -67.53 138.13 56.29 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.997 164.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.482 ' HE2' HD11 ' A' ' 48' ' ' LEU . 3.8 m-85 -93.76 143.32 26.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.358 167.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.94 -56.48 22.31 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -174.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 39.6 p-10 -142.72 179.14 7.17 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 114.636 -0.782 . . . . 0.0 110.624 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.668 ' HZ3' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -61.71 -38.84 89.36 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.524 -178.553 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.6 m -70.99 -39.34 72.5 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.177 -169.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -74.32 -24.08 59.15 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.054 174.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.533 ' O ' HG23 ' A' ' 41' ' ' VAL . 73.2 t80 -62.21 -64.37 0.95 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.057 169.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.652 ' O ' HG13 ' A' ' 42' ' ' VAL . 74.1 m -60.25 -29.32 68.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.99 -171.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.705 ' HA ' HG22 ' A' ' 42' ' ' VAL . 31.6 m-20 -73.24 -31.38 64.08 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.173 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -61.67 -29.23 69.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.377 168.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 1.016 HG22 HD23 ' A' ' 48' ' ' LEU . 35.6 t -82.12 -42.58 18.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.524 -176.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.705 HG22 ' HA ' ' A' ' 39' ' ' ASN . 18.8 m -78.37 -34.29 18.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.209 -171.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.476 ' OE1' HG23 ' A' ' 42' ' ' VAL . 1.5 mp0 -64.09 -32.25 73.74 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.238 167.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.96 -21.79 63.82 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.734 -172.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.9 m120 69.17 25.53 5.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.131 -168.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.5 85.96 0.09 OUTLIER Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 -170.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.9 t -151.77 -36.67 0.12 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.083 0.468 . . . . 0.0 110.514 166.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.016 HD23 HG22 ' A' ' 41' ' ' VAL . 0.8 OUTLIER -79.87 160.27 26.12 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.584 175.832 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.441 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 2.7 t -174.18 164.19 3.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.991 -174.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.686 HD21 ' CE1' ' A' ' 53' ' ' PHE . 5.8 tp -76.29 129.02 36.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.131 -164.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.628 ' O ' HG21 ' A' ' 4' ' ' VAL . 38.6 t -77.23 -42.24 38.08 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.454 171.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.663 ' CE1' ' HB3' ' A' ' 24' ' ' CYS . 1.7 p-80 -174.06 167.42 4.22 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.267 175.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.686 ' CE1' HD21 ' A' ' 50' ' ' LEU . 20.3 m-85 -94.72 89.23 5.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.248 168.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -155.96 -139.24 2.72 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.496 -1.041 . . . . 0.0 110.496 -175.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.431 ' HG2' ' HG2' ' A' ' 22' ' ' PRO . 6.8 mtpp -139.82 41.11 2.0 Allowed 'General case' 0 C--O 1.24 0.602 0 CA-C-N 115.26 -0.47 . . . . 0.0 109.874 170.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 C--O 1.241 0.647 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.022 161.915 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.8 pt? . . . . . 0 N--CA 1.474 0.771 0 CA-C-O 121.173 0.511 . . . . 0.0 109.905 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.73 -165.55 1.28 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.261 170.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -141.51 19.95 2.2 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.193 163.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.718 ' O ' HD23 ' A' ' 50' ' ' LEU . 8.6 t 61.8 27.64 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.505 163.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.3 p -130.69 159.41 37.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.427 -168.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.802 ' CG2' HD22 ' A' ' 50' ' ' LEU . 11.7 t -145.34 117.02 2.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.118 -164.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -73.27 117.74 15.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.466 169.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.516 ' SG ' HG12 ' A' ' 6' ' ' VAL . 59.8 m -138.08 44.38 2.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.115 177.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.66 58.56 3.12 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.373 -177.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -172.81 -24.33 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.539 -177.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.478 ' CD2' ' HB2' ' A' ' 38' ' ' CYS . 71.2 m-85 -60.69 159.73 23.66 Favored Pre-proline 0 C--O 1.236 0.345 0 CA-C-N 114.024 -1.443 . . . . 0.0 110.414 172.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.586 ' N ' HG21 ' A' ' 42' ' ' VAL . 56.2 Cg_endo -78.63 163.98 85.26 Favored 'Cis proline' 0 CA--C 1.519 -0.23 0 C-N-CA 122.511 -1.87 . . . . 0.0 109.337 5.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.403 ' CE ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -78.83 165.6 48.19 Favored Pre-proline 0 C--O 1.234 0.258 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.736 -166.496 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.403 ' HD2' ' CE ' ' A' ' 13' ' ' LYS . 3.6 Cg_exo -55.54 -63.9 0.17 Allowed 'Trans proline' 0 C--N 1.362 1.277 0 C-N-CA 122.215 1.943 . . . . 0.0 110.236 172.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -163.59 116.07 1.47 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.125 167.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.1 t -61.56 152.07 31.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.279 -167.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.6 p -148.11 125.29 11.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.434 -165.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.24 0.573 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.398 -170.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.492 ' HG3' ' N ' ' A' ' 20' ' ' TYR . 2.2 tp10 . . . . . 0 N--CA 1.475 0.823 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.492 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 10.0 t80 -105.92 142.43 35.63 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.072 164.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.466 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 1.0 OUTLIER 177.36 133.77 0.21 Allowed Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.582 154.117 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 21' ' ' ARG . 71.9 Cg_endo -88.25 139.52 4.35 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.53 2.82 . . . . 0.0 109.413 -160.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.682 HD23 ' CD2' ' A' ' 53' ' ' PHE . 0.2 OUTLIER -121.92 -163.84 1.1 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.884 160.051 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.584 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 17.5 t -127.24 142.94 51.35 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.702 159.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -78.08 179.38 51.62 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 169.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 60.0 p -98.28 26.59 5.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.434 0.635 . . . . 0.0 110.404 169.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.743 ' HB3' HD12 ' A' ' 48' ' ' LEU . 42.4 p-10 -123.1 13.49 9.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.615 -168.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 69.66 32.35 3.33 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.519 -176.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.1 mtpt -141.51 127.7 19.71 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.205 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.416 HG22 ' N ' ' A' ' 31' ' ' TYR . 84.5 m -62.03 163.39 7.96 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.179 162.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.416 ' N ' HG22 ' A' ' 30' ' ' THR . 25.4 m-85 -138.04 123.72 19.82 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.403 178.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.48 -43.54 99.18 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -167.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.408 ' HB3' ' HA ' ' A' ' 20' ' ' TYR . 0.9 OUTLIER -149.54 166.88 27.86 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 114.755 -0.723 . . . . 0.0 110.399 178.526 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -61.37 -28.46 69.25 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.522 -164.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.0 p -71.12 -39.43 72.03 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.366 -176.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 -75.96 -24.0 55.41 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.42 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.433 ' O ' HG23 ' A' ' 41' ' ' VAL . 57.4 t80 -61.37 -63.36 1.31 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.803 164.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.665 ' O ' HG13 ' A' ' 42' ' ' VAL . 86.1 m -62.19 -32.82 73.51 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.538 -161.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.789 ' HA ' HG22 ' A' ' 42' ' ' VAL . 6.3 p30 -78.13 -22.17 49.23 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 114.607 -1.178 . . . . 0.0 110.172 -176.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -66.36 -26.07 67.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.247 164.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.834 HG22 ' CD2' ' A' ' 48' ' ' LEU . 62.1 t -80.44 -46.74 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.094 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.474 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.789 HG22 ' HA ' ' A' ' 39' ' ' ASN . 15.6 m -74.78 -35.44 36.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.174 -169.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.444 ' OE1' HG23 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -60.73 -32.47 71.75 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.348 167.024 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.24 -32.64 72.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.404 -173.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 69.57 50.96 0.49 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.437 176.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.87 24.34 55.7 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 176.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 97.8 m -96.12 -87.84 0.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.378 -0.411 . . . . 0.0 110.169 169.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.834 ' CD2' HG22 ' A' ' 41' ' ' VAL . 1.0 OUTLIER -68.25 151.24 47.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.29 -161.917 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 31.9 p -151.34 -178.87 6.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.188 168.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.802 HD22 ' CG2' ' A' ' 6' ' ' VAL . 3.6 tp -79.55 140.84 37.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.158 -166.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.5 t -96.39 -35.02 11.33 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.451 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.584 ' CE1' ' HB3' ' A' ' 24' ' ' CYS . 1.0 OUTLIER 174.73 157.49 0.16 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.335 178.649 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.774 ' CE1' HD21 ' A' ' 50' ' ' LEU . 20.7 m-85 -91.37 141.32 28.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.345 173.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 113.11 40.67 1.04 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 166.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.419 ' CE ' ' HB2' ' A' ' 22' ' ' PRO . 0.2 OUTLIER 60.73 171.44 0.1 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.441 -0.88 . . . . 0.0 110.553 -174.757 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.523 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 1.8 t . . . . . 0 C--O 1.241 0.621 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.032 -157.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.689 ' O ' HD23 ' A' ' 1' ' ' LEU . 7.0 tt . . . . . 0 N--CA 1.473 0.686 0 CA-C-O 121.149 0.5 . . . . 0.0 109.849 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -175.02 162.38 3.07 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.267 -170.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -143.7 106.61 4.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.245 168.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.722 HG22 ' CE1' ' A' ' 53' ' ' PHE . 7.3 p -120.19 94.68 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.459 169.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.5 p -123.17 174.84 7.0 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.349 -173.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.726 ' CG2' HD22 ' A' ' 50' ' ' LEU . 9.0 t -129.44 140.32 49.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.848 -172.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.83 90.53 3.17 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.736 -156.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.536 ' SG ' HG12 ' A' ' 6' ' ' VAL . 66.4 m -138.58 39.41 2.22 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.089 -158.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.4 t -90.81 61.51 4.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.213 169.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.38 -23.75 0.01 OUTLIER 'General case' 0 C--O 1.235 0.315 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.794 -175.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.532 ' O ' HG11 ' A' ' 42' ' ' VAL . 41.2 m-85 -59.25 161.43 9.87 Favored Pre-proline 0 C--O 1.239 0.543 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.541 167.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.41 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 35.0 Cg_endo -77.93 150.16 88.94 Favored 'Cis proline' 0 CA--C 1.517 -0.339 0 C-N-CA 122.779 -1.759 . . . . 0.0 109.304 1.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.476 ' HG2' ' CD2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -109.65 152.12 42.65 Favored Pre-proline 0 C--O 1.237 0.411 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.225 -179.628 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -76.29 -21.53 13.44 Favored 'Trans proline' 0 CA--C 1.514 -0.511 0 C-N-CA 122.647 2.231 . . . . 0.0 110.721 -172.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -121.4 118.13 28.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.267 -166.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.9 m -97.41 -176.05 3.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.982 165.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 17' ' ' THR . 1.6 t -125.43 35.81 4.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.175 169.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.8 tt . . . . . 0 C--O 1.24 0.581 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.306 -168.819 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 . . . . . 0 N--CA 1.475 0.78 0 CA-C-O 121.076 0.465 . . . . 0.0 109.783 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.497 ' CD1' ' N ' ' A' ' 21' ' ' ARG . 27.9 t80 -61.79 154.2 26.43 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.157 174.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.497 ' N ' ' CD1' ' A' ' 20' ' ' TYR . 6.2 ptp180 176.72 154.98 0.42 Allowed Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.671 154.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.454 ' HB2' ' HG3' ' A' ' 55' ' ' LYS . 61.6 Cg_endo -90.55 100.45 0.27 Allowed 'Trans proline' 0 C--O 1.237 0.43 0 C-N-CA 123.776 2.984 . . . . 0.0 109.278 -162.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.582 ' O ' HG22 ' A' ' 30' ' ' THR . 0.1 OUTLIER -110.67 178.61 4.31 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 121.971 -0.455 . . . . 0.0 109.924 157.089 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.669 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 36.7 t -132.03 124.38 29.14 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 154.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.28 -165.49 1.89 Allowed Glycine 0 CA--C 1.529 0.968 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 173.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.8 t -98.26 39.13 1.26 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.591 0.71 . . . . 0.0 110.387 165.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.696 ' HB3' HD12 ' A' ' 48' ' ' LEU . 31.4 p-10 -123.24 13.58 9.63 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.672 -171.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 66.17 32.27 8.17 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.663 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.12 159.89 18.15 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 114.691 -1.141 . . . . 0.0 110.767 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.582 HG22 ' O ' ' A' ' 23' ' ' LEU . 1.0 OUTLIER -71.71 165.28 24.34 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.347 178.247 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.5 ' O ' HD12 ' A' ' 23' ' ' LEU . 62.1 m-85 -126.66 141.76 51.75 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.067 162.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.3 -85.82 0.31 Allowed Glycine 0 CA--C 1.525 0.658 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.551 177.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.412 ' ND2' ' HB2' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -78.0 158.0 29.43 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.932 -0.634 . . . . 0.0 109.755 -178.865 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.538 ' HD2' HG13 ' A' ' 6' ' ' VAL . 6.6 ttpm? -61.06 -27.68 68.52 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.859 172.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 25.6 p -90.12 -26.13 20.36 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.722 -169.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.412 ' HB2' ' ND2' ' A' ' 33' ' ' ASN . 1.3 m120 -79.34 -24.91 42.43 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.326 168.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.623 ' CE1' HD21 ' A' ' 48' ' ' LEU . 30.4 t80 -62.18 -69.96 0.22 Allowed 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.628 164.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.592 ' O ' HG22 ' A' ' 42' ' ' VAL . 96.6 m -67.77 -25.7 65.74 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.366 -164.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -65.08 -28.86 69.75 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.766 171.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.525 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -74.94 -33.22 61.92 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.425 174.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.665 HG22 ' CD2' ' A' ' 48' ' ' LEU . 97.2 t -62.98 -60.19 3.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.251 175.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.748 HG23 ' OE1' ' A' ' 43' ' ' GLU . 5.9 m -63.56 -34.08 65.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.19 -169.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.748 ' OE1' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -64.5 -36.57 84.63 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.43 174.893 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.723 ' HB2' HG22 ' A' ' 47' ' ' THR . 20.5 p -71.99 -19.28 61.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.438 -174.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 69.69 30.36 3.91 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.378 177.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.64 44.65 4.83 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 167.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.723 HG22 ' HB2' ' A' ' 44' ' ' SER . 3.5 t -115.8 -37.55 3.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.281 -0.459 . . . . 0.0 110.51 171.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.696 HD12 ' HB3' ' A' ' 27' ' ' ASP . 1.4 tt -74.21 -82.61 0.06 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.507 -164.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.684 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.2 OUTLIER 61.96 161.84 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.326 -179.769 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.726 HD22 ' CG2' ' A' ' 6' ' ' VAL . 3.3 tp -83.47 132.8 34.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.125 -165.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.2 t -78.23 -39.92 38.87 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 114.302 -1.317 . . . . 0.0 110.509 175.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.669 ' CE1' ' HB3' ' A' ' 24' ' ' CYS . 2.0 p-80 -176.57 174.51 1.86 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.137 176.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.722 ' CE1' HG22 ' A' ' 4' ' ' VAL . 19.2 m-85 -98.39 71.6 2.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.078 163.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -142.56 -156.97 6.97 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 178.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.454 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 14.9 mtpp -119.17 40.61 3.28 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 114.931 -0.635 . . . . 0.0 109.942 -178.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.49 ' HB2' HG23 ' A' ' 30' ' ' THR . 2.0 t . . . . . 0 C--O 1.241 0.611 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.137 156.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.473 0.716 0 CA-C-O 121.054 0.454 . . . . 0.0 109.835 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -100.47 -82.9 0.45 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.313 -169.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 61.58 74.2 0.45 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.273 172.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.45 ' O ' HD23 ' A' ' 50' ' ' LEU . 15.6 m -78.69 85.29 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.316 -165.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.9 t -132.36 -177.93 4.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.25 165.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.816 ' CG2' HD22 ' A' ' 50' ' ' LEU . 8.7 t -145.62 134.76 17.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.247 -166.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -99.71 97.42 8.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.485 -174.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.504 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 58.6 m -125.8 31.08 5.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.922 -171.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.6 t -87.46 60.87 6.28 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.192 -176.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -173.81 -25.17 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.064 -1.426 . . . . 0.0 109.214 -172.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.689 ' O ' HG11 ' A' ' 42' ' ' VAL . 63.1 m-85 -58.27 162.39 6.02 Favored Pre-proline 0 C--O 1.238 0.496 0 CA-C-N 113.948 -1.478 . . . . 0.0 110.636 163.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.44 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.3 Cg_endo -78.72 138.28 49.03 Favored 'Cis proline' 0 CA--C 1.516 -0.377 0 C-N-CA 122.838 -1.734 . . . . 0.0 109.239 1.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.421 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 1.3 mttp -88.13 170.4 11.57 Favored Pre-proline 0 C--O 1.24 0.596 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.986 172.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 13' ' ' LYS 0.253 11.5 Cg_endo -91.7 -18.84 0.86 Allowed 'Trans proline' 0 CA--C 1.512 -0.599 0 C-N-CA 122.595 2.196 . . . . 0.0 110.768 173.373 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.51 -170.45 0.52 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.001 0.429 . . . . 0.0 110.295 -172.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 61.2 m 64.46 139.65 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.492 174.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 17' ' ' THR . 1.4 t -172.12 23.77 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.369 -169.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.241 0.623 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.335 178.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' A' ' 21' ' ' ARG . 10.2 t80 -78.93 147.67 32.94 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.055 -165.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.481 ' N ' ' CD1' ' A' ' 20' ' ' TYR . 0.0 OUTLIER 177.73 134.86 0.22 Allowed Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.535 155.915 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.455 ' HB2' ' HG3' ' A' ' 55' ' ' LYS . 55.3 Cg_endo -83.45 127.74 4.53 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 123.684 2.922 . . . . 0.0 109.457 -160.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.422 HD23 ' CD2' ' A' ' 53' ' ' PHE . 0.2 OUTLIER -111.43 -170.12 1.59 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.903 160.304 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.634 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 17.4 t -124.16 145.32 49.38 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.643 158.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -78.97 176.13 54.82 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 166.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -98.09 43.73 1.06 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.357 -0.422 . . . . 0.0 110.319 164.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.523 ' HB3' HD12 ' A' ' 48' ' ' LEU . 26.8 p-10 -129.96 12.45 5.69 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.701 178.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.7 m120 69.68 34.05 2.8 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.581 -177.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -137.53 127.12 25.16 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.273 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 57.8 m -66.73 155.51 37.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.245 163.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.502 ' OH ' ' HB1' ' A' ' 40' ' ' ALA . 8.1 m-85 -135.31 128.69 32.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.439 -172.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.17 -49.34 79.11 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 -165.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.4 ' HB2' ' H ' ' A' ' 35' ' ' CYS . 0.1 OUTLIER -126.17 -169.4 2.01 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.269 -0.465 . . . . 0.0 109.825 -179.019 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.9 tptp -68.21 -33.35 74.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.277 160.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.4 ' H ' ' HB2' ' A' ' 33' ' ' ASN . 15.3 m -81.75 -21.11 38.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.223 -168.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -89.65 -25.37 21.29 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.313 174.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.619 ' O ' HG23 ' A' ' 41' ' ' VAL . 49.1 t80 -61.28 -66.4 0.54 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.109 166.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.504 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 72.9 m -61.12 -33.68 73.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.516 -164.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.458 ' HA ' HG22 ' A' ' 42' ' ' VAL . 79.4 m-20 -71.43 -30.37 65.98 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.106 179.008 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -61.54 -33.58 74.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.333 168.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.919 HG22 HD22 ' A' ' 48' ' ' LEU . 66.7 t -76.37 -52.76 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.515 -172.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.772 HG23 ' OE1' ' A' ' 43' ' ' GLU . 10.5 m -62.14 -29.22 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.205 -178.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.772 ' OE1' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -70.3 -39.42 74.84 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 113.804 -1.544 . . . . 0.0 110.499 173.267 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.2 p -61.98 -16.6 52.62 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.5 -175.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 67.86 35.31 3.91 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.393 176.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.62 80.67 0.66 Allowed Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 173.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.9 t -171.47 -39.89 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.973 -0.613 . . . . 0.0 110.566 -170.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.919 HD22 HG22 ' A' ' 41' ' ' VAL . 4.9 tt -75.82 -83.02 0.07 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.379 -168.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.846 ' N ' HD23 ' A' ' 48' ' ' LEU . 6.7 p 59.09 163.47 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.072 -178.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.816 HD22 ' CG2' ' A' ' 6' ' ' VAL . 2.9 tp -81.1 159.84 24.61 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.303 -159.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.481 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 41.3 t -113.07 -39.84 4.1 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 114.482 -1.236 . . . . 0.0 110.63 174.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.634 ' CE1' ' HB3' ' A' ' 24' ' ' CYS . 1.9 p-80 -175.92 160.49 2.34 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.327 -176.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.546 ' CD1' HD21 ' A' ' 50' ' ' LEU . 29.8 m-85 -100.54 22.89 11.08 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.564 -165.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -119.07 -174.69 15.95 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 164.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.455 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -61.38 170.12 1.93 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.137 -0.531 . . . . 0.0 109.977 163.077 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.495 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 1.2 t . . . . . 0 N--CA 1.471 0.604 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.879 -155.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.474 0.748 0 CA-C-O 121.207 0.527 . . . . 0.0 109.812 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.567 ' HB1' ' OG ' ' A' ' 5' ' ' SER . . . -66.07 169.23 7.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.229 170.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.497 ' O ' HG12 ' A' ' 4' ' ' VAL . . . -108.09 74.4 0.94 Allowed 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.229 -173.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 3' ' ' ALA . 4.5 p 59.05 27.13 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.339 -176.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.567 ' OG ' ' HB1' ' A' ' 2' ' ' ALA . 2.2 p -108.11 179.43 4.22 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.46 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.802 ' CG2' HD22 ' A' ' 50' ' ' LEU . 97.2 t -139.3 145.47 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.054 -171.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -132.4 94.75 3.49 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.993 -156.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.494 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 61.1 m -133.43 35.23 3.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.195 -161.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.34 61.45 6.65 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.272 174.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.03 -24.81 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.159 -1.382 . . . . 0.0 109.356 -175.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.659 ' C ' HG11 ' A' ' 42' ' ' VAL . 41.2 m-85 -57.92 160.66 8.02 Favored Pre-proline 0 C--O 1.237 0.413 0 CA-C-N 114.083 -1.417 . . . . 0.0 110.544 161.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.699 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.0 Cg_endo -88.17 165.22 42.38 Favored 'Cis proline' 0 CA--C 1.519 -0.264 0 C-N-CA 123.185 -1.59 . . . . 0.0 109.364 9.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -136.2 97.09 12.25 Favored Pre-proline 0 C--O 1.237 0.4 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.266 -170.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -51.85 -20.84 10.57 Favored 'Trans proline' 0 C--N 1.36 1.149 0 C-N-CA 122.841 2.361 . . . . 0.0 110.871 175.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.02 88.03 2.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.359 165.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 81.3 m -113.61 -172.11 2.01 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.966 166.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.2 20.82 5.3 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.446 162.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.8 mt . . . . . 0 C--O 1.24 0.582 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.306 173.653 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.6 pm0 . . . . . 0 N--CA 1.474 0.73 0 CA-C-O 121.124 0.487 . . . . 0.0 109.754 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.463 ' CD1' ' HA ' ' A' ' 21' ' ' ARG . 10.6 t80 -91.76 144.42 25.52 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.161 171.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.463 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 1.1 ptm180 177.37 131.91 0.2 Allowed Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.531 154.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 21' ' ' ARG . 66.8 Cg_endo -85.48 139.21 6.71 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 123.684 2.923 . . . . 0.0 109.512 -159.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.793 ' O ' HG23 ' A' ' 30' ' ' THR . 0.2 OUTLIER -117.2 -168.92 1.56 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.88 159.485 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.552 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 21.8 t -119.78 118.61 31.3 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.413 158.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.434 ' HA3' ' CE2' ' A' ' 31' ' ' TYR . . . -86.53 144.11 19.6 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 168.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.72 40.08 1.15 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.379 -0.41 . . . . 0.0 110.314 -164.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.918 ' HB3' HD12 ' A' ' 48' ' ' LEU . 22.1 p-10 -99.49 -45.71 5.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.013 167.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -175.03 -30.1 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.043 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -119.66 154.4 34.1 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.446 -155.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.793 HG23 ' O ' ' A' ' 23' ' ' LEU . 69.9 m -75.71 146.82 39.85 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.047 159.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.459 ' CE1' ' HB2' ' A' ' 40' ' ' ALA . 19.9 m-85 -114.66 127.35 55.72 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.445 -173.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.49 -47.29 91.48 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -167.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -137.64 171.77 13.95 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-O 121.416 0.627 . . . . 0.0 110.438 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.4 ' CE ' HG13 ' A' ' 6' ' ' VAL . 6.8 tttm -70.68 -27.44 64.02 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.531 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.5 t -73.45 -20.66 60.66 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.074 -0.967 . . . . 0.0 110.635 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -102.13 -22.12 14.28 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.833 -178.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.776 ' O ' HG23 ' A' ' 41' ' ' VAL . 75.9 t80 -62.21 -60.04 4.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.952 164.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.525 ' O ' HG22 ' A' ' 42' ' ' VAL . 72.1 m -60.19 -28.87 68.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.946 -173.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.508 ' HA ' HG22 ' A' ' 42' ' ' VAL . 3.1 m120 -73.98 -31.27 62.91 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.215 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -61.33 -28.59 69.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.326 168.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.895 HG22 ' CD2' ' A' ' 48' ' ' LEU . 28.7 t -88.4 -46.66 15.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.525 -168.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.726 HG23 ' OE1' ' A' ' 43' ' ' GLU . 8.7 m -61.94 -35.36 67.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.346 174.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.726 ' OE1' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -63.11 -46.58 86.67 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.373 178.938 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.422 ' CB ' HG22 ' A' ' 47' ' ' THR . 5.7 p -76.72 -10.12 59.16 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.847 -168.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.294 0.1 OUTLIER 75.29 27.52 1.08 Allowed 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.209 -1.36 . . . . 0.0 109.626 173.113 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.58 40.32 4.76 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 166.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.422 HG22 ' CB ' ' A' ' 44' ' ' SER . 14.6 t -126.67 -37.47 2.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.981 0.42 . . . . 0.0 110.329 -171.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.918 HD12 ' HB3' ' A' ' 27' ' ' ASP . 1.3 tt -78.94 148.58 32.61 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.171 168.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.503 HG22 ' H ' ' A' ' 50' ' ' LEU . 3.8 m -157.14 167.85 29.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.327 174.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.802 HD22 ' CG2' ' A' ' 6' ' ' VAL . 7.6 tp -74.65 130.95 40.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.157 -169.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.5 t -84.64 -37.28 21.25 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.535 174.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.552 ' CE1' ' HB3' ' A' ' 24' ' ' CYS . 1.2 p-80 176.96 151.16 0.17 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.204 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.702 ' CE1' HD21 ' A' ' 50' ' ' LEU . 45.4 m-85 -78.16 166.1 23.16 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.318 177.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 62.71 -179.41 5.06 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.331 -1.107 . . . . 0.0 110.331 -162.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.57 -175.62 1.69 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 114.93 -0.635 . . . . 0.0 110.333 -174.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.504 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 3.0 t . . . . . 0 C--O 1.241 0.632 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.215 -155.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 16.9 tp . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.47 75.67 0.4 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.384 -171.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -116.62 25.24 10.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.233 -167.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.8 p -108.54 19.14 6.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.423 167.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.1 p -118.94 165.62 13.86 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.375 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.847 ' CG2' HD22 ' A' ' 50' ' ' LEU . 11.3 t -131.43 110.96 18.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.283 -166.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -72.35 123.58 23.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.44 166.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.548 ' SG ' HG12 ' A' ' 6' ' ' VAL . 60.7 m -138.51 41.9 2.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.126 175.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.1 59.17 3.49 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.295 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -173.27 -24.58 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 114.137 -1.392 . . . . 0.0 109.467 -174.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.538 ' O ' HG11 ' A' ' 42' ' ' VAL . 42.6 m-85 -58.98 162.82 6.45 Favored Pre-proline 0 C--O 1.24 0.571 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.605 167.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.426 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 31.6 Cg_endo -77.74 141.69 67.98 Favored 'Cis proline' 0 CA--C 1.517 -0.331 0 C-N-CA 122.947 -1.689 . . . . 0.0 109.325 0.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.426 ' HE3' ' HA ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -73.0 172.78 7.1 Favored Pre-proline 0 N--CA 1.455 -0.213 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.163 -178.604 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -53.91 -62.88 0.26 Allowed 'Trans proline' 0 C--N 1.361 1.202 0 C-N-CA 122.754 2.303 . . . . 0.0 110.585 172.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -114.87 116.12 28.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.262 -165.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.2 m -120.06 77.25 1.23 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.46 168.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.4 m -153.25 128.52 9.82 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.391 175.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.549 HD13 ' C ' ' A' ' 18' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.24 0.592 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.234 -173.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.451 ' HA ' HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.474 0.771 0 CA-C-O 121.658 0.742 . . . . 0.0 109.758 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -83.06 -52.66 6.44 Favored 'General case' 0 C--O 1.248 1.023 0 CA-C-O 117.576 -1.202 . . . . 0.0 109.054 165.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.0 ptp85 -53.9 138.07 54.7 Favored Pre-proline 0 CA--C 1.537 0.454 0 O-C-N 120.456 -1.402 . . . . 0.0 110.967 -145.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -101.88 167.34 0.31 Allowed 'Trans proline' 0 N--CA 1.476 0.444 0 C-N-CA 123.978 3.119 . . . . 0.0 109.405 -148.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.632 HD23 ' CD2' ' A' ' 53' ' ' PHE . 0.2 OUTLIER -132.88 -162.27 1.22 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 158.404 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.527 ' O ' HD12 ' A' ' 50' ' ' LEU . 19.9 t -130.18 146.53 51.82 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.478 157.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.04 -167.65 41.69 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.069 -1.213 . . . . 0.0 110.069 175.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.22 27.04 4.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.457 0.646 . . . . 0.0 110.42 166.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.704 ' HB3' HD12 ' A' ' 48' ' ' LEU . 54.5 p-10 -122.48 11.81 9.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.869 -167.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.6 m120 68.55 34.48 3.56 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.629 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.1 mttp -141.16 138.88 33.73 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.323 -178.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.3 m -76.89 145.94 37.96 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.281 163.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.539 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 3.2 m-85 -121.81 133.69 54.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.434 -175.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.8 -73.11 0.54 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -169.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.417 ' ND2' ' HB3' ' A' ' 35' ' ' CYS . 1.0 OUTLIER -110.13 165.29 11.86 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.256 0.551 . . . . 0.0 110.56 175.464 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -62.84 -15.9 56.31 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.457 172.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.417 ' HB3' ' ND2' ' A' ' 33' ' ' ASN . 2.4 t -80.9 -18.23 47.91 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.463 178.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -103.89 -21.73 13.6 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.656 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.543 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 52.3 t80 -61.47 -64.92 0.79 Allowed 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.779 162.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.603 ' O ' HG22 ' A' ' 42' ' ' VAL . 81.0 m -59.9 -26.64 66.07 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.228 -172.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.566 ' HA ' HG22 ' A' ' 42' ' ' VAL . 3.0 m120 -73.29 -29.97 63.08 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.135 177.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -61.87 -39.24 91.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.309 165.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.914 HG22 HD23 ' A' ' 48' ' ' LEU . 86.4 t -70.48 -48.79 57.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.476 -174.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.781 HG23 ' OE1' ' A' ' 43' ' ' GLU . 12.8 m -73.49 -34.98 44.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.154 -172.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.781 ' OE1' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -66.66 -31.82 72.75 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.291 -1.322 . . . . 0.0 110.57 170.291 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.809 ' OG ' HG22 ' A' ' 47' ' ' THR . 12.7 t -68.56 -27.95 66.53 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.298 -177.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 61.77 16.89 8.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.498 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.43 92.08 2.13 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 176.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.809 HG22 ' OG ' ' A' ' 44' ' ' SER . 5.3 t -175.21 -33.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.362 -0.419 . . . . 0.0 110.171 163.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.914 HD23 HG22 ' A' ' 41' ' ' VAL . 1.0 OUTLIER -67.53 -81.03 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.473 -164.16 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.44 153.1 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.293 178.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.847 HD22 ' CG2' ' A' ' 6' ' ' VAL . 2.7 tp -81.59 158.63 24.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.324 -164.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.469 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 35.8 t -109.11 -46.09 3.65 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.602 177.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.543 ' CE1' ' HA ' ' A' ' 56' ' ' CYS . 1.7 p-80 -165.99 -178.8 4.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.47 173.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.67 ' CE1' HD21 ' A' ' 50' ' ' LEU . 1.8 m-85 -112.44 106.87 15.46 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.271 167.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -170.93 -105.6 0.18 Allowed Glycine 0 CA--C 1.53 1.028 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 164.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.5 64.95 0.88 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 123.121 1.438 . . . . 0.0 110.16 156.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.543 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 1.1 t . . . . . 0 N--CA 1.47 0.538 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.194 159.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 43.3 tp . . . . . 0 N--CA 1.474 0.746 0 CA-C-O 121.164 0.506 . . . . 0.0 109.811 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.49 79.3 0.26 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.367 -170.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -168.69 75.9 0.11 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.27 -168.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.42 HG13 ' O ' ' A' ' 4' ' ' VAL . 8.6 p -62.54 83.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.358 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.91 -177.08 5.25 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 114.832 -1.077 . . . . 0.0 110.328 -177.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.863 ' CG2' HD22 ' A' ' 50' ' ' LEU . 11.3 t -135.04 120.28 29.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.283 -166.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -72.84 80.65 1.16 Allowed 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.407 177.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 60.8 m -103.02 42.22 1.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.217 174.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.2 59.34 3.03 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.231 -178.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -173.66 -24.6 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 114.074 -1.421 . . . . 0.0 109.239 -173.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.537 ' HB3' ' HA ' ' A' ' 12' ' ' PRO . 47.9 m-85 -58.05 160.3 9.04 Favored Pre-proline 0 C--O 1.237 0.409 0 CA-C-N 113.98 -1.464 . . . . 0.0 110.714 164.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.537 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 33.6 Cg_endo -83.06 139.96 38.51 Favored 'Cis proline' 0 C--O 1.235 0.334 0 C-N-CA 122.894 -1.711 . . . . 0.0 109.409 8.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.423 ' CG ' ' HD3' ' A' ' 14' ' ' PRO . 1.9 tttp -78.83 149.97 74.78 Favored Pre-proline 0 C--O 1.237 0.421 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.937 164.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.423 ' HD3' ' CG ' ' A' ' 13' ' ' LYS . 13.6 Cg_endo -78.33 -21.48 10.35 Favored 'Trans proline' 0 C--O 1.238 0.516 0 C-N-CA 122.714 2.276 . . . . 0.0 110.794 -170.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -129.54 123.64 31.91 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 122.093 -0.38 . . . . 0.0 110.268 -161.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 21.8 m -80.07 -170.68 2.58 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.927 159.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.7 t -145.51 25.2 1.36 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.569 165.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.638 HD13 ' OD1' ' A' ' 33' ' ' ASN . 9.3 tt . . . . . 0 C--O 1.241 0.624 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.496 -174.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.453 ' HG2' ' N ' ' A' ' 20' ' ' TYR . 4.1 tt0 . . . . . 0 N--CA 1.475 0.803 0 CA-C-O 121.114 0.483 . . . . 0.0 109.715 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.466 ' CD1' ' HA ' ' A' ' 21' ' ' ARG . 11.2 t80 -71.63 144.62 49.37 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.165 -175.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.466 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 0.0 OUTLIER 177.3 133.49 0.21 Allowed Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.359 155.179 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.428 ' HB2' ' CD ' ' A' ' 55' ' ' LYS . 57.9 Cg_endo -83.14 134.23 6.85 Favored 'Trans proline' 0 CA--C 1.515 -0.434 0 C-N-CA 123.729 2.953 . . . . 0.0 109.549 -159.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.569 ' O ' HG23 ' A' ' 30' ' ' THR . 0.2 OUTLIER -114.94 -170.12 1.69 Allowed 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.874 166.16 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 18.5 t -133.81 102.9 5.62 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.416 158.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.422 ' H ' ' HD2' ' A' ' 31' ' ' TYR . . . -63.93 155.49 45.34 Favored Glycine 0 N--CA 1.467 0.722 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 164.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.0 p -96.25 41.38 1.11 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.144 -0.528 . . . . 0.0 110.33 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.544 ' HB3' HD12 ' A' ' 48' ' ' LEU . 32.1 p-10 -108.08 21.85 16.79 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.862 0.839 . . . . 0.0 109.994 164.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . 0.399 0.1 OUTLIER 90.79 -17.55 0.18 Allowed 'General case' 0 C--O 1.239 0.53 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.948 -173.232 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.7 mttm -100.94 135.71 41.94 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 122.179 -0.326 . . . . 0.0 110.417 -159.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.569 HG23 ' O ' ' A' ' 23' ' ' LEU . 67.3 m -79.46 130.03 35.03 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.852 157.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.472 ' HE2' HD11 ' A' ' 48' ' ' LEU . 11.0 m-85 -102.21 123.59 46.31 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.449 -168.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.59 -42.21 99.72 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -169.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.638 ' OD1' HD13 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -156.64 161.85 39.87 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 114.918 -0.641 . . . . 0.0 110.231 -175.614 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.82 -29.18 69.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.737 -163.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.2 p -66.54 -31.35 72.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.312 -175.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -92.65 -25.72 18.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.505 -175.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.461 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 37.2 t80 -62.72 -71.65 0.15 Allowed 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.642 166.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 71.1 m -61.45 -32.56 72.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.44 -165.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.563 ' HA ' HG22 ' A' ' 42' ' ' VAL . 2.4 m-80 -67.25 -23.57 65.71 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.019 177.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.611 ' C ' HD22 ' A' ' 48' ' ' LEU . . . -82.38 -22.31 35.48 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 114.351 -1.295 . . . . 0.0 110.377 175.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.823 HG22 HD23 ' A' ' 48' ' ' LEU . 90.2 t -72.27 -59.01 3.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.519 171.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.732 HG23 ' OE1' ' A' ' 43' ' ' GLU . 22.6 m -61.92 -27.28 42.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.07 -170.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.732 ' OE1' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -69.32 -47.42 64.52 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 113.697 -1.592 . . . . 0.0 110.584 174.956 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.938 ' CB ' HG22 ' A' ' 47' ' ' THR . 1.1 p -62.11 -17.79 58.82 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.697 -177.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 24.8 m120 62.16 16.61 8.47 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.319 -176.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.99 68.24 0.83 Allowed Glycine 0 CA--C 1.527 0.798 0 CA-C-N 114.618 -1.173 . . . . 0.0 110.475 -173.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.938 HG22 ' CB ' ' A' ' 44' ' ' SER . 1.4 t -136.29 -36.28 0.73 Allowed 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.373 0.606 . . . . 0.0 110.684 161.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.823 HD23 HG22 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -75.24 -92.42 0.02 OUTLIER 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.529 -178.52 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 17.3 p 52.3 176.75 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 121.513 -0.742 . . . . 0.0 112.594 -172.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.863 HD22 ' CG2' ' A' ' 6' ' ' VAL . 3.3 tp -91.4 123.03 34.51 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.287 -159.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.9 t -60.64 -61.96 2.21 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.317 162.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.65 ' C ' HD11 ' A' ' 50' ' ' LEU . 1.6 p-80 -158.97 163.11 36.76 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.112 173.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.824 ' CZ ' HG22 ' A' ' 6' ' ' VAL . 36.2 m-85 -77.66 176.03 9.35 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.333 169.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.48 173.4 3.31 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -164.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.428 ' CD ' ' HB2' ' A' ' 22' ' ' PRO . 7.7 mmmt -61.56 171.89 1.37 Allowed 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.261 -0.469 . . . . 0.0 110.208 169.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.481 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 1.5 t . . . . . 0 C--O 1.24 0.599 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.932 -158.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.501 ' O ' HD23 ' A' ' 1' ' ' LEU . 1.2 tt . . . . . 0 N--CA 1.473 0.721 0 CA-C-O 121.515 0.674 . . . . 0.0 109.944 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 1' ' ' LEU . . . 61.88 153.43 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.56 -175.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 61.78 98.39 0.03 OUTLIER 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.395 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.44 HG22 ' CZ ' ' A' ' 53' ' ' PHE . 13.2 p -80.39 -20.19 11.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.325 -168.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.3 t -59.99 165.87 3.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.683 -160.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.838 HG23 HD22 ' A' ' 50' ' ' LEU . 6.5 t -107.48 129.84 60.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.976 -159.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -107.58 107.85 18.87 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.537 170.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 35.2 m -111.71 47.1 1.06 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.436 -177.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.6 m -96.24 39.12 1.16 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 114.196 -1.365 . . . . 0.0 110.374 166.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -129.91 25.48 5.29 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.977 161.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.541 ' HB2' HG11 ' A' ' 42' ' ' VAL . 85.1 m-85 -126.63 166.87 19.42 Favored Pre-proline 0 C--O 1.236 0.386 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.704 -170.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.631 ' HB3' HD21 ' A' ' 39' ' ' ASN . 36.2 Cg_endo -72.42 138.88 57.18 Favored 'Cis proline' 0 CA--C 1.518 -0.319 0 C-N-CA 122.064 -2.057 . . . . 0.0 108.98 -7.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.476 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -80.7 -178.07 1.08 Allowed Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.264 176.887 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -53.29 -62.75 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.131 0 C-N-CA 122.702 2.268 . . . . 0.0 110.792 174.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -175.49 -163.64 0.12 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.427 -165.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 t -158.3 172.23 18.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.846 -166.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.484 ' O ' HD22 ' A' ' 18' ' ' LEU . 26.4 p -98.26 25.62 6.06 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.486 176.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.484 HD22 ' O ' ' A' ' 17' ' ' THR . 0.1 OUTLIER . . . . . 0 C--O 1.24 0.566 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.329 167.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 N--CA 1.473 0.678 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.469 ' CD1' ' N ' ' A' ' 21' ' ' ARG . 10.9 t80 -76.85 147.05 37.34 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.211 -169.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.469 ' N ' ' CD1' ' A' ' 20' ' ' TYR . 0.0 OUTLIER 177.73 135.61 0.22 Allowed Pre-proline 0 CA--C 1.536 0.413 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.531 155.848 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.421 ' HB2' ' HB3' ' A' ' 55' ' ' LYS . 47.7 Cg_endo -84.09 143.93 10.49 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.775 2.983 . . . . 0.0 109.593 -158.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.12 -165.52 1.69 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.055 158.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.623 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 21.1 t -132.6 148.53 52.37 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.293 158.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -81.87 -169.63 43.2 Favored Glycine 0 CA--C 1.531 1.093 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 174.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.4 m -97.62 19.9 12.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.98 -0.61 . . . . 0.0 110.454 161.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.705 ' HB3' HD12 ' A' ' 48' ' ' LEU . 34.1 p-10 -107.14 9.23 30.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.147 -175.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 67.91 38.61 2.78 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.587 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.91 137.6 34.95 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 114.583 -1.189 . . . . 0.0 110.342 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.6 m -72.48 147.65 45.84 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.24 162.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -122.74 125.04 44.73 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.394 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.34 -50.27 68.6 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -167.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.421 ' HB3' ' HA ' ' A' ' 20' ' ' TYR . 1.7 p30 -125.04 175.38 7.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.203 -0.498 . . . . 0.0 110.482 170.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.421 ' HE3' ' CG1' ' A' ' 6' ' ' VAL . 4.8 tttp -69.23 -17.57 63.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.414 169.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 22.8 m -60.99 -51.61 68.52 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.545 172.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -80.4 -21.33 42.37 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.859 -171.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.683 ' O ' HG23 ' A' ' 41' ' ' VAL . 57.7 t80 -61.29 -67.64 0.39 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.967 165.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.84 ' O ' HG22 ' A' ' 42' ' ' VAL . 96.8 m -65.05 -29.85 70.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.638 -163.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.631 HD21 ' HB3' ' A' ' 12' ' ' PRO . 6.4 m120 -65.37 -33.78 76.76 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.02 173.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -69.35 -24.22 63.87 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.324 174.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.936 HG22 HD22 ' A' ' 48' ' ' LEU . 59.3 t -87.9 -55.18 6.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.387 -172.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.84 HG22 ' O ' ' A' ' 38' ' ' CYS . 6.6 m -62.33 -23.09 31.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.149 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.76 ' OE1' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -77.13 -37.99 52.95 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 113.774 -1.557 . . . . 0.0 110.621 173.003 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.1 p -62.28 -19.99 63.82 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.628 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 69.27 41.61 1.33 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.274 -171.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.68 88.12 0.03 OUTLIER Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 172.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.1 t -176.4 -42.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.262 -0.469 . . . . 0.0 110.322 -167.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.936 HD22 HG22 ' A' ' 41' ' ' VAL . 1.0 OUTLIER -61.71 -73.93 0.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.367 172.25 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.858 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.2 OUTLIER 66.89 160.31 0.15 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.431 175.621 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.838 HD22 HG23 ' A' ' 6' ' ' VAL . 5.6 tp -82.7 162.05 21.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.286 -168.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.462 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 16.2 t -112.95 -41.44 3.75 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.671 173.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.623 ' CE1' ' HB3' ' A' ' 24' ' ' CYS . 1.6 p-80 -177.79 167.63 2.12 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.371 -173.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.756 ' CE1' HD21 ' A' ' 50' ' ' LEU . 2.2 m-85 -108.25 30.81 6.07 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.347 -177.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.67 -140.25 6.6 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 168.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 22' ' ' PRO . 1.2 pttm -131.82 63.84 1.61 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 123.2 1.476 . . . . 0.0 110.29 161.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.457 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 1.5 t . . . . . 0 C--O 1.24 0.57 0 O-C-N 121.345 -0.847 . . . . 0.0 110.187 158.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 1' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.474 0.753 0 CA-C-O 121.29 0.567 . . . . 0.0 109.791 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.48 24.59 14.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.417 171.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -174.38 44.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.305 169.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.555 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.4 p -89.66 83.59 2.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.345 -178.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -159.5 146.84 16.96 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.448 169.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.797 ' CG2' HD22 ' A' ' 50' ' ' LEU . 4.9 t -145.91 111.77 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.998 -177.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -67.81 114.22 6.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.408 167.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.476 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 57.8 m -133.39 37.16 3.36 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.036 177.105 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.1 m -91.23 58.7 3.75 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.221 -175.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -173.31 -24.19 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 114.081 -1.418 . . . . 0.0 109.488 -174.126 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.595 ' O ' HG11 ' A' ' 42' ' ' VAL . 74.3 m-85 -58.69 160.38 10.55 Favored Pre-proline 0 C--O 1.238 0.459 0 CA-C-N 113.987 -1.461 . . . . 0.0 110.617 166.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.48 ' HB3' HG21 ' A' ' 42' ' ' VAL . 31.9 Cg_endo -78.32 139.99 58.33 Favored 'Cis proline' 0 C--O 1.233 0.261 0 C-N-CA 122.771 -1.762 . . . . 0.0 109.369 3.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.465 ' HG3' ' HD3' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -70.02 159.13 85.47 Favored Pre-proline 0 C--O 1.24 0.575 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.834 164.249 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.465 ' HD3' ' HG3' ' A' ' 13' ' ' LYS . 30.5 Cg_endo -78.62 -64.24 0.02 OUTLIER 'Trans proline' 0 CA--C 1.519 -0.264 0 C-N-CA 122.885 2.39 . . . . 0.0 109.257 -175.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -135.38 130.73 35.37 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.242 -167.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.2 t -117.03 157.91 25.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.367 -168.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -112.51 130.03 56.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.424 -169.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.24 0.57 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.372 -170.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.721 0 CA-C-O 121.592 0.71 . . . . 0.0 109.841 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.5 ' CD2' ' N ' ' A' ' 21' ' ' ARG . 93.7 t80 -61.62 167.0 3.75 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.026 -177.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.5 ' N ' ' CD2' ' A' ' 20' ' ' TYR . 1.7 ptm180 178.52 172.28 0.44 Allowed Pre-proline 0 C--O 1.248 0.983 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.406 151.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.431 ' HG2' ' CE ' ' A' ' 55' ' ' LYS 0.253 82.6 Cg_endo -110.15 92.52 0.02 OUTLIER 'Trans proline' 0 CA--C 1.515 -0.435 0 C-N-CA 122.252 1.968 . . . . 0.0 109.232 -178.7 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.594 HD23 ' CD2' ' A' ' 53' ' ' PHE . 0.2 OUTLIER -90.15 -171.22 3.04 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.855 162.439 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.639 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 21.6 t -146.06 135.93 23.45 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.221 156.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.27 -171.75 41.56 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 114.387 -1.278 . . . . 0.0 110.316 -177.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.25 26.62 5.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.42 0.629 . . . . 0.0 110.479 170.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.89 ' HB3' HD12 ' A' ' 48' ' ' LEU . 24.9 p-10 -126.9 13.09 7.33 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.827 -166.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 69.24 32.51 3.58 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.289 -0.868 . . . . 0.0 110.59 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.73 137.9 38.78 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.285 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 23' ' ' LEU . 1.3 m -77.73 148.95 34.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.337 164.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -121.55 129.99 53.23 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.455 -176.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.55 -93.01 0.01 OUTLIER Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 168.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.0 p-10 -99.9 157.6 16.41 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.998 -0.601 . . . . 0.0 110.577 -168.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -61.59 -15.53 39.89 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.569 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.1 m -66.13 -45.44 81.06 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.471 173.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -89.59 -23.33 21.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.373 -168.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.492 ' O ' HG23 ' A' ' 41' ' ' VAL . 36.2 t80 -61.84 -69.11 0.26 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.877 162.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.551 ' O ' HG22 ' A' ' 42' ' ' VAL . 85.2 m -61.79 -30.92 71.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.574 -168.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.521 ' HA ' HG22 ' A' ' 42' ' ' VAL . 90.0 m-20 -67.07 -31.44 71.95 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.942 175.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -71.17 -17.24 62.55 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.372 174.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.824 HG22 ' CD2' ' A' ' 48' ' ' LEU . 43.7 t -85.8 -52.5 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.501 177.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.748 HG23 ' OE1' ' A' ' 43' ' ' GLU . 4.4 m -70.1 -32.99 53.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.245 -170.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.748 ' OE1' HG23 ' A' ' 42' ' ' VAL . 2.0 mp0 -70.51 -29.81 66.42 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.498 170.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.66 -30.61 70.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.548 175.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 70.22 51.93 0.38 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.301 -166.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.69 21.93 55.95 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.192 176.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 40.5 m -66.9 -86.82 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 157.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.89 HD12 ' HB3' ' A' ' 27' ' ' ASP . 1.0 OUTLIER -61.3 148.66 40.49 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.302 -163.333 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 77.0 p -138.89 -172.43 3.32 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.921 165.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.797 HD22 ' CG2' ' A' ' 6' ' ' VAL . 5.8 tp -86.8 133.19 33.67 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.369 -173.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.449 ' O ' HG21 ' A' ' 4' ' ' VAL . 36.6 t -82.82 -37.04 24.98 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 113.921 -1.49 . . . . 0.0 110.597 173.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.639 ' CE1' ' HB3' ' A' ' 24' ' ' CYS . 1.1 p-80 173.47 162.66 0.15 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.334 -178.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.697 ' CE1' HD21 ' A' ' 50' ' ' LEU . 1.3 m-85 -98.78 74.9 2.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.894 160.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -152.39 21.79 0.84 Allowed Glycine 0 CA--C 1.523 0.57 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.811 -172.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.431 ' CE ' ' HG2' ' A' ' 22' ' ' PRO . 9.1 mttp 61.27 35.25 18.27 Favored 'General case' 0 C--O 1.239 0.506 0 O-C-N 122.753 -0.263 . . . . 0.0 110.307 164.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.474 0.734 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.734 156.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.474 0.763 0 CA-C-O 121.181 0.515 . . . . 0.0 109.881 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.85 142.96 48.17 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.274 170.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -174.9 102.02 0.09 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.295 -176.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.3 p -74.35 97.53 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.279 166.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.7 p -164.72 -177.11 4.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.261 -167.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.645 HG13 ' CZ ' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -136.79 -175.58 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.282 -167.248 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -153.94 65.86 0.72 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.342 -168.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.527 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 59.4 m -99.83 32.78 2.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.973 -174.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.72 60.5 5.59 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.196 -176.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -173.71 -24.98 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.326 -172.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.474 ' CE2' ' HD2' ' A' ' 13' ' ' LYS . 79.1 m-85 -58.33 160.29 9.82 Favored Pre-proline 0 C--O 1.236 0.374 0 CA-C-N 113.894 -1.503 . . . . 0.0 110.529 163.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.499 ' HB3' HG21 ' A' ' 42' ' ' VAL . 30.5 Cg_endo -78.69 135.83 38.53 Favored 'Cis proline' 0 CA--C 1.518 -0.277 0 C-N-CA 122.667 -1.806 . . . . 0.0 109.378 6.022 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.474 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.8 OUTLIER -67.91 162.1 61.74 Favored Pre-proline 0 C--O 1.238 0.459 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.065 179.205 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.445 ' HD2' ' H ' ' A' ' 15' ' ' ALA . 30.3 Cg_endo -76.13 -57.57 0.05 OUTLIER 'Trans proline' 0 CA--C 1.516 -0.376 0 C-N-CA 122.615 2.21 . . . . 0.0 109.328 -178.229 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.445 ' H ' ' HD2' ' A' ' 14' ' ' PRO . . . -130.73 112.14 12.81 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.272 -177.034 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.6 m -62.49 -165.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.98 164.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 17' ' ' THR . 1.6 t -155.17 49.3 0.56 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.411 169.042 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.678 HD23 ' ND2' ' A' ' 33' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--O 1.241 0.627 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.367 169.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.475 0.799 0 CA-C-O 121.465 0.65 . . . . 0.0 109.808 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.486 ' CD1' ' N ' ' A' ' 21' ' ' ARG . 10.5 t80 -108.87 146.86 33.04 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.288 -177.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.486 ' N ' ' CD1' ' A' ' 20' ' ' TYR . 0.0 OUTLIER 177.44 135.14 0.21 Allowed Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.712 155.586 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 21' ' ' ARG . 59.5 Cg_endo -86.11 139.14 6.08 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.539 2.826 . . . . 0.0 109.368 -161.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.758 ' O ' HG23 ' A' ' 30' ' ' THR . 0.3 OUTLIER -123.88 -165.09 1.3 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.999 161.57 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.58 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 15.9 t -134.58 118.09 16.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.874 165.334 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.54 -173.9 2.03 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.7 t -98.81 30.78 3.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.724 0.773 . . . . 0.0 110.356 165.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.832 ' HB3' HD12 ' A' ' 48' ' ' LEU . 32.2 p-10 -123.84 13.71 9.24 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.473 -166.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 66.74 31.97 7.17 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.532 178.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.37 141.96 19.83 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.81 173.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.758 HG23 ' O ' ' A' ' 23' ' ' LEU . 94.0 m -65.82 148.53 51.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.261 165.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -106.85 138.41 43.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.353 166.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.02 -53.58 41.65 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.678 ' ND2' HD23 ' A' ' 18' ' ' LEU . 5.0 p-10 -128.08 169.78 13.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.418 -0.391 . . . . 0.0 110.301 -173.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.38 -31.88 73.26 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.497 174.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.2 t -74.73 -21.84 59.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.573 -173.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -97.75 -22.75 16.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.66 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.502 ' O ' HG23 ' A' ' 41' ' ' VAL . 59.5 t80 -61.59 -68.09 0.35 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.762 164.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.527 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 64.4 m -61.0 -32.69 72.27 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.538 -167.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.429 ' HA ' HG22 ' A' ' 42' ' ' VAL . 5.6 m120 -73.45 -25.0 60.3 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.209 -178.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -65.31 -43.0 92.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.183 165.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.842 HG22 ' CD2' ' A' ' 48' ' ' LEU . 60.8 t -61.82 -51.97 66.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.54 -175.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.718 HG23 ' OE1' ' A' ' 43' ' ' GLU . 18.8 m -74.3 -34.07 36.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.1 -168.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.718 ' OE1' HG23 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -65.48 -29.51 70.18 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.442 169.748 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.5 t -80.75 -17.26 51.55 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.332 -172.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 53.3 t30 71.33 50.72 0.28 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.568 167.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.88 -21.2 47.3 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 164.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 46.0 m -62.02 -85.71 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.238 -0.481 . . . . 0.0 110.002 177.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.842 ' CD2' HG22 ' A' ' 41' ' ' VAL . 1.4 tt -59.98 148.19 36.2 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.495 -157.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.417 HG23 ' N ' ' A' ' 50' ' ' LEU . 0.9 OUTLIER -146.81 -163.21 1.7 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.619 167.108 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.66 HD11 ' C ' ' A' ' 52' ' ' HIS . 6.6 tp -94.45 118.68 32.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.15 -169.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.8 t -61.62 -42.16 98.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.493 167.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.66 ' C ' HD11 ' A' ' 50' ' ' LEU . 0.9 OUTLIER 173.73 158.1 0.13 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.182 178.967 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.652 ' CE1' HD21 ' A' ' 50' ' ' LEU . 5.2 m-85 -84.51 170.97 12.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.217 168.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.59 32.08 10.67 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 168.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.447 ' HG2' ' HG2' ' A' ' 22' ' ' PRO . 4.9 mttp 61.14 167.7 0.09 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 114.541 -0.829 . . . . 0.0 110.455 -174.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.582 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 2.2 t . . . . . 0 C--O 1.24 0.594 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.034 -160.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.848 0.356 . . . . 0.0 110.348 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.662 HG13 ' CZ ' ' A' ' 53' ' ' PHE . 0.6 OUTLIER -146.11 -175.18 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.206 -165.551 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -145.97 63.87 1.23 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.037 -155.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.458 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 76.6 m -117.11 42.49 2.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.279 -165.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.8 m -89.76 61.57 5.45 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.343 172.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -173.01 -24.44 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.349 -175.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.709 ' O ' HG11 ' A' ' 42' ' ' VAL . 29.2 m-85 -58.18 158.12 14.79 Favored Pre-proline 0 C--O 1.236 0.382 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.636 163.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.481 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.3 Cg_endo -86.67 154.46 48.3 Favored 'Cis proline' 0 C--O 1.232 0.22 0 C-N-CA 122.914 -1.702 . . . . 0.0 109.449 10.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.531 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.894 166.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 . . . . . 0 N--CA 1.473 0.699 0 CA-C-O 121.267 0.556 . . . . 0.0 109.882 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -87.67 -51.61 5.78 Favored 'General case' 0 C--O 1.251 1.145 0 CA-C-O 117.581 -1.2 . . . . 0.0 109.368 171.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.402 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.4 ptp180 -54.13 131.05 59.96 Favored Pre-proline 0 CA--C 1.54 0.583 0 O-C-N 120.427 -1.421 . . . . 0.0 110.768 -145.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.452 ' HG2' ' HG3' ' A' ' 55' ' ' LYS . 72.5 Cg_endo -93.67 166.71 2.21 Favored 'Trans proline' 0 CA--C 1.517 -0.347 0 C-N-CA 124.293 3.329 . . . . 0.0 109.526 -150.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.674 HD12 ' HB2' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -126.33 -170.7 2.24 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.939 164.185 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.471 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 17.8 t -131.1 119.62 22.22 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.612 157.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.1 174.5 7.35 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 172.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.07 40.57 1.17 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.009 -0.596 . . . . 0.0 110.471 167.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.428 ' HB3' HD12 ' A' ' 48' ' ' LEU . 37.8 p-10 -131.4 13.76 5.04 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.595 -177.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 69.73 33.64 2.89 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.62 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -139.12 132.44 30.01 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.532 178.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 23' ' ' LEU . 84.9 m -78.71 154.22 30.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.316 165.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -127.17 126.73 43.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.454 -170.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.01 -9.18 86.89 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.224 -169.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -159.57 176.22 12.3 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.099 -0.551 . . . . 0.0 110.498 171.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.5 mttp -61.65 -22.36 65.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.398 166.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 95.5 m -75.72 -43.91 44.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.359 -169.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -82.13 -22.81 35.99 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.866 178.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.674 ' HB2' HD12 ' A' ' 23' ' ' LEU . 29.8 t80 -61.86 -67.94 0.37 Allowed 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.028 167.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.571 ' O ' HG22 ' A' ' 42' ' ' VAL . 71.9 m -69.56 -25.35 63.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.271 -167.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.419 ' HA ' HG22 ' A' ' 42' ' ' VAL . 96.2 m-20 -65.93 -31.07 71.79 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.118 171.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -69.68 -36.2 75.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.491 172.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.799 HG22 HD23 ' A' ' 48' ' ' LEU . 84.7 t -65.89 -53.93 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.511 -179.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.709 HG11 ' O ' ' A' ' 11' ' ' TYR . 5.1 m -62.3 -35.27 68.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.121 -172.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.654 ' OE1' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -62.2 -37.16 84.25 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 114.125 -1.398 . . . . 0.0 110.419 171.077 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.666 ' HB2' HG22 ' A' ' 47' ' ' THR . 10.8 p -72.15 -24.4 61.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.41 -170.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 69.12 36.73 2.33 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.41 -172.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.67 94.28 0.01 OUTLIER Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -170.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.666 HG22 ' HB2' ' A' ' 44' ' ' SER . 6.1 t -169.99 -35.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.437 -0.381 . . . . 0.0 110.183 173.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.799 HD23 HG22 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -61.47 -83.19 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.314 166.731 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.478 HG22 ' H ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER 61.85 171.69 0.12 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.45 179.41 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.679 HD11 ' C ' ' A' ' 52' ' ' HIS . 8.2 tp -91.84 120.28 32.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.111 -166.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.8 t -64.21 -41.91 96.84 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.595 166.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.679 ' C ' HD11 ' A' ' 50' ' ' LEU . 1.9 p80 174.25 146.17 0.06 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.156 -178.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.662 ' CZ ' HG13 ' A' ' 6' ' ' VAL . 20.4 m-85 -67.88 170.1 8.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.2 171.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.87 170.49 8.07 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -164.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.452 ' HG3' ' HG2' ' A' ' 22' ' ' PRO . 4.2 mttm -62.47 176.31 0.65 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.339 -0.431 . . . . 0.0 110.246 170.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.45 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.8 OUTLIER . . . . . 0 N--CA 1.472 0.628 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.732 -158.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.7 p . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.795 0.331 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.679 ' CG2' HD22 ' A' ' 50' ' ' LEU . 98.3 t -151.49 127.08 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.29 -164.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -87.77 114.75 24.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.358 -172.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.617 ' SG ' HG12 ' A' ' 6' ' ' VAL . 57.1 m -138.85 35.5 2.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.958 -166.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.3 t -89.83 59.92 4.79 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.389 -176.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.43 -25.56 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.264 -175.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.491 ' O ' HG11 ' A' ' 42' ' ' VAL . 97.5 m-85 -60.17 160.47 16.75 Favored Pre-proline 0 C--O 1.238 0.474 0 CA-C-N 113.904 -1.498 . . . . 0.0 110.375 168.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.541 ' CG ' HG21 ' A' ' 42' ' ' VAL . 56.5 Cg_endo -79.12 147.3 79.82 Favored 'Cis proline' 0 C--O 1.233 0.273 0 C-N-CA 122.58 -1.842 . . . . 0.0 109.371 4.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.561 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.849 162.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 . . . . . 0 N--CA 1.475 0.816 0 CA-C-O 121.548 0.69 . . . . 0.0 109.809 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -93.09 -50.04 5.71 Favored 'General case' 0 C--O 1.249 1.07 0 CA-C-O 117.468 -1.253 . . . . 0.0 108.918 168.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.5 ptp85 -53.75 140.77 48.39 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 120.47 -1.393 . . . . 0.0 111.152 -144.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.453 ' HG2' ' HG2' ' A' ' 55' ' ' LYS . 60.4 Cg_endo -99.11 153.47 0.62 Allowed 'Trans proline' 0 N--CA 1.475 0.387 0 C-N-CA 124.133 3.222 . . . . 0.0 109.253 -150.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.59 HD22 HD13 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -119.46 -166.88 1.32 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.956 160.831 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.471 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 18.7 t -121.4 116.68 25.23 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.464 159.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.465 ' HA3' ' CE2' ' A' ' 31' ' ' TYR . . . -61.67 152.61 41.97 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 167.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.38 39.73 1.23 Allowed 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 115.196 -0.502 . . . . 0.0 110.403 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.72 ' HB3' HD12 ' A' ' 48' ' ' LEU . 13.7 p-10 -113.53 -48.73 2.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.362 174.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -176.34 -26.82 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.128 178.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.28 158.07 21.91 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.304 -156.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.685 HG21 ' HD2' ' A' ' 55' ' ' LYS . 60.1 m -77.03 133.29 39.16 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.901 157.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.565 ' HE2' HD11 ' A' ' 48' ' ' LEU . 18.1 m-85 -96.88 138.07 35.0 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.445 176.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.05 -69.76 1.22 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -177.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -131.92 167.32 19.82 Favored 'General case' 0 C--O 1.232 0.163 0 O-C-N 121.794 -0.827 . . . . 0.0 110.597 -178.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.98 -14.06 20.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.705 -169.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.8 m -72.35 -60.14 2.38 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.453 176.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -61.31 -25.6 67.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.798 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.455 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 53.5 t80 -62.12 -66.22 0.57 Allowed 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.872 170.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.546 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 96.7 m -66.21 -31.57 72.48 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.671 -160.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.54 ' HA ' HG22 ' A' ' 42' ' ' VAL . 5.1 p30 -72.16 -23.79 61.34 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.119 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.468 ' C ' HD22 ' A' ' 48' ' ' LEU . . . -69.33 -27.98 65.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.294 166.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.883 HG22 HD23 ' A' ' 48' ' ' LEU . 89.8 t -75.89 -45.62 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.578 -178.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.541 HG21 ' CG ' ' A' ' 12' ' ' PRO . 20.3 m -70.71 -35.32 60.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.084 -172.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.51 ' OE1' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -60.88 -33.8 73.66 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.335 168.413 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.55 ' OG ' HG22 ' A' ' 47' ' ' THR . 0.1 OUTLIER -70.98 -39.42 72.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.291 -169.41 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 69.09 24.16 6.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.223 -163.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.462 ' H ' ' HB3' ' A' ' 44' ' ' SER . . . 86.16 40.82 7.31 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 166.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.55 HG22 ' OG ' ' A' ' 44' ' ' SER . 6.1 t -100.88 -39.06 7.96 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.199 0.524 . . . . 0.0 110.268 165.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.883 HD23 HG22 ' A' ' 41' ' ' VAL . 0.3 OUTLIER -62.14 -86.99 0.01 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.408 -179.326 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.404 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER 67.17 164.13 0.2 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.488 174.234 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.761 HD21 ' CE1' ' A' ' 53' ' ' PHE . 5.0 tp -86.6 137.13 32.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.276 -168.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.7 t -92.4 -43.48 9.2 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.409 177.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.471 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.6 p80 -177.51 150.09 0.67 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.217 177.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.761 ' CE1' HD21 ' A' ' 50' ' ' LEU . 9.1 m-85 -76.78 157.17 31.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.303 175.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.6 166.29 23.47 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 -163.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.685 ' HD2' HG21 ' A' ' 30' ' ' THR . 4.4 mtmm -63.22 -179.0 0.28 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.419 -0.39 . . . . 0.0 110.267 177.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.453 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.8 OUTLIER . . . . . 0 N--CA 1.473 0.689 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.819 -155.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.507 ' O ' HG13 ' A' ' 6' ' ' VAL . 24.1 p . . . . . 0 C--O 1.233 0.2 0 CA-C-O 120.71 0.29 . . . . 0.0 110.33 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.519 HG21 ' CE2' ' A' ' 37' ' ' PHE . 0.4 OUTLIER -156.36 -176.01 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.25 -167.633 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -146.24 80.74 1.57 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.939 -156.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.445 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 62.4 m -125.49 48.03 2.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.22 -165.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.5 p -96.13 55.69 1.57 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.191 -175.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -173.2 -23.76 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.181 -1.372 . . . . 0.0 109.648 -174.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.533 ' O ' HG11 ' A' ' 42' ' ' VAL . 67.3 m-85 -59.83 161.63 11.4 Favored Pre-proline 0 C--O 1.239 0.52 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.505 170.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.409 ' CG ' HG21 ' A' ' 42' ' ' VAL . 35.9 Cg_endo -77.09 156.63 97.25 Favored 'Cis proline' 0 C--O 1.233 0.26 0 C-N-CA 122.676 -1.802 . . . . 0.0 109.14 -0.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.45 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 2.1 mtpm? . . . . . 0 C--O 1.234 0.263 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.135 -164.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 . . . . . 0 N--CA 1.474 0.733 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.462 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 31.5 t80 -63.19 -52.82 60.77 Favored 'General case' 0 C--O 1.247 0.943 0 CA-C-O 118.114 -0.946 . . . . 0.0 109.279 -166.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.459 ' NH1' ' HB3' ' A' ' 21' ' ' ARG . 2.0 ptp180 -54.4 142.75 49.24 Favored Pre-proline 0 CA--C 1.539 0.527 0 O-C-N 120.734 -1.229 . . . . 0.0 110.941 -146.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.462 ' HG3' ' CE2' ' A' ' 20' ' ' TYR 0.259 91.4 Cg_endo -119.47 -179.34 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 123.314 2.676 . . . . 0.0 108.907 -142.676 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.668 HD21 ' HZ3' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -142.2 -164.17 1.75 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.968 162.354 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.463 ' HB3' ' NE2' ' A' ' 52' ' ' HIS . 34.3 t -125.37 126.89 45.74 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 158.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.55 -171.95 48.52 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.3 p -97.74 34.43 1.87 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.001 -0.6 . . . . 0.0 110.312 163.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.406 ' HB3' ' CD1' ' A' ' 48' ' ' LEU . 24.2 p-10 -96.4 11.09 36.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.485 170.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.5 m120 62.76 42.95 7.57 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.594 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.69 168.51 9.01 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.846 173.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.5 m -67.53 138.13 56.29 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.997 164.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.482 ' HE2' HD11 ' A' ' 48' ' ' LEU . 3.8 m-85 -93.76 143.32 26.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.358 167.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.94 -56.48 22.31 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -174.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 39.6 p-10 -142.72 179.14 7.17 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 114.636 -0.782 . . . . 0.0 110.624 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.668 ' HZ3' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -61.71 -38.84 89.36 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.524 -178.553 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.6 m -70.99 -39.34 72.5 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.177 -169.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -74.32 -24.08 59.15 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.054 174.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.533 ' O ' HG23 ' A' ' 41' ' ' VAL . 73.2 t80 -62.21 -64.37 0.95 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.057 169.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.652 ' O ' HG13 ' A' ' 42' ' ' VAL . 74.1 m -60.25 -29.32 68.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.99 -171.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.705 ' HA ' HG22 ' A' ' 42' ' ' VAL . 31.6 m-20 -73.24 -31.38 64.08 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.173 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -61.67 -29.23 69.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.377 168.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 1.016 HG22 HD23 ' A' ' 48' ' ' LEU . 35.6 t -82.12 -42.58 18.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.524 -176.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.705 HG22 ' HA ' ' A' ' 39' ' ' ASN . 18.8 m -78.37 -34.29 18.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.209 -171.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.476 ' OE1' HG23 ' A' ' 42' ' ' VAL . 1.5 mp0 -64.09 -32.25 73.74 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.238 167.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.96 -21.79 63.82 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.734 -172.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 69.17 25.53 5.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.131 -168.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.5 85.96 0.09 OUTLIER Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 -170.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.9 t -151.77 -36.67 0.12 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.083 0.468 . . . . 0.0 110.514 166.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.016 HD23 HG22 ' A' ' 41' ' ' VAL . 0.8 OUTLIER -79.87 160.27 26.12 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.584 175.832 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.441 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 2.7 t -174.18 164.19 3.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.991 -174.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.686 HD21 ' CE1' ' A' ' 53' ' ' PHE . 5.8 tp -76.29 129.02 36.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.131 -164.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.6 t -77.23 -42.24 38.08 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.454 171.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.638 ' C ' HD11 ' A' ' 50' ' ' LEU . 1.0 OUTLIER -174.06 167.42 4.22 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.267 175.05 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.686 ' CE1' HD21 ' A' ' 50' ' ' LEU . 20.3 m-85 -94.72 89.23 5.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.248 168.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -155.96 -139.24 2.72 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.496 -1.041 . . . . 0.0 110.496 -175.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.431 ' HG2' ' HG2' ' A' ' 22' ' ' PRO . 6.8 mtpp -139.82 41.11 2.0 Allowed 'General case' 0 C--O 1.24 0.602 0 CA-C-N 115.26 -0.47 . . . . 0.0 109.874 170.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 C--O 1.241 0.647 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.022 161.915 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.3 p . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.844 0.354 . . . . 0.0 110.427 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.802 ' CG2' HD22 ' A' ' 50' ' ' LEU . 11.7 t -145.34 117.02 2.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.118 -164.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -73.27 117.74 15.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.466 169.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.516 ' SG ' HG12 ' A' ' 6' ' ' VAL . 59.8 m -138.08 44.38 2.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.115 177.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.66 58.56 3.12 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.373 -177.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -172.81 -24.33 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.539 -177.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.478 ' CD2' ' HB2' ' A' ' 38' ' ' CYS . 71.2 m-85 -60.69 159.73 23.66 Favored Pre-proline 0 C--O 1.236 0.345 0 CA-C-N 114.024 -1.443 . . . . 0.0 110.414 172.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.586 ' N ' HG21 ' A' ' 42' ' ' VAL . 56.2 Cg_endo -78.63 163.98 85.26 Favored 'Cis proline' 0 CA--C 1.519 -0.23 0 C-N-CA 122.511 -1.87 . . . . 0.0 109.337 5.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.258 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.736 -166.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.492 ' HG3' ' N ' ' A' ' 20' ' ' TYR . 2.2 tp10 . . . . . 0 N--CA 1.475 0.823 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.492 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 10.0 t80 -105.92 142.43 35.63 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.072 164.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.466 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 1.0 OUTLIER 177.36 133.77 0.21 Allowed Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.582 154.117 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 21' ' ' ARG . 71.9 Cg_endo -88.25 139.52 4.35 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.53 2.82 . . . . 0.0 109.413 -160.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.682 HD23 ' CD2' ' A' ' 53' ' ' PHE . 0.2 OUTLIER -121.92 -163.84 1.1 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.884 160.051 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.469 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 17.5 t -127.24 142.94 51.35 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.702 159.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -78.08 179.38 51.62 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 169.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 60.0 p -98.28 26.59 5.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.434 0.635 . . . . 0.0 110.404 169.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.743 ' HB3' HD12 ' A' ' 48' ' ' LEU . 42.4 p-10 -123.1 13.49 9.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.615 -168.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 69.66 32.35 3.33 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.519 -176.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.1 mtpt -141.51 127.7 19.71 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.205 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.416 HG22 ' N ' ' A' ' 31' ' ' TYR . 84.5 m -62.03 163.39 7.96 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.179 162.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.416 ' N ' HG22 ' A' ' 30' ' ' THR . 25.4 m-85 -138.04 123.72 19.82 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.403 178.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.48 -43.54 99.18 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -167.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.408 ' HB3' ' HA ' ' A' ' 20' ' ' TYR . 0.9 OUTLIER -149.54 166.88 27.86 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 114.755 -0.723 . . . . 0.0 110.399 178.526 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -61.37 -28.46 69.25 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.522 -164.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.0 p -71.12 -39.43 72.03 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.366 -176.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -75.96 -24.0 55.41 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.42 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.433 ' O ' HG23 ' A' ' 41' ' ' VAL . 57.4 t80 -61.37 -63.36 1.31 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.803 164.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.665 ' O ' HG13 ' A' ' 42' ' ' VAL . 86.1 m -62.19 -32.82 73.51 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.538 -161.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.789 ' HA ' HG22 ' A' ' 42' ' ' VAL . 6.3 p30 -78.13 -22.17 49.23 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 114.607 -1.178 . . . . 0.0 110.172 -176.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -66.36 -26.07 67.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.247 164.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.834 HG22 ' CD2' ' A' ' 48' ' ' LEU . 62.1 t -80.44 -46.74 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.094 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.474 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.789 HG22 ' HA ' ' A' ' 39' ' ' ASN . 15.6 m -74.78 -35.44 36.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.174 -169.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.444 ' OE1' HG23 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -60.73 -32.47 71.75 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.348 167.024 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.24 -32.64 72.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.404 -173.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 69.57 50.96 0.49 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.437 176.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.87 24.34 55.7 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 176.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 97.8 m -96.12 -87.84 0.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.378 -0.411 . . . . 0.0 110.169 169.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.834 ' CD2' HG22 ' A' ' 41' ' ' VAL . 1.0 OUTLIER -68.25 151.24 47.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.29 -161.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 31.9 p -151.34 -178.87 6.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.188 168.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.802 HD22 ' CG2' ' A' ' 6' ' ' VAL . 3.6 tp -79.55 140.84 37.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.158 -166.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.5 t -96.39 -35.02 11.33 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.451 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.469 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.6 p80 174.73 157.49 0.16 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.335 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.774 ' CE1' HD21 ' A' ' 50' ' ' LEU . 20.7 m-85 -91.37 141.32 28.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.345 173.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 113.11 40.67 1.04 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 166.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.419 ' CE ' ' HB2' ' A' ' 22' ' ' PRO . 0.2 OUTLIER 60.73 171.44 0.1 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.441 -0.88 . . . . 0.0 110.553 -174.757 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.458 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 1.8 t . . . . . 0 C--O 1.241 0.621 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.032 -157.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.5 p . . . . . 0 C--O 1.233 0.188 0 CA-C-O 120.84 0.352 . . . . 0.0 110.349 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.726 ' CG2' HD22 ' A' ' 50' ' ' LEU . 9.0 t -129.44 140.32 49.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.848 -172.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.83 90.53 3.17 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.736 -156.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.536 ' SG ' HG12 ' A' ' 6' ' ' VAL . 66.4 m -138.58 39.41 2.22 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.089 -158.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.4 t -90.81 61.51 4.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.213 169.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.38 -23.75 0.01 OUTLIER 'General case' 0 C--O 1.235 0.315 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.794 -175.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.532 ' O ' HG11 ' A' ' 42' ' ' VAL . 41.2 m-85 -59.25 161.43 9.87 Favored Pre-proline 0 C--O 1.239 0.543 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.541 167.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.41 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 35.0 Cg_endo -77.93 150.16 88.94 Favored 'Cis proline' 0 CA--C 1.517 -0.339 0 C-N-CA 122.779 -1.759 . . . . 0.0 109.304 1.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.476 ' HG2' ' CD2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.237 0.411 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.225 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 . . . . . 0 N--CA 1.475 0.78 0 CA-C-O 121.076 0.465 . . . . 0.0 109.783 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.497 ' CD1' ' N ' ' A' ' 21' ' ' ARG . 27.9 t80 -61.79 154.2 26.43 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.157 174.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.497 ' N ' ' CD1' ' A' ' 20' ' ' TYR . 6.2 ptp180 176.72 154.98 0.42 Allowed Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.671 154.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.454 ' HB2' ' HG3' ' A' ' 55' ' ' LYS . 61.6 Cg_endo -90.55 100.45 0.27 Allowed 'Trans proline' 0 C--O 1.237 0.43 0 C-N-CA 123.776 2.984 . . . . 0.0 109.278 -162.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.582 ' O ' HG22 ' A' ' 30' ' ' THR . 0.1 OUTLIER -110.67 178.61 4.31 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 121.971 -0.455 . . . . 0.0 109.924 157.089 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 36.7 t -132.03 124.38 29.14 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 154.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.28 -165.49 1.89 Allowed Glycine 0 CA--C 1.529 0.968 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 173.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.8 t -98.26 39.13 1.26 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.591 0.71 . . . . 0.0 110.387 165.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.696 ' HB3' HD12 ' A' ' 48' ' ' LEU . 31.4 p-10 -123.24 13.58 9.63 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.672 -171.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.3 m120 66.17 32.27 8.17 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.663 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.12 159.89 18.15 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 114.691 -1.141 . . . . 0.0 110.767 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.582 HG22 ' O ' ' A' ' 23' ' ' LEU . 1.0 OUTLIER -71.71 165.28 24.34 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.347 178.247 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.5 ' O ' HD12 ' A' ' 23' ' ' LEU . 62.1 m-85 -126.66 141.76 51.75 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.067 162.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.3 -85.82 0.31 Allowed Glycine 0 CA--C 1.525 0.658 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.551 177.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.412 ' ND2' ' HB2' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -78.0 158.0 29.43 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.932 -0.634 . . . . 0.0 109.755 -178.865 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.538 ' HD2' HG13 ' A' ' 6' ' ' VAL . 6.6 ttpm? -61.06 -27.68 68.52 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.859 172.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 25.6 p -90.12 -26.13 20.36 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.722 -169.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.412 ' HB2' ' ND2' ' A' ' 33' ' ' ASN . 0.9 OUTLIER -79.34 -24.91 42.43 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.326 168.855 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.623 ' CE1' HD21 ' A' ' 48' ' ' LEU . 30.4 t80 -62.18 -69.96 0.22 Allowed 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.628 164.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.592 ' O ' HG22 ' A' ' 42' ' ' VAL . 96.6 m -67.77 -25.7 65.74 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.366 -164.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -65.08 -28.86 69.75 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.766 171.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.525 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -74.94 -33.22 61.92 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.425 174.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.665 HG22 ' CD2' ' A' ' 48' ' ' LEU . 97.2 t -62.98 -60.19 3.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.251 175.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.748 HG23 ' OE1' ' A' ' 43' ' ' GLU . 5.9 m -63.56 -34.08 65.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.19 -169.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.748 ' OE1' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -64.5 -36.57 84.63 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.43 174.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.723 ' HB2' HG22 ' A' ' 47' ' ' THR . 20.5 p -71.99 -19.28 61.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.438 -174.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 69.69 30.36 3.91 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.378 177.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.64 44.65 4.83 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 167.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.723 HG22 ' HB2' ' A' ' 44' ' ' SER . 3.5 t -115.8 -37.55 3.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.281 -0.459 . . . . 0.0 110.51 171.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.696 HD12 ' HB3' ' A' ' 27' ' ' ASP . 1.4 tt -74.21 -82.61 0.06 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.507 -164.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.684 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.2 OUTLIER 61.96 161.84 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.326 -179.769 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.726 HD22 ' CG2' ' A' ' 6' ' ' VAL . 3.3 tp -83.47 132.8 34.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.125 -165.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.2 t -78.23 -39.92 38.87 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 114.302 -1.317 . . . . 0.0 110.509 175.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.624 ' O ' HD11 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -176.57 174.51 1.86 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.137 176.671 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.659 ' CZ ' HG22 ' A' ' 6' ' ' VAL . 19.2 m-85 -98.39 71.6 2.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.078 163.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -142.56 -156.97 6.97 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 178.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.454 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 14.9 mtpp -119.17 40.61 3.28 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 114.931 -0.635 . . . . 0.0 109.942 -178.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.49 ' HB2' HG23 ' A' ' 30' ' ' THR . 2.0 t . . . . . 0 C--O 1.241 0.611 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.137 156.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 C--O 1.233 0.204 0 CA-C-O 120.712 0.292 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.816 ' CG2' HD22 ' A' ' 50' ' ' LEU . 8.7 t -145.62 134.76 17.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.247 -166.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -99.71 97.42 8.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.485 -174.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.504 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 58.6 m -125.8 31.08 5.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.922 -171.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.6 t -87.46 60.87 6.28 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.192 -176.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -173.81 -25.17 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.064 -1.426 . . . . 0.0 109.214 -172.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.689 ' O ' HG11 ' A' ' 42' ' ' VAL . 63.1 m-85 -58.27 162.39 6.02 Favored Pre-proline 0 C--O 1.238 0.496 0 CA-C-N 113.948 -1.478 . . . . 0.0 110.636 163.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.44 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.3 Cg_endo -78.72 138.28 49.03 Favored 'Cis proline' 0 CA--C 1.516 -0.377 0 C-N-CA 122.838 -1.734 . . . . 0.0 109.239 1.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.3 mttp . . . . . 0 C--O 1.24 0.596 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.986 172.939 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' A' ' 21' ' ' ARG . 10.2 t80 -78.93 147.67 32.94 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.055 -165.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.481 ' N ' ' CD1' ' A' ' 20' ' ' TYR . 0.0 OUTLIER 177.73 134.86 0.22 Allowed Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.535 155.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.455 ' HB2' ' HG3' ' A' ' 55' ' ' LYS . 55.3 Cg_endo -83.45 127.74 4.53 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 123.684 2.922 . . . . 0.0 109.457 -160.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.422 HD23 ' CD2' ' A' ' 53' ' ' PHE . 0.2 OUTLIER -111.43 -170.12 1.59 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.903 160.304 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.469 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 17.4 t -124.16 145.32 49.38 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.643 158.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -78.97 176.13 54.82 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 166.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -98.09 43.73 1.06 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.357 -0.422 . . . . 0.0 110.319 164.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.523 ' HB3' HD12 ' A' ' 48' ' ' LEU . 26.8 p-10 -129.96 12.45 5.69 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.701 178.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 69.68 34.05 2.8 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.581 -177.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -137.53 127.12 25.16 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.273 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 57.8 m -66.73 155.51 37.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.245 163.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.502 ' OH ' ' HB1' ' A' ' 40' ' ' ALA . 8.1 m-85 -135.31 128.69 32.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.439 -172.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.17 -49.34 79.11 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 -165.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.4 ' HB2' ' H ' ' A' ' 35' ' ' CYS . 0.1 OUTLIER -126.17 -169.4 2.01 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.269 -0.465 . . . . 0.0 109.825 -179.019 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.9 tptp -68.21 -33.35 74.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.277 160.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.4 ' H ' ' HB2' ' A' ' 33' ' ' ASN . 15.3 m -81.75 -21.11 38.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.223 -168.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -89.65 -25.37 21.29 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.313 174.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.619 ' O ' HG23 ' A' ' 41' ' ' VAL . 49.1 t80 -61.28 -66.4 0.54 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.109 166.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.504 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 72.9 m -61.12 -33.68 73.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.516 -164.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.458 ' HA ' HG22 ' A' ' 42' ' ' VAL . 79.4 m-20 -71.43 -30.37 65.98 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.106 179.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -61.54 -33.58 74.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.333 168.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.919 HG22 HD22 ' A' ' 48' ' ' LEU . 66.7 t -76.37 -52.76 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.515 -172.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.772 HG23 ' OE1' ' A' ' 43' ' ' GLU . 10.5 m -62.14 -29.22 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.205 -178.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.772 ' OE1' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -70.3 -39.42 74.84 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 113.804 -1.544 . . . . 0.0 110.499 173.267 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.2 p -61.98 -16.6 52.62 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.5 -175.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 67.86 35.31 3.91 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.393 176.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.62 80.67 0.66 Allowed Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 173.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.9 t -171.47 -39.89 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.973 -0.613 . . . . 0.0 110.566 -170.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.919 HD22 HG22 ' A' ' 41' ' ' VAL . 4.9 tt -75.82 -83.02 0.07 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.379 -168.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.846 ' N ' HD23 ' A' ' 48' ' ' LEU . 6.7 p 59.09 163.47 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.072 -178.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.816 HD22 ' CG2' ' A' ' 6' ' ' VAL . 2.9 tp -81.1 159.84 24.61 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.303 -159.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.481 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 41.3 t -113.07 -39.84 4.1 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 114.482 -1.236 . . . . 0.0 110.63 174.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.518 ' O ' HD11 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -175.92 160.49 2.34 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.327 -176.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.546 ' CD1' HD21 ' A' ' 50' ' ' LEU . 29.8 m-85 -100.54 22.89 11.08 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.564 -165.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -119.07 -174.69 15.95 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 164.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.455 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -61.38 170.12 1.93 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.137 -0.531 . . . . 0.0 109.977 163.077 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.456 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 1.2 t . . . . . 0 N--CA 1.471 0.604 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.879 -155.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.454 -0.258 0 CA-C-O 120.643 0.259 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.802 ' CG2' HD22 ' A' ' 50' ' ' LEU . 97.2 t -139.3 145.47 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.054 -171.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -132.4 94.75 3.49 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.993 -156.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.494 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 61.1 m -133.43 35.23 3.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.195 -161.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.34 61.45 6.65 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.272 174.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.03 -24.81 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.159 -1.382 . . . . 0.0 109.356 -175.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.659 ' C ' HG11 ' A' ' 42' ' ' VAL . 41.2 m-85 -57.92 160.66 8.02 Favored Pre-proline 0 C--O 1.237 0.413 0 CA-C-N 114.083 -1.417 . . . . 0.0 110.544 161.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.699 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.0 Cg_endo -88.17 165.22 42.38 Favored 'Cis proline' 0 CA--C 1.519 -0.264 0 C-N-CA 123.185 -1.59 . . . . 0.0 109.364 9.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.2 mttt . . . . . 0 C--O 1.237 0.4 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.266 -170.857 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.6 pm0 . . . . . 0 N--CA 1.474 0.73 0 CA-C-O 121.124 0.487 . . . . 0.0 109.754 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.463 ' CD1' ' HA ' ' A' ' 21' ' ' ARG . 10.6 t80 -91.76 144.42 25.52 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.161 171.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.463 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 1.1 ptm180 177.37 131.91 0.2 Allowed Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.531 154.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 21' ' ' ARG . 66.8 Cg_endo -85.48 139.21 6.71 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 123.684 2.923 . . . . 0.0 109.512 -159.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.793 ' O ' HG23 ' A' ' 30' ' ' THR . 0.2 OUTLIER -117.2 -168.92 1.56 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.88 159.485 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.469 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 21.8 t -119.78 118.61 31.3 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.413 158.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.434 ' HA3' ' CE2' ' A' ' 31' ' ' TYR . . . -86.53 144.11 19.6 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 168.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.72 40.08 1.15 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.379 -0.41 . . . . 0.0 110.314 -164.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.918 ' HB3' HD12 ' A' ' 48' ' ' LEU . 22.1 p-10 -99.49 -45.71 5.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.013 167.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -175.03 -30.1 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.043 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -119.66 154.4 34.1 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.446 -155.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.793 HG23 ' O ' ' A' ' 23' ' ' LEU . 69.9 m -75.71 146.82 39.85 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.047 159.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.459 ' CE1' ' HB2' ' A' ' 40' ' ' ALA . 19.9 m-85 -114.66 127.35 55.72 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.445 -173.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.49 -47.29 91.48 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -167.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -137.64 171.77 13.95 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-O 121.416 0.627 . . . . 0.0 110.438 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.4 ' CE ' HG13 ' A' ' 6' ' ' VAL . 6.8 tttm -70.68 -27.44 64.02 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.531 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.5 t -73.45 -20.66 60.66 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.074 -0.967 . . . . 0.0 110.635 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -102.13 -22.12 14.28 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.833 -178.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.776 ' O ' HG23 ' A' ' 41' ' ' VAL . 75.9 t80 -62.21 -60.04 4.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.952 164.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.525 ' O ' HG22 ' A' ' 42' ' ' VAL . 72.1 m -60.19 -28.87 68.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.946 -173.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.508 ' HA ' HG22 ' A' ' 42' ' ' VAL . 2.2 m-80 -73.98 -31.27 62.91 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.215 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -61.33 -28.59 69.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.326 168.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.895 HG22 ' CD2' ' A' ' 48' ' ' LEU . 28.7 t -88.4 -46.66 15.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.525 -168.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.726 HG23 ' OE1' ' A' ' 43' ' ' GLU . 8.7 m -61.94 -35.36 67.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.346 174.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.726 ' OE1' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -63.11 -46.58 86.67 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.373 178.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.422 ' CB ' HG22 ' A' ' 47' ' ' THR . 5.7 p -76.72 -10.12 59.16 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.847 -168.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.294 0.0 OUTLIER 75.29 27.52 1.08 Allowed 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.209 -1.36 . . . . 0.0 109.626 173.113 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.58 40.32 4.76 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 166.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.422 HG22 ' CB ' ' A' ' 44' ' ' SER . 14.6 t -126.67 -37.47 2.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.981 0.42 . . . . 0.0 110.329 -171.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.918 HD12 ' HB3' ' A' ' 27' ' ' ASP . 1.3 tt -78.94 148.58 32.61 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.171 168.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.503 HG22 ' H ' ' A' ' 50' ' ' LEU . 3.8 m -157.14 167.85 29.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.327 174.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.802 HD22 ' CG2' ' A' ' 6' ' ' VAL . 7.6 tp -74.65 130.95 40.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.157 -169.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.5 t -84.64 -37.28 21.25 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.535 174.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.469 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.6 p80 176.96 151.16 0.17 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.204 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.702 ' CE1' HD21 ' A' ' 50' ' ' LEU . 45.4 m-85 -78.16 166.1 23.16 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.318 177.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 62.71 -179.41 5.06 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.331 -1.107 . . . . 0.0 110.331 -162.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.57 -175.62 1.69 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 114.93 -0.635 . . . . 0.0 110.333 -174.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.458 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 3.0 t . . . . . 0 C--O 1.241 0.632 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.215 -155.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.1 p . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.645 0.26 . . . . 0.0 110.375 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.847 ' CG2' HD22 ' A' ' 50' ' ' LEU . 11.3 t -131.43 110.96 18.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.283 -166.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -72.35 123.58 23.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.44 166.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.548 ' SG ' HG12 ' A' ' 6' ' ' VAL . 60.7 m -138.51 41.9 2.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.126 175.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.1 59.17 3.49 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.295 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -173.27 -24.58 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 114.137 -1.392 . . . . 0.0 109.467 -174.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.538 ' O ' HG11 ' A' ' 42' ' ' VAL . 42.6 m-85 -58.98 162.82 6.45 Favored Pre-proline 0 C--O 1.24 0.571 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.605 167.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.426 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 31.6 Cg_endo -77.74 141.69 67.98 Favored 'Cis proline' 0 CA--C 1.517 -0.331 0 C-N-CA 122.947 -1.689 . . . . 0.0 109.325 0.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.426 ' HE3' ' HA ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.213 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.163 -178.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.474 0.771 0 CA-C-O 121.658 0.742 . . . . 0.0 109.758 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -83.06 -52.66 6.44 Favored 'General case' 0 C--O 1.248 1.023 0 CA-C-O 117.576 -1.202 . . . . 0.0 109.054 165.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.0 ptp85 -53.9 138.07 54.7 Favored Pre-proline 0 CA--C 1.537 0.454 0 O-C-N 120.456 -1.402 . . . . 0.0 110.967 -145.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -101.88 167.34 0.31 Allowed 'Trans proline' 0 N--CA 1.476 0.444 0 C-N-CA 123.978 3.119 . . . . 0.0 109.405 -148.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.632 HD23 ' CD2' ' A' ' 53' ' ' PHE . 0.2 OUTLIER -132.88 -162.27 1.22 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 158.404 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.527 ' O ' HD12 ' A' ' 50' ' ' LEU . 19.9 t -130.18 146.53 51.82 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.478 157.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.04 -167.65 41.69 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.069 -1.213 . . . . 0.0 110.069 175.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.22 27.04 4.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.457 0.646 . . . . 0.0 110.42 166.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.704 ' HB3' HD12 ' A' ' 48' ' ' LEU . 54.5 p-10 -122.48 11.81 9.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.869 -167.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 68.55 34.48 3.56 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.629 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.1 mttp -141.16 138.88 33.73 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.323 -178.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.3 m -76.89 145.94 37.96 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.281 163.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.539 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 3.2 m-85 -121.81 133.69 54.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.434 -175.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.8 -73.11 0.54 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -169.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.417 ' ND2' ' HB3' ' A' ' 35' ' ' CYS . 1.0 OUTLIER -110.13 165.29 11.86 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.256 0.551 . . . . 0.0 110.56 175.464 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -62.84 -15.9 56.31 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.457 172.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.417 ' HB3' ' ND2' ' A' ' 33' ' ' ASN . 2.4 t -80.9 -18.23 47.91 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.463 178.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -103.89 -21.73 13.6 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.656 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.543 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 52.3 t80 -61.47 -64.92 0.79 Allowed 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.779 162.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.603 ' O ' HG22 ' A' ' 42' ' ' VAL . 81.0 m -59.9 -26.64 66.07 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.228 -172.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.566 ' HA ' HG22 ' A' ' 42' ' ' VAL . 2.2 m-80 -73.29 -29.97 63.08 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.135 177.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -61.87 -39.24 91.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.309 165.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.914 HG22 HD23 ' A' ' 48' ' ' LEU . 86.4 t -70.48 -48.79 57.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.476 -174.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.781 HG23 ' OE1' ' A' ' 43' ' ' GLU . 12.8 m -73.49 -34.98 44.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.154 -172.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.781 ' OE1' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -66.66 -31.82 72.75 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.291 -1.322 . . . . 0.0 110.57 170.291 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.809 ' OG ' HG22 ' A' ' 47' ' ' THR . 12.7 t -68.56 -27.95 66.53 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.298 -177.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.8 m120 61.77 16.89 8.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.498 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.43 92.08 2.13 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 176.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.809 HG22 ' OG ' ' A' ' 44' ' ' SER . 5.3 t -175.21 -33.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.362 -0.419 . . . . 0.0 110.171 163.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.914 HD23 HG22 ' A' ' 41' ' ' VAL . 1.0 OUTLIER -67.53 -81.03 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.473 -164.16 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.44 153.1 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.293 178.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.847 HD22 ' CG2' ' A' ' 6' ' ' VAL . 2.7 tp -81.59 158.63 24.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.324 -164.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.469 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 35.8 t -109.11 -46.09 3.65 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.602 177.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.488 ' CD2' ' N ' ' A' ' 52' ' ' HIS . 0.8 OUTLIER -165.99 -178.8 4.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.47 173.055 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.67 ' CE1' HD21 ' A' ' 50' ' ' LEU . 1.8 m-85 -112.44 106.87 15.46 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.271 167.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -170.93 -105.6 0.18 Allowed Glycine 0 CA--C 1.53 1.028 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 164.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.5 64.95 0.88 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 123.121 1.438 . . . . 0.0 110.16 156.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.41 ' CA ' ' HB2' ' A' ' 24' ' ' CYS . 1.1 t . . . . . 0 N--CA 1.47 0.538 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.194 159.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.16 0 CA-C-O 120.715 0.293 . . . . 0.0 110.328 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.863 ' CG2' HD22 ' A' ' 50' ' ' LEU . 11.3 t -135.04 120.28 29.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.283 -166.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -72.84 80.65 1.16 Allowed 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.407 177.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 60.8 m -103.02 42.22 1.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.217 174.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.2 59.34 3.03 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.231 -178.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -173.66 -24.6 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 114.074 -1.421 . . . . 0.0 109.239 -173.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.537 ' HB3' ' HA ' ' A' ' 12' ' ' PRO . 47.9 m-85 -58.05 160.3 9.04 Favored Pre-proline 0 C--O 1.237 0.409 0 CA-C-N 113.98 -1.464 . . . . 0.0 110.714 164.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.537 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 33.6 Cg_endo -83.06 139.96 38.51 Favored 'Cis proline' 0 C--O 1.235 0.334 0 C-N-CA 122.894 -1.711 . . . . 0.0 109.409 8.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.9 tttp . . . . . 0 C--O 1.237 0.421 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.937 164.932 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.453 ' HG2' ' N ' ' A' ' 20' ' ' TYR . 4.1 tt0 . . . . . 0 N--CA 1.475 0.803 0 CA-C-O 121.114 0.483 . . . . 0.0 109.715 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.466 ' CD1' ' HA ' ' A' ' 21' ' ' ARG . 11.2 t80 -71.63 144.62 49.37 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.165 -175.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.466 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 0.0 OUTLIER 177.3 133.49 0.21 Allowed Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.359 155.179 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.428 ' HB2' ' CD ' ' A' ' 55' ' ' LYS . 57.9 Cg_endo -83.14 134.23 6.85 Favored 'Trans proline' 0 CA--C 1.515 -0.434 0 C-N-CA 123.729 2.953 . . . . 0.0 109.549 -159.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.569 ' O ' HG23 ' A' ' 30' ' ' THR . 0.2 OUTLIER -114.94 -170.12 1.69 Allowed 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.874 166.16 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 18.5 t -133.81 102.9 5.62 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.416 158.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.422 ' H ' ' HD2' ' A' ' 31' ' ' TYR . . . -63.93 155.49 45.34 Favored Glycine 0 N--CA 1.467 0.722 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 164.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.0 p -96.25 41.38 1.11 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.144 -0.528 . . . . 0.0 110.33 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.544 ' HB3' HD12 ' A' ' 48' ' ' LEU . 32.1 p-10 -108.08 21.85 16.79 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.862 0.839 . . . . 0.0 109.994 164.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . 0.399 0.0 OUTLIER 90.79 -17.55 0.18 Allowed 'General case' 0 C--O 1.239 0.53 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.948 -173.232 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.7 mttm -100.94 135.71 41.94 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 122.179 -0.326 . . . . 0.0 110.417 -159.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.569 HG23 ' O ' ' A' ' 23' ' ' LEU . 67.3 m -79.46 130.03 35.03 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.852 157.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.472 ' HE2' HD11 ' A' ' 48' ' ' LEU . 11.0 m-85 -102.21 123.59 46.31 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.449 -168.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.59 -42.21 99.72 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -169.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.425 ' HB3' ' HA ' ' A' ' 20' ' ' TYR . 1.0 OUTLIER -156.64 161.85 39.87 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 114.918 -0.641 . . . . 0.0 110.231 -175.614 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.82 -29.18 69.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.737 -163.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.2 p -66.54 -31.35 72.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.312 -175.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -92.65 -25.72 18.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.505 -175.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.461 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 37.2 t80 -62.72 -71.65 0.15 Allowed 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.642 166.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 71.1 m -61.45 -32.56 72.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.44 -165.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.563 ' HA ' HG22 ' A' ' 42' ' ' VAL . 2.4 m-80 -67.25 -23.57 65.71 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.019 177.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.611 ' C ' HD22 ' A' ' 48' ' ' LEU . . . -82.38 -22.31 35.48 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 114.351 -1.295 . . . . 0.0 110.377 175.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.823 HG22 HD23 ' A' ' 48' ' ' LEU . 90.2 t -72.27 -59.01 3.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.519 171.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.732 HG23 ' OE1' ' A' ' 43' ' ' GLU . 22.6 m -61.92 -27.28 42.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.07 -170.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.732 ' OE1' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -69.32 -47.42 64.52 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 113.697 -1.592 . . . . 0.0 110.584 174.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.938 ' CB ' HG22 ' A' ' 47' ' ' THR . 1.1 p -62.11 -17.79 58.82 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.697 -177.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 24.8 m120 62.16 16.61 8.47 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.319 -176.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.99 68.24 0.83 Allowed Glycine 0 CA--C 1.527 0.798 0 CA-C-N 114.618 -1.173 . . . . 0.0 110.475 -173.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.938 HG22 ' CB ' ' A' ' 44' ' ' SER . 1.4 t -136.29 -36.28 0.73 Allowed 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.373 0.606 . . . . 0.0 110.684 161.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.823 HD23 HG22 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -75.24 -92.42 0.02 OUTLIER 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.529 -178.52 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 17.3 p 52.3 176.75 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 121.513 -0.742 . . . . 0.0 112.594 -172.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.863 HD22 ' CG2' ' A' ' 6' ' ' VAL . 3.3 tp -91.4 123.03 34.51 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.287 -159.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.9 t -60.64 -61.96 2.21 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.317 162.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.65 ' C ' HD11 ' A' ' 50' ' ' LEU . 2.5 p80 -158.97 163.11 36.76 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.112 173.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.824 ' CZ ' HG22 ' A' ' 6' ' ' VAL . 36.2 m-85 -77.66 176.03 9.35 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.333 169.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.48 173.4 3.31 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -164.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.428 ' CD ' ' HB2' ' A' ' 22' ' ' PRO . 7.7 mmmt -61.56 171.89 1.37 Allowed 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.261 -0.469 . . . . 0.0 110.208 169.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.462 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 1.5 t . . . . . 0 C--O 1.24 0.599 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.932 -158.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.3 t . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.836 0.35 . . . . 0.0 110.683 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.838 HG23 HD22 ' A' ' 50' ' ' LEU . 6.5 t -107.48 129.84 60.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.976 -159.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -107.58 107.85 18.87 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.537 170.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 35.2 m -111.71 47.1 1.06 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.436 -177.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.6 m -96.24 39.12 1.16 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 114.196 -1.365 . . . . 0.0 110.374 166.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -129.91 25.48 5.29 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.977 161.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.541 ' HB2' HG11 ' A' ' 42' ' ' VAL . 85.1 m-85 -126.63 166.87 19.42 Favored Pre-proline 0 C--O 1.236 0.386 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.704 -170.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.414 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.2 Cg_endo -72.42 138.88 57.18 Favored 'Cis proline' 0 CA--C 1.518 -0.319 0 C-N-CA 122.064 -2.057 . . . . 0.0 108.98 -7.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.476 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.184 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.264 176.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 N--CA 1.473 0.678 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.469 ' CD1' ' N ' ' A' ' 21' ' ' ARG . 10.9 t80 -76.85 147.05 37.34 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.211 -169.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.469 ' N ' ' CD1' ' A' ' 20' ' ' TYR . 0.0 OUTLIER 177.73 135.61 0.22 Allowed Pre-proline 0 CA--C 1.536 0.413 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.531 155.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.421 ' HB2' ' HB3' ' A' ' 55' ' ' LYS . 47.7 Cg_endo -84.09 143.93 10.49 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.775 2.983 . . . . 0.0 109.593 -158.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.12 -165.52 1.69 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.055 158.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.522 ' O ' HD12 ' A' ' 50' ' ' LEU . 21.1 t -132.6 148.53 52.37 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.293 158.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -81.87 -169.63 43.2 Favored Glycine 0 CA--C 1.531 1.093 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 174.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.4 m -97.62 19.9 12.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.98 -0.61 . . . . 0.0 110.454 161.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.705 ' HB3' HD12 ' A' ' 48' ' ' LEU . 34.1 p-10 -107.14 9.23 30.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.147 -175.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.9 m120 67.91 38.61 2.78 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.587 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.91 137.6 34.95 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 114.583 -1.189 . . . . 0.0 110.342 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.6 m -72.48 147.65 45.84 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.24 162.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -122.74 125.04 44.73 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.394 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.34 -50.27 68.6 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -167.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.421 ' HB3' ' HA ' ' A' ' 20' ' ' TYR . 1.7 p30 -125.04 175.38 7.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.203 -0.498 . . . . 0.0 110.482 170.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.421 ' HE3' ' CG1' ' A' ' 6' ' ' VAL . 4.8 tttp -69.23 -17.57 63.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.414 169.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 22.8 m -60.99 -51.61 68.52 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.545 172.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -80.4 -21.33 42.37 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.859 -171.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.683 ' O ' HG23 ' A' ' 41' ' ' VAL . 57.7 t80 -61.29 -67.64 0.39 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.967 165.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.84 ' O ' HG22 ' A' ' 42' ' ' VAL . 96.8 m -65.05 -29.85 70.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.638 -163.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -65.37 -33.78 76.76 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.02 173.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -69.35 -24.22 63.87 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.324 174.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.936 HG22 HD22 ' A' ' 48' ' ' LEU . 59.3 t -87.9 -55.18 6.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.387 -172.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.84 HG22 ' O ' ' A' ' 38' ' ' CYS . 6.6 m -62.33 -23.09 31.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.149 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.76 ' OE1' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -77.13 -37.99 52.95 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 113.774 -1.557 . . . . 0.0 110.621 173.003 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.1 p -62.28 -19.99 63.82 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.628 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 69.27 41.61 1.33 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.274 -171.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.68 88.12 0.03 OUTLIER Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 172.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.1 t -176.4 -42.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.262 -0.469 . . . . 0.0 110.322 -167.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.936 HD22 HG22 ' A' ' 41' ' ' VAL . 1.0 OUTLIER -61.71 -73.93 0.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.367 172.25 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.858 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.2 OUTLIER 66.89 160.31 0.15 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.431 175.621 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.838 HD22 HG23 ' A' ' 6' ' ' VAL . 5.6 tp -82.7 162.05 21.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.286 -168.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.462 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 16.2 t -112.95 -41.44 3.75 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.671 173.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.431 ' NE2' ' HB3' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -177.79 167.63 2.12 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.371 -173.332 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.756 ' CE1' HD21 ' A' ' 50' ' ' LEU . 2.2 m-85 -108.25 30.81 6.07 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.347 -177.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.67 -140.25 6.6 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 168.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 22' ' ' PRO . 1.2 pttm -131.82 63.84 1.61 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 123.2 1.476 . . . . 0.0 110.29 161.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.24 0.57 0 O-C-N 121.345 -0.847 . . . . 0.0 110.187 158.983 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.455 -0.198 0 CA-C-O 121.329 0.585 . . . . 0.0 110.448 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.797 ' CG2' HD22 ' A' ' 50' ' ' LEU . 4.9 t -145.91 111.77 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.998 -177.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -67.81 114.22 6.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.408 167.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.476 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 57.8 m -133.39 37.16 3.36 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.036 177.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.1 m -91.23 58.7 3.75 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.221 -175.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -173.31 -24.19 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 114.081 -1.418 . . . . 0.0 109.488 -174.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.595 ' O ' HG11 ' A' ' 42' ' ' VAL . 74.3 m-85 -58.69 160.38 10.55 Favored Pre-proline 0 C--O 1.238 0.459 0 CA-C-N 113.987 -1.461 . . . . 0.0 110.617 166.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.48 ' HB3' HG21 ' A' ' 42' ' ' VAL . 31.9 Cg_endo -78.32 139.99 58.33 Favored 'Cis proline' 0 C--O 1.233 0.261 0 C-N-CA 122.771 -1.762 . . . . 0.0 109.369 3.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.24 0.575 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.834 164.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.721 0 CA-C-O 121.592 0.71 . . . . 0.0 109.841 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.5 ' CD2' ' N ' ' A' ' 21' ' ' ARG . 93.7 t80 -61.62 167.0 3.75 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.026 -177.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.5 ' N ' ' CD2' ' A' ' 20' ' ' TYR . 1.7 ptm180 178.52 172.28 0.44 Allowed Pre-proline 0 C--O 1.248 0.983 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.406 151.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.431 ' HG2' ' CE ' ' A' ' 55' ' ' LYS 0.253 82.6 Cg_endo -110.15 92.52 0.02 OUTLIER 'Trans proline' 0 CA--C 1.515 -0.435 0 C-N-CA 122.252 1.968 . . . . 0.0 109.232 -178.7 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.594 HD23 ' CD2' ' A' ' 53' ' ' PHE . 0.2 OUTLIER -90.15 -171.22 3.04 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.855 162.439 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.439 ' HB3' ' NE2' ' A' ' 52' ' ' HIS . 21.6 t -146.06 135.93 23.45 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.221 156.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.27 -171.75 41.56 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 114.387 -1.278 . . . . 0.0 110.316 -177.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.25 26.62 5.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.42 0.629 . . . . 0.0 110.479 170.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.89 ' HB3' HD12 ' A' ' 48' ' ' LEU . 24.9 p-10 -126.9 13.09 7.33 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.827 -166.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.5 m120 69.24 32.51 3.58 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.289 -0.868 . . . . 0.0 110.59 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.73 137.9 38.78 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.285 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 23' ' ' LEU . 1.3 m -77.73 148.95 34.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.337 164.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -121.55 129.99 53.23 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.455 -176.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.55 -93.01 0.01 OUTLIER Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 168.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.0 p-10 -99.9 157.6 16.41 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.998 -0.601 . . . . 0.0 110.577 -168.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -61.59 -15.53 39.89 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.569 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.1 m -66.13 -45.44 81.06 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.471 173.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -89.59 -23.33 21.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.373 -168.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.492 ' O ' HG23 ' A' ' 41' ' ' VAL . 36.2 t80 -61.84 -69.11 0.26 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.877 162.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.551 ' O ' HG22 ' A' ' 42' ' ' VAL . 85.2 m -61.79 -30.92 71.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.574 -168.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.521 ' HA ' HG22 ' A' ' 42' ' ' VAL . 90.0 m-20 -67.07 -31.44 71.95 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.942 175.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -71.17 -17.24 62.55 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.372 174.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.824 HG22 ' CD2' ' A' ' 48' ' ' LEU . 43.7 t -85.8 -52.5 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.501 177.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.748 HG23 ' OE1' ' A' ' 43' ' ' GLU . 4.4 m -70.1 -32.99 53.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.245 -170.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.748 ' OE1' HG23 ' A' ' 42' ' ' VAL . 2.0 mp0 -70.51 -29.81 66.42 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.498 170.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.66 -30.61 70.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.548 175.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 70.22 51.93 0.38 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.301 -166.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.69 21.93 55.95 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.192 176.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 40.5 m -66.9 -86.82 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 157.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.89 HD12 ' HB3' ' A' ' 27' ' ' ASP . 1.0 OUTLIER -61.3 148.66 40.49 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.302 -163.333 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 77.0 p -138.89 -172.43 3.32 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.921 165.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.797 HD22 ' CG2' ' A' ' 6' ' ' VAL . 5.8 tp -86.8 133.19 33.67 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.369 -173.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.6 t -82.82 -37.04 24.98 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 113.921 -1.49 . . . . 0.0 110.597 173.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.439 ' NE2' ' HB3' ' A' ' 24' ' ' CYS . 0.7 OUTLIER 173.47 162.66 0.15 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.334 -178.676 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.697 ' CE1' HD21 ' A' ' 50' ' ' LEU . 1.3 m-85 -98.78 74.9 2.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.894 160.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -152.39 21.79 0.84 Allowed Glycine 0 CA--C 1.523 0.57 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.811 -172.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.431 ' CE ' ' HG2' ' A' ' 22' ' ' PRO . 9.1 mttp 61.27 35.25 18.27 Favored 'General case' 0 C--O 1.239 0.506 0 O-C-N 122.753 -0.263 . . . . 0.0 110.307 164.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.427 ' H ' ' CE1' ' A' ' 52' ' ' HIS . 0.7 OUTLIER . . . . . 0 N--CA 1.474 0.734 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.734 156.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.7 p . . . . . 0 C--O 1.231 0.103 0 CA-C-O 121.043 0.449 . . . . 0.0 110.261 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.645 HG13 ' CZ ' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -136.79 -175.58 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.282 -167.248 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -153.94 65.86 0.72 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.342 -168.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.527 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 59.4 m -99.83 32.78 2.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.973 -174.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.72 60.5 5.59 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.196 -176.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -173.71 -24.98 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.326 -172.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.474 ' CE2' ' HD2' ' A' ' 13' ' ' LYS . 79.1 m-85 -58.33 160.29 9.82 Favored Pre-proline 0 C--O 1.236 0.374 0 CA-C-N 113.894 -1.503 . . . . 0.0 110.529 163.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.499 ' HB3' HG21 ' A' ' 42' ' ' VAL . 30.5 Cg_endo -78.69 135.83 38.53 Favored 'Cis proline' 0 CA--C 1.518 -0.277 0 C-N-CA 122.667 -1.806 . . . . 0.0 109.378 6.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.474 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.8 OUTLIER . . . . . 0 C--O 1.238 0.459 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.065 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.475 0.799 0 CA-C-O 121.465 0.65 . . . . 0.0 109.808 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.486 ' CD1' ' N ' ' A' ' 21' ' ' ARG . 10.5 t80 -108.87 146.86 33.04 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.288 -177.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.486 ' N ' ' CD1' ' A' ' 20' ' ' TYR . 0.0 OUTLIER 177.44 135.14 0.21 Allowed Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.712 155.586 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 21' ' ' ARG . 59.5 Cg_endo -86.11 139.14 6.08 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.539 2.826 . . . . 0.0 109.368 -161.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.758 ' O ' HG23 ' A' ' 30' ' ' THR . 0.3 OUTLIER -123.88 -165.09 1.3 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.999 161.57 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.454 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 15.9 t -134.58 118.09 16.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.874 165.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.54 -173.9 2.03 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.7 t -98.81 30.78 3.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.724 0.773 . . . . 0.0 110.356 165.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.832 ' HB3' HD12 ' A' ' 48' ' ' LEU . 32.2 p-10 -123.84 13.71 9.24 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.473 -166.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 66.74 31.97 7.17 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.532 178.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.37 141.96 19.83 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.81 173.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.758 HG23 ' O ' ' A' ' 23' ' ' LEU . 94.0 m -65.82 148.53 51.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.261 165.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -106.85 138.41 43.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.353 166.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.02 -53.58 41.65 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.434 ' HB3' ' HA ' ' A' ' 20' ' ' TYR . 5.0 p-10 -128.08 169.78 13.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.418 -0.391 . . . . 0.0 110.301 -173.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.38 -31.88 73.26 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.497 174.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.2 t -74.73 -21.84 59.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.573 -173.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -97.75 -22.75 16.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.66 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.502 ' O ' HG23 ' A' ' 41' ' ' VAL . 59.5 t80 -61.59 -68.09 0.35 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.762 164.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.527 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 64.4 m -61.0 -32.69 72.27 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.538 -167.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.429 ' HA ' HG22 ' A' ' 42' ' ' VAL . 2.6 m-80 -73.45 -25.0 60.3 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.209 -178.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -65.31 -43.0 92.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.183 165.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.842 HG22 ' CD2' ' A' ' 48' ' ' LEU . 60.8 t -61.82 -51.97 66.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.54 -175.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.718 HG23 ' OE1' ' A' ' 43' ' ' GLU . 18.8 m -74.3 -34.07 36.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.1 -168.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.718 ' OE1' HG23 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -65.48 -29.51 70.18 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.442 169.748 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.5 t -80.75 -17.26 51.55 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.332 -172.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 53.3 t30 71.33 50.72 0.28 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.568 167.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.88 -21.2 47.3 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 164.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 46.0 m -62.02 -85.71 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.238 -0.481 . . . . 0.0 110.002 177.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.842 ' CD2' HG22 ' A' ' 41' ' ' VAL . 1.4 tt -59.98 148.19 36.2 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.495 -157.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.417 HG23 ' N ' ' A' ' 50' ' ' LEU . 0.9 OUTLIER -146.81 -163.21 1.7 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.619 167.108 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.66 HD11 ' C ' ' A' ' 52' ' ' HIS . 6.6 tp -94.45 118.68 32.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.15 -169.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.8 t -61.62 -42.16 98.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.493 167.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.66 ' C ' HD11 ' A' ' 50' ' ' LEU . 1.8 p80 173.73 158.1 0.13 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.182 178.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.652 ' CE1' HD21 ' A' ' 50' ' ' LEU . 5.2 m-85 -84.51 170.97 12.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.217 168.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.59 32.08 10.67 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 168.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.447 ' HG2' ' HG2' ' A' ' 22' ' ' PRO . 4.9 mttp 61.14 167.7 0.09 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 114.541 -0.829 . . . . 0.0 110.455 -174.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.457 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 2.2 t . . . . . 0 C--O 1.24 0.594 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.034 -160.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 8.2 tt . . . . . 0 N--CA 1.473 0.708 0 CA-C-O 121.308 0.575 . . . . 0.0 109.982 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.07 129.83 42.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.311 -171.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -154.49 103.33 2.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.17 172.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.619 HG13 ' HD1' ' A' ' 53' ' ' PHE . 11.6 t -126.68 68.89 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.244 -165.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.24 -175.55 4.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.348 170.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.662 HG13 ' CZ ' ' A' ' 53' ' ' PHE . 0.6 OUTLIER -146.11 -175.18 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.206 -165.551 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -145.97 63.87 1.23 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.037 -155.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.458 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 76.6 m -117.11 42.49 2.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.279 -165.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.8 m -89.76 61.57 5.45 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.343 172.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -173.01 -24.44 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.349 -175.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.709 ' O ' HG11 ' A' ' 42' ' ' VAL . 29.2 m-85 -58.18 158.12 14.79 Favored Pre-proline 0 C--O 1.236 0.382 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.636 163.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.481 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.3 Cg_endo -86.67 154.46 48.3 Favored 'Cis proline' 0 C--O 1.232 0.22 0 C-N-CA 122.914 -1.702 . . . . 0.0 109.449 10.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.458 ' HG3' ' HD3' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -88.45 158.73 48.36 Favored Pre-proline 0 C--O 1.239 0.531 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.894 166.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.458 ' HD3' ' HG3' ' A' ' 13' ' ' LYS . 11.7 Cg_endo -76.71 -22.66 11.74 Favored 'Trans proline' 0 CA--C 1.514 -0.494 0 C-N-CA 122.672 2.248 . . . . 0.0 110.695 -171.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -171.04 172.9 5.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.345 -168.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.5 t -172.31 159.94 4.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.981 -166.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.7 p -100.26 44.24 1.03 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.334 -164.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.241 0.622 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.377 168.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 . . . . . 0 N--CA 1.473 0.699 0 CA-C-O 121.267 0.556 . . . . 0.0 109.882 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -87.67 -51.61 5.78 Favored 'General case' 0 C--O 1.251 1.145 0 CA-C-O 117.581 -1.2 . . . . 0.0 109.368 171.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.402 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.4 ptp180 -54.13 131.05 59.96 Favored Pre-proline 0 CA--C 1.54 0.583 0 O-C-N 120.427 -1.421 . . . . 0.0 110.768 -145.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.452 ' HG2' ' HG3' ' A' ' 55' ' ' LYS . 72.5 Cg_endo -93.67 166.71 2.21 Favored 'Trans proline' 0 CA--C 1.517 -0.347 0 C-N-CA 124.293 3.329 . . . . 0.0 109.526 -150.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.674 HD12 ' HB2' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -126.33 -170.7 2.24 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.939 164.185 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.471 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 17.8 t -131.1 119.62 22.22 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.612 157.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.1 174.5 7.35 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 172.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.07 40.57 1.17 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.009 -0.596 . . . . 0.0 110.471 167.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.428 ' HB3' HD12 ' A' ' 48' ' ' LEU . 37.8 p-10 -131.4 13.76 5.04 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.595 -177.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 69.73 33.64 2.89 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.62 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -139.12 132.44 30.01 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.532 178.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 23' ' ' LEU . 84.9 m -78.71 154.22 30.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.316 165.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -127.17 126.73 43.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.454 -170.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.01 -9.18 86.89 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.224 -169.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -159.57 176.22 12.3 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.099 -0.551 . . . . 0.0 110.498 171.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.5 mttp -61.65 -22.36 65.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.398 166.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 95.5 m -75.72 -43.91 44.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.359 -169.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -82.13 -22.81 35.99 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.866 178.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.674 ' HB2' HD12 ' A' ' 23' ' ' LEU . 29.8 t80 -61.86 -67.94 0.37 Allowed 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.028 167.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.571 ' O ' HG22 ' A' ' 42' ' ' VAL . 71.9 m -69.56 -25.35 63.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.271 -167.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.419 ' HA ' HG22 ' A' ' 42' ' ' VAL . 96.2 m-20 -65.93 -31.07 71.79 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.118 171.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -69.68 -36.2 75.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.491 172.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.799 HG22 HD23 ' A' ' 48' ' ' LEU . 84.7 t -65.89 -53.93 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.511 -179.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.709 HG11 ' O ' ' A' ' 11' ' ' TYR . 5.1 m -62.3 -35.27 68.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.121 -172.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.654 ' OE1' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -62.2 -37.16 84.25 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 114.125 -1.398 . . . . 0.0 110.419 171.077 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.666 ' HB2' HG22 ' A' ' 47' ' ' THR . 10.8 p -72.15 -24.4 61.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.41 -170.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 69.12 36.73 2.33 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.41 -172.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.67 94.28 0.01 OUTLIER Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -170.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.666 HG22 ' HB2' ' A' ' 44' ' ' SER . 6.1 t -169.99 -35.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.437 -0.381 . . . . 0.0 110.183 173.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.799 HD23 HG22 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -61.47 -83.19 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.314 166.731 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.478 HG22 ' H ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER 61.85 171.69 0.12 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.45 179.41 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.679 HD11 ' C ' ' A' ' 52' ' ' HIS . 8.2 tp -91.84 120.28 32.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.111 -166.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.8 t -64.21 -41.91 96.84 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.595 166.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.679 ' C ' HD11 ' A' ' 50' ' ' LEU . 1.9 p80 174.25 146.17 0.06 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.156 -178.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.662 ' CZ ' HG13 ' A' ' 6' ' ' VAL . 20.4 m-85 -67.88 170.1 8.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.2 171.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.87 170.49 8.07 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -164.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.452 ' HG3' ' HG2' ' A' ' 22' ' ' PRO . 4.2 mttm -62.47 176.31 0.65 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.339 -0.431 . . . . 0.0 110.246 170.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.45 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.8 OUTLIER . . . . . 0 N--CA 1.472 0.628 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.732 -158.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.7 mp . . . . . 0 N--CA 1.473 0.705 0 CA-C-O 121.211 0.529 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.34 -24.37 66.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.421 -170.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -115.7 97.63 6.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.373 172.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.789 ' O ' HD23 ' A' ' 50' ' ' LEU . 30.4 m -112.73 94.46 3.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.012 164.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.7 p -117.58 177.94 4.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.357 -164.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.679 ' CG2' HD22 ' A' ' 50' ' ' LEU . 98.3 t -151.49 127.08 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.29 -164.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -87.77 114.75 24.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.358 -172.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.617 ' SG ' HG12 ' A' ' 6' ' ' VAL . 57.1 m -138.85 35.5 2.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.958 -166.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.3 t -89.83 59.92 4.79 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.389 -176.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.43 -25.56 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.264 -175.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.491 ' O ' HG11 ' A' ' 42' ' ' VAL . 97.5 m-85 -60.17 160.47 16.75 Favored Pre-proline 0 C--O 1.238 0.474 0 CA-C-N 113.904 -1.498 . . . . 0.0 110.375 168.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.541 ' CG ' HG21 ' A' ' 42' ' ' VAL . 56.5 Cg_endo -79.12 147.3 79.82 Favored 'Cis proline' 0 C--O 1.233 0.273 0 C-N-CA 122.58 -1.842 . . . . 0.0 109.371 4.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.4 ' HB3' ' CD ' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -74.33 178.11 1.84 Allowed Pre-proline 0 C--O 1.24 0.561 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.849 162.601 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.4 ' CD ' ' HB3' ' A' ' 13' ' ' LYS . 17.8 Cg_endo -90.63 -54.2 0.02 OUTLIER 'Trans proline' 0 CA--C 1.517 -0.336 0 C-N-CA 122.576 2.184 . . . . 0.0 109.533 170.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -148.5 138.01 22.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.29 -171.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.6 m -130.7 168.69 16.75 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.398 172.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 86.4 m -158.34 -40.2 0.06 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.268 167.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.54 HD23 ' HA ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER . . . . . 0 C--O 1.24 0.572 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.319 167.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.54 ' HA ' HD23 ' A' ' 18' ' ' LEU . 2.3 mt-10 . . . . . 0 N--CA 1.475 0.816 0 CA-C-O 121.548 0.69 . . . . 0.0 109.809 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -93.09 -50.04 5.71 Favored 'General case' 0 C--O 1.249 1.07 0 CA-C-O 117.468 -1.253 . . . . 0.0 108.918 168.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.5 ptp85 -53.75 140.77 48.39 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 120.47 -1.393 . . . . 0.0 111.152 -144.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.453 ' HG2' ' HG2' ' A' ' 55' ' ' LYS . 60.4 Cg_endo -99.11 153.47 0.62 Allowed 'Trans proline' 0 N--CA 1.475 0.387 0 C-N-CA 124.133 3.222 . . . . 0.0 109.253 -150.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.59 HD22 HD13 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -119.46 -166.88 1.32 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.956 160.831 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.471 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 18.7 t -121.4 116.68 25.23 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.464 159.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.465 ' HA3' ' CE2' ' A' ' 31' ' ' TYR . . . -61.67 152.61 41.97 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 167.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.38 39.73 1.23 Allowed 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 115.196 -0.502 . . . . 0.0 110.403 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.72 ' HB3' HD12 ' A' ' 48' ' ' LEU . 13.7 p-10 -113.53 -48.73 2.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.362 174.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -176.34 -26.82 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.128 178.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.28 158.07 21.91 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.304 -156.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.685 HG21 ' HD2' ' A' ' 55' ' ' LYS . 60.1 m -77.03 133.29 39.16 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.901 157.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.565 ' HE2' HD11 ' A' ' 48' ' ' LEU . 18.1 m-85 -96.88 138.07 35.0 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.445 176.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.05 -69.76 1.22 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -177.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -131.92 167.32 19.82 Favored 'General case' 0 C--O 1.232 0.163 0 O-C-N 121.794 -0.827 . . . . 0.0 110.597 -178.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.98 -14.06 20.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.705 -169.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.8 m -72.35 -60.14 2.38 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.453 176.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -61.31 -25.6 67.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.798 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.455 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 53.5 t80 -62.12 -66.22 0.57 Allowed 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.872 170.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.546 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 96.7 m -66.21 -31.57 72.48 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.671 -160.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.54 ' HA ' HG22 ' A' ' 42' ' ' VAL . 5.1 p30 -72.16 -23.79 61.34 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.119 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.468 ' C ' HD22 ' A' ' 48' ' ' LEU . . . -69.33 -27.98 65.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.294 166.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.883 HG22 HD23 ' A' ' 48' ' ' LEU . 89.8 t -75.89 -45.62 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.578 -178.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.541 HG21 ' CG ' ' A' ' 12' ' ' PRO . 20.3 m -70.71 -35.32 60.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.084 -172.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.51 ' OE1' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -60.88 -33.8 73.66 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.335 168.413 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.55 ' OG ' HG22 ' A' ' 47' ' ' THR . 0.1 OUTLIER -70.98 -39.42 72.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.291 -169.41 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 69.09 24.16 6.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.223 -163.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.462 ' H ' ' HB3' ' A' ' 44' ' ' SER . . . 86.16 40.82 7.31 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 166.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.55 HG22 ' OG ' ' A' ' 44' ' ' SER . 6.1 t -100.88 -39.06 7.96 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.199 0.524 . . . . 0.0 110.268 165.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.883 HD23 HG22 ' A' ' 41' ' ' VAL . 0.3 OUTLIER -62.14 -86.99 0.01 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.408 -179.326 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.404 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER 67.17 164.13 0.2 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.488 174.234 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.789 HD23 ' O ' ' A' ' 4' ' ' VAL . 5.0 tp -86.6 137.13 32.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.276 -168.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.7 t -92.4 -43.48 9.2 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.409 177.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.471 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.6 p80 -177.51 150.09 0.67 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.217 177.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.761 ' CE1' HD21 ' A' ' 50' ' ' LEU . 9.1 m-85 -76.78 157.17 31.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.303 175.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.6 166.29 23.47 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 -163.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.685 ' HD2' HG21 ' A' ' 30' ' ' THR . 4.4 mtmm -63.22 -179.0 0.28 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.419 -0.39 . . . . 0.0 110.267 177.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.453 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.8 OUTLIER . . . . . 0 N--CA 1.473 0.689 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.819 -155.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 33.4 tp . . . . . 0 N--CA 1.474 0.737 0 CA-C-O 121.265 0.555 . . . . 0.0 109.827 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.24 -79.77 0.05 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.306 175.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 61.69 -164.49 0.24 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.308 171.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.63 ' O ' HD23 ' A' ' 50' ' ' LEU . 17.7 m -113.16 63.69 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.318 -167.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.507 ' O ' HG13 ' A' ' 6' ' ' VAL . 24.1 p -121.77 -175.96 3.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.33 169.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.519 HG21 ' CE2' ' A' ' 37' ' ' PHE . 0.4 OUTLIER -156.36 -176.01 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.25 -167.633 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -146.24 80.74 1.57 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.939 -156.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.445 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 62.4 m -125.49 48.03 2.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.22 -165.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.5 p -96.13 55.69 1.57 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.191 -175.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -173.2 -23.76 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.181 -1.372 . . . . 0.0 109.648 -174.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.533 ' O ' HG11 ' A' ' 42' ' ' VAL . 67.3 m-85 -59.83 161.63 11.4 Favored Pre-proline 0 C--O 1.239 0.52 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.505 170.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.409 ' CG ' HG21 ' A' ' 42' ' ' VAL . 35.9 Cg_endo -77.09 156.63 97.25 Favored 'Cis proline' 0 C--O 1.233 0.26 0 C-N-CA 122.676 -1.802 . . . . 0.0 109.14 -0.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.45 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 2.1 mtpm? -109.77 163.8 16.27 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.135 -164.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -55.86 -69.71 0.05 OUTLIER 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 122.306 2.004 . . . . 0.0 110.061 175.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -108.09 107.44 18.09 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.361 -153.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.4 m -149.67 128.34 12.41 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.427 156.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.508 ' C ' HD23 ' A' ' 18' ' ' LEU . 0.6 OUTLIER -102.58 127.7 49.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.437 -165.188 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.508 HD23 ' C ' ' A' ' 17' ' ' THR . 4.6 mt . . . . . 0 C--O 1.241 0.631 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.324 -168.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 . . . . . 0 N--CA 1.474 0.733 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.462 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 31.5 t80 -63.19 -52.82 60.77 Favored 'General case' 0 C--O 1.247 0.943 0 CA-C-O 118.114 -0.946 . . . . 0.0 109.279 -166.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.459 ' NH1' ' HB3' ' A' ' 21' ' ' ARG . 2.0 ptp180 -54.4 142.75 49.24 Favored Pre-proline 0 CA--C 1.539 0.527 0 O-C-N 120.734 -1.229 . . . . 0.0 110.941 -146.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.462 ' HG3' ' CE2' ' A' ' 20' ' ' TYR 0.259 91.4 Cg_endo -119.47 -179.34 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 123.314 2.676 . . . . 0.0 108.907 -142.676 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.668 HD21 ' HZ3' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -142.2 -164.17 1.75 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.968 162.354 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.463 ' HB3' ' NE2' ' A' ' 52' ' ' HIS . 34.3 t -125.37 126.89 45.74 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 158.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.55 -171.95 48.52 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.3 p -97.74 34.43 1.87 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.001 -0.6 . . . . 0.0 110.312 163.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.406 ' HB3' ' CD1' ' A' ' 48' ' ' LEU . 24.2 p-10 -96.4 11.09 36.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.485 170.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.5 m120 62.76 42.95 7.57 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.594 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.69 168.51 9.01 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.846 173.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.5 m -67.53 138.13 56.29 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.997 164.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.482 ' HE2' HD11 ' A' ' 48' ' ' LEU . 3.8 m-85 -93.76 143.32 26.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.358 167.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.94 -56.48 22.31 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -174.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 39.6 p-10 -142.72 179.14 7.17 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 114.636 -0.782 . . . . 0.0 110.624 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.668 ' HZ3' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -61.71 -38.84 89.36 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.524 -178.553 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.6 m -70.99 -39.34 72.5 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.177 -169.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -74.32 -24.08 59.15 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.054 174.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.533 ' O ' HG23 ' A' ' 41' ' ' VAL . 73.2 t80 -62.21 -64.37 0.95 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.057 169.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.652 ' O ' HG13 ' A' ' 42' ' ' VAL . 74.1 m -60.25 -29.32 68.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.99 -171.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.705 ' HA ' HG22 ' A' ' 42' ' ' VAL . 31.6 m-20 -73.24 -31.38 64.08 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.173 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -61.67 -29.23 69.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.377 168.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 1.016 HG22 HD23 ' A' ' 48' ' ' LEU . 35.6 t -82.12 -42.58 18.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.524 -176.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.705 HG22 ' HA ' ' A' ' 39' ' ' ASN . 18.8 m -78.37 -34.29 18.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.209 -171.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.476 ' OE1' HG23 ' A' ' 42' ' ' VAL . 1.5 mp0 -64.09 -32.25 73.74 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.238 167.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.96 -21.79 63.82 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.734 -172.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 69.17 25.53 5.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.131 -168.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.5 85.96 0.09 OUTLIER Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 -170.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.9 t -151.77 -36.67 0.12 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.083 0.468 . . . . 0.0 110.514 166.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.016 HD23 HG22 ' A' ' 41' ' ' VAL . 0.8 OUTLIER -79.87 160.27 26.12 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.584 175.832 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.441 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 2.7 t -174.18 164.19 3.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.991 -174.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.686 HD21 ' CE1' ' A' ' 53' ' ' PHE . 5.8 tp -76.29 129.02 36.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.131 -164.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.628 ' O ' HG21 ' A' ' 4' ' ' VAL . 38.6 t -77.23 -42.24 38.08 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.454 171.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.638 ' C ' HD11 ' A' ' 50' ' ' LEU . 1.0 OUTLIER -174.06 167.42 4.22 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.267 175.05 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.686 ' CE1' HD21 ' A' ' 50' ' ' LEU . 20.3 m-85 -94.72 89.23 5.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.248 168.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -155.96 -139.24 2.72 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.496 -1.041 . . . . 0.0 110.496 -175.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.431 ' HG2' ' HG2' ' A' ' 22' ' ' PRO . 6.8 mtpp -139.82 41.11 2.0 Allowed 'General case' 0 C--O 1.24 0.602 0 CA-C-N 115.26 -0.47 . . . . 0.0 109.874 170.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 C--O 1.241 0.647 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.022 161.915 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.8 pt? . . . . . 0 N--CA 1.474 0.771 0 CA-C-O 121.173 0.511 . . . . 0.0 109.905 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.73 -165.55 1.28 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.261 170.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -141.51 19.95 2.2 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.193 163.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.718 ' O ' HD23 ' A' ' 50' ' ' LEU . 8.6 t 61.8 27.64 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.505 163.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.3 p -130.69 159.41 37.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.427 -168.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.802 ' CG2' HD22 ' A' ' 50' ' ' LEU . 11.7 t -145.34 117.02 2.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.118 -164.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -73.27 117.74 15.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.466 169.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.516 ' SG ' HG12 ' A' ' 6' ' ' VAL . 59.8 m -138.08 44.38 2.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.115 177.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.66 58.56 3.12 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.373 -177.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -172.81 -24.33 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.539 -177.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.478 ' CD2' ' HB2' ' A' ' 38' ' ' CYS . 71.2 m-85 -60.69 159.73 23.66 Favored Pre-proline 0 C--O 1.236 0.345 0 CA-C-N 114.024 -1.443 . . . . 0.0 110.414 172.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.586 ' N ' HG21 ' A' ' 42' ' ' VAL . 56.2 Cg_endo -78.63 163.98 85.26 Favored 'Cis proline' 0 CA--C 1.519 -0.23 0 C-N-CA 122.511 -1.87 . . . . 0.0 109.337 5.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.403 ' CE ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -78.83 165.6 48.19 Favored Pre-proline 0 C--O 1.234 0.258 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.736 -166.496 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.403 ' HD2' ' CE ' ' A' ' 13' ' ' LYS . 3.6 Cg_exo -55.54 -63.9 0.17 Allowed 'Trans proline' 0 C--N 1.362 1.277 0 C-N-CA 122.215 1.943 . . . . 0.0 110.236 172.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -163.59 116.07 1.47 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.125 167.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.1 t -61.56 152.07 31.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.279 -167.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.6 p -148.11 125.29 11.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.434 -165.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.24 0.573 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.398 -170.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.492 ' HG3' ' N ' ' A' ' 20' ' ' TYR . 2.2 tp10 . . . . . 0 N--CA 1.475 0.823 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.492 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 10.0 t80 -105.92 142.43 35.63 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.072 164.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.466 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 1.0 OUTLIER 177.36 133.77 0.21 Allowed Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.582 154.117 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 21' ' ' ARG . 71.9 Cg_endo -88.25 139.52 4.35 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.53 2.82 . . . . 0.0 109.413 -160.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.682 HD23 ' CD2' ' A' ' 53' ' ' PHE . 0.2 OUTLIER -121.92 -163.84 1.1 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.884 160.051 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.469 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 17.5 t -127.24 142.94 51.35 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.702 159.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -78.08 179.38 51.62 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 169.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 60.0 p -98.28 26.59 5.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.434 0.635 . . . . 0.0 110.404 169.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.743 ' HB3' HD12 ' A' ' 48' ' ' LEU . 42.4 p-10 -123.1 13.49 9.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.615 -168.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 69.66 32.35 3.33 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.519 -176.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.1 mtpt -141.51 127.7 19.71 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.205 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.416 HG22 ' N ' ' A' ' 31' ' ' TYR . 84.5 m -62.03 163.39 7.96 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.179 162.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.416 ' N ' HG22 ' A' ' 30' ' ' THR . 25.4 m-85 -138.04 123.72 19.82 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.403 178.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.48 -43.54 99.18 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -167.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.408 ' HB3' ' HA ' ' A' ' 20' ' ' TYR . 0.9 OUTLIER -149.54 166.88 27.86 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 114.755 -0.723 . . . . 0.0 110.399 178.526 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -61.37 -28.46 69.25 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.522 -164.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.0 p -71.12 -39.43 72.03 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.366 -176.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -75.96 -24.0 55.41 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.42 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.433 ' O ' HG23 ' A' ' 41' ' ' VAL . 57.4 t80 -61.37 -63.36 1.31 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.803 164.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.665 ' O ' HG13 ' A' ' 42' ' ' VAL . 86.1 m -62.19 -32.82 73.51 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.538 -161.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.789 ' HA ' HG22 ' A' ' 42' ' ' VAL . 6.3 p30 -78.13 -22.17 49.23 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 114.607 -1.178 . . . . 0.0 110.172 -176.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -66.36 -26.07 67.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.247 164.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.834 HG22 ' CD2' ' A' ' 48' ' ' LEU . 62.1 t -80.44 -46.74 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.094 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.474 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.789 HG22 ' HA ' ' A' ' 39' ' ' ASN . 15.6 m -74.78 -35.44 36.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.174 -169.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.444 ' OE1' HG23 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -60.73 -32.47 71.75 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.348 167.024 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.24 -32.64 72.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.404 -173.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 69.57 50.96 0.49 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.437 176.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.87 24.34 55.7 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 176.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 97.8 m -96.12 -87.84 0.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.378 -0.411 . . . . 0.0 110.169 169.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.834 ' CD2' HG22 ' A' ' 41' ' ' VAL . 1.0 OUTLIER -68.25 151.24 47.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.29 -161.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 31.9 p -151.34 -178.87 6.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.188 168.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.802 HD22 ' CG2' ' A' ' 6' ' ' VAL . 3.6 tp -79.55 140.84 37.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.158 -166.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.5 t -96.39 -35.02 11.33 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.451 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.525 ' HA ' HG13 ' A' ' 4' ' ' VAL . 1.6 p80 174.73 157.49 0.16 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.335 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.774 ' CE1' HD21 ' A' ' 50' ' ' LEU . 20.7 m-85 -91.37 141.32 28.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.345 173.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 113.11 40.67 1.04 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 166.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.419 ' CE ' ' HB2' ' A' ' 22' ' ' PRO . 0.2 OUTLIER 60.73 171.44 0.1 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.441 -0.88 . . . . 0.0 110.553 -174.757 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.458 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 1.8 t . . . . . 0 C--O 1.241 0.621 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.032 -157.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.689 HD23 ' O ' ' A' ' 1' ' ' LEU . 7.0 tt . . . . . 0 N--CA 1.473 0.686 0 CA-C-O 121.149 0.5 . . . . 0.0 109.849 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -175.02 162.38 3.07 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.267 -170.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -143.7 106.61 4.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.245 168.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.722 HG22 ' CE1' ' A' ' 53' ' ' PHE . 7.3 p -120.19 94.68 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.459 169.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.5 p -123.17 174.84 7.0 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.349 -173.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.726 ' CG2' HD22 ' A' ' 50' ' ' LEU . 9.0 t -129.44 140.32 49.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.848 -172.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.83 90.53 3.17 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.736 -156.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.536 ' SG ' HG12 ' A' ' 6' ' ' VAL . 66.4 m -138.58 39.41 2.22 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.089 -158.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.4 t -90.81 61.51 4.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.213 169.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.38 -23.75 0.01 OUTLIER 'General case' 0 C--O 1.235 0.315 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.794 -175.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.532 ' O ' HG11 ' A' ' 42' ' ' VAL . 41.2 m-85 -59.25 161.43 9.87 Favored Pre-proline 0 C--O 1.239 0.543 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.541 167.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.41 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 35.0 Cg_endo -77.93 150.16 88.94 Favored 'Cis proline' 0 CA--C 1.517 -0.339 0 C-N-CA 122.779 -1.759 . . . . 0.0 109.304 1.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.476 ' HG2' ' CD2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -109.65 152.12 42.65 Favored Pre-proline 0 C--O 1.237 0.411 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.225 -179.628 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -76.29 -21.53 13.44 Favored 'Trans proline' 0 CA--C 1.514 -0.511 0 C-N-CA 122.647 2.231 . . . . 0.0 110.721 -172.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -121.4 118.13 28.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.267 -166.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.9 m -97.41 -176.05 3.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.982 165.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 17' ' ' THR . 1.6 t -125.43 35.81 4.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.175 169.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.8 tt . . . . . 0 C--O 1.24 0.581 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.306 -168.819 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 . . . . . 0 N--CA 1.475 0.78 0 CA-C-O 121.076 0.465 . . . . 0.0 109.783 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.497 ' CD1' ' N ' ' A' ' 21' ' ' ARG . 27.9 t80 -61.79 154.2 26.43 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.157 174.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.497 ' N ' ' CD1' ' A' ' 20' ' ' TYR . 6.2 ptp180 176.72 154.98 0.42 Allowed Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.671 154.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.454 ' HB2' ' HG3' ' A' ' 55' ' ' LYS . 61.6 Cg_endo -90.55 100.45 0.27 Allowed 'Trans proline' 0 C--O 1.237 0.43 0 C-N-CA 123.776 2.984 . . . . 0.0 109.278 -162.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.582 ' O ' HG22 ' A' ' 30' ' ' THR . 0.1 OUTLIER -110.67 178.61 4.31 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 121.971 -0.455 . . . . 0.0 109.924 157.089 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 36.7 t -132.03 124.38 29.14 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 154.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.28 -165.49 1.89 Allowed Glycine 0 CA--C 1.529 0.968 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 173.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.8 t -98.26 39.13 1.26 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.591 0.71 . . . . 0.0 110.387 165.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.696 ' HB3' HD12 ' A' ' 48' ' ' LEU . 31.4 p-10 -123.24 13.58 9.63 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.672 -171.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.3 m120 66.17 32.27 8.17 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.663 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.12 159.89 18.15 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 114.691 -1.141 . . . . 0.0 110.767 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.582 HG22 ' O ' ' A' ' 23' ' ' LEU . 1.0 OUTLIER -71.71 165.28 24.34 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.347 178.247 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.5 ' O ' HD12 ' A' ' 23' ' ' LEU . 62.1 m-85 -126.66 141.76 51.75 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.067 162.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.3 -85.82 0.31 Allowed Glycine 0 CA--C 1.525 0.658 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.551 177.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.412 ' ND2' ' HB2' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -78.0 158.0 29.43 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.932 -0.634 . . . . 0.0 109.755 -178.865 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.538 ' HD2' HG13 ' A' ' 6' ' ' VAL . 6.6 ttpm? -61.06 -27.68 68.52 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.859 172.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 25.6 p -90.12 -26.13 20.36 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.722 -169.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.412 ' HB2' ' ND2' ' A' ' 33' ' ' ASN . 0.9 OUTLIER -79.34 -24.91 42.43 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.326 168.855 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.623 ' CE1' HD21 ' A' ' 48' ' ' LEU . 30.4 t80 -62.18 -69.96 0.22 Allowed 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.628 164.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.592 ' O ' HG22 ' A' ' 42' ' ' VAL . 96.6 m -67.77 -25.7 65.74 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.366 -164.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -65.08 -28.86 69.75 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.766 171.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.525 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -74.94 -33.22 61.92 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.425 174.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.665 HG22 ' CD2' ' A' ' 48' ' ' LEU . 97.2 t -62.98 -60.19 3.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.251 175.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.748 HG23 ' OE1' ' A' ' 43' ' ' GLU . 5.9 m -63.56 -34.08 65.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.19 -169.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.748 ' OE1' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -64.5 -36.57 84.63 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.43 174.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.723 ' HB2' HG22 ' A' ' 47' ' ' THR . 20.5 p -71.99 -19.28 61.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.438 -174.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 69.69 30.36 3.91 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.378 177.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.64 44.65 4.83 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 167.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.723 HG22 ' HB2' ' A' ' 44' ' ' SER . 3.5 t -115.8 -37.55 3.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.281 -0.459 . . . . 0.0 110.51 171.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.696 HD12 ' HB3' ' A' ' 27' ' ' ASP . 1.4 tt -74.21 -82.61 0.06 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.507 -164.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.684 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.2 OUTLIER 61.96 161.84 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.326 -179.769 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.726 HD22 ' CG2' ' A' ' 6' ' ' VAL . 3.3 tp -83.47 132.8 34.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.125 -165.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.2 t -78.23 -39.92 38.87 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 114.302 -1.317 . . . . 0.0 110.509 175.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.624 ' O ' HD11 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -176.57 174.51 1.86 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.137 176.671 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.722 ' CE1' HG22 ' A' ' 4' ' ' VAL . 19.2 m-85 -98.39 71.6 2.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.078 163.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -142.56 -156.97 6.97 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 178.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.454 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 14.9 mtpp -119.17 40.61 3.28 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 114.931 -0.635 . . . . 0.0 109.942 -178.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.49 ' HB2' HG23 ' A' ' 30' ' ' THR . 2.0 t . . . . . 0 C--O 1.241 0.611 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.137 156.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.473 0.716 0 CA-C-O 121.054 0.454 . . . . 0.0 109.835 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -100.47 -82.9 0.45 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.313 -169.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 61.58 74.2 0.45 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.273 172.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.45 ' O ' HD23 ' A' ' 50' ' ' LEU . 15.6 m -78.69 85.29 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.316 -165.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.9 t -132.36 -177.93 4.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.25 165.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.816 ' CG2' HD22 ' A' ' 50' ' ' LEU . 8.7 t -145.62 134.76 17.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.247 -166.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -99.71 97.42 8.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.485 -174.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.504 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 58.6 m -125.8 31.08 5.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.922 -171.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.6 t -87.46 60.87 6.28 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.192 -176.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -173.81 -25.17 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.064 -1.426 . . . . 0.0 109.214 -172.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.689 ' O ' HG11 ' A' ' 42' ' ' VAL . 63.1 m-85 -58.27 162.39 6.02 Favored Pre-proline 0 C--O 1.238 0.496 0 CA-C-N 113.948 -1.478 . . . . 0.0 110.636 163.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.44 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.3 Cg_endo -78.72 138.28 49.03 Favored 'Cis proline' 0 CA--C 1.516 -0.377 0 C-N-CA 122.838 -1.734 . . . . 0.0 109.239 1.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.421 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 1.3 mttp -88.13 170.4 11.57 Favored Pre-proline 0 C--O 1.24 0.596 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.986 172.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 13' ' ' LYS 0.253 11.5 Cg_endo -91.7 -18.84 0.86 Allowed 'Trans proline' 0 CA--C 1.512 -0.599 0 C-N-CA 122.595 2.196 . . . . 0.0 110.768 173.373 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.51 -170.45 0.52 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.001 0.429 . . . . 0.0 110.295 -172.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 61.2 m 64.46 139.65 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.492 174.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 17' ' ' THR . 1.4 t -172.12 23.77 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.369 -169.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.241 0.623 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.335 178.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' A' ' 21' ' ' ARG . 10.2 t80 -78.93 147.67 32.94 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.055 -165.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.481 ' N ' ' CD1' ' A' ' 20' ' ' TYR . 0.0 OUTLIER 177.73 134.86 0.22 Allowed Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.535 155.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.455 ' HB2' ' HG3' ' A' ' 55' ' ' LYS . 55.3 Cg_endo -83.45 127.74 4.53 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 123.684 2.922 . . . . 0.0 109.457 -160.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.422 HD23 ' CD2' ' A' ' 53' ' ' PHE . 0.2 OUTLIER -111.43 -170.12 1.59 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.903 160.304 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.469 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 17.4 t -124.16 145.32 49.38 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.643 158.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -78.97 176.13 54.82 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 166.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -98.09 43.73 1.06 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.357 -0.422 . . . . 0.0 110.319 164.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.523 ' HB3' HD12 ' A' ' 48' ' ' LEU . 26.8 p-10 -129.96 12.45 5.69 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.701 178.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 69.68 34.05 2.8 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.581 -177.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -137.53 127.12 25.16 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.273 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 57.8 m -66.73 155.51 37.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.245 163.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.502 ' OH ' ' HB1' ' A' ' 40' ' ' ALA . 8.1 m-85 -135.31 128.69 32.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.439 -172.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.17 -49.34 79.11 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 -165.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.4 ' HB2' ' H ' ' A' ' 35' ' ' CYS . 0.1 OUTLIER -126.17 -169.4 2.01 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.269 -0.465 . . . . 0.0 109.825 -179.019 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.9 tptp -68.21 -33.35 74.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.277 160.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.4 ' H ' ' HB2' ' A' ' 33' ' ' ASN . 15.3 m -81.75 -21.11 38.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.223 -168.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -89.65 -25.37 21.29 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.313 174.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.619 ' O ' HG23 ' A' ' 41' ' ' VAL . 49.1 t80 -61.28 -66.4 0.54 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.109 166.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.504 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 72.9 m -61.12 -33.68 73.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.516 -164.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.458 ' HA ' HG22 ' A' ' 42' ' ' VAL . 79.4 m-20 -71.43 -30.37 65.98 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.106 179.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -61.54 -33.58 74.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.333 168.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.919 HG22 HD22 ' A' ' 48' ' ' LEU . 66.7 t -76.37 -52.76 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.515 -172.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.772 HG23 ' OE1' ' A' ' 43' ' ' GLU . 10.5 m -62.14 -29.22 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.205 -178.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.772 ' OE1' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -70.3 -39.42 74.84 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 113.804 -1.544 . . . . 0.0 110.499 173.267 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.2 p -61.98 -16.6 52.62 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.5 -175.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 67.86 35.31 3.91 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.393 176.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.62 80.67 0.66 Allowed Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 173.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.9 t -171.47 -39.89 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.973 -0.613 . . . . 0.0 110.566 -170.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.919 HD22 HG22 ' A' ' 41' ' ' VAL . 4.9 tt -75.82 -83.02 0.07 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.379 -168.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.846 ' N ' HD23 ' A' ' 48' ' ' LEU . 6.7 p 59.09 163.47 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.072 -178.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.816 HD22 ' CG2' ' A' ' 6' ' ' VAL . 2.9 tp -81.1 159.84 24.61 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.303 -159.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.481 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 41.3 t -113.07 -39.84 4.1 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 114.482 -1.236 . . . . 0.0 110.63 174.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.518 ' O ' HD11 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -175.92 160.49 2.34 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.327 -176.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.546 ' CD1' HD21 ' A' ' 50' ' ' LEU . 29.8 m-85 -100.54 22.89 11.08 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.564 -165.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -119.07 -174.69 15.95 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 164.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.455 ' HG3' ' HB2' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -61.38 170.12 1.93 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.137 -0.531 . . . . 0.0 109.977 163.077 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.456 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 1.2 t . . . . . 0 N--CA 1.471 0.604 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.879 -155.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.474 0.748 0 CA-C-O 121.207 0.527 . . . . 0.0 109.812 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.567 ' HB1' ' OG ' ' A' ' 5' ' ' SER . . . -66.07 169.23 7.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.229 170.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.497 ' O ' HG12 ' A' ' 4' ' ' VAL . . . -108.09 74.4 0.94 Allowed 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.229 -173.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 3' ' ' ALA . 4.5 p 59.05 27.13 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.339 -176.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.567 ' OG ' ' HB1' ' A' ' 2' ' ' ALA . 2.2 p -108.11 179.43 4.22 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.46 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.802 ' CG2' HD22 ' A' ' 50' ' ' LEU . 97.2 t -139.3 145.47 27.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.054 -171.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -132.4 94.75 3.49 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.993 -156.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.494 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 61.1 m -133.43 35.23 3.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.195 -161.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.34 61.45 6.65 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.272 174.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.03 -24.81 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.159 -1.382 . . . . 0.0 109.356 -175.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.659 ' C ' HG11 ' A' ' 42' ' ' VAL . 41.2 m-85 -57.92 160.66 8.02 Favored Pre-proline 0 C--O 1.237 0.413 0 CA-C-N 114.083 -1.417 . . . . 0.0 110.544 161.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.699 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.0 Cg_endo -88.17 165.22 42.38 Favored 'Cis proline' 0 CA--C 1.519 -0.264 0 C-N-CA 123.185 -1.59 . . . . 0.0 109.364 9.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -136.2 97.09 12.25 Favored Pre-proline 0 C--O 1.237 0.4 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.266 -170.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -51.85 -20.84 10.57 Favored 'Trans proline' 0 C--N 1.36 1.149 0 C-N-CA 122.841 2.361 . . . . 0.0 110.871 175.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.02 88.03 2.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.359 165.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 81.3 m -113.61 -172.11 2.01 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.966 166.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.2 20.82 5.3 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.446 162.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.8 mt . . . . . 0 C--O 1.24 0.582 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.306 173.653 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.6 pm0 . . . . . 0 N--CA 1.474 0.73 0 CA-C-O 121.124 0.487 . . . . 0.0 109.754 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.463 ' CD1' ' HA ' ' A' ' 21' ' ' ARG . 10.6 t80 -91.76 144.42 25.52 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.161 171.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.463 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 1.1 ptm180 177.37 131.91 0.2 Allowed Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.531 154.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 21' ' ' ARG . 66.8 Cg_endo -85.48 139.21 6.71 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 123.684 2.923 . . . . 0.0 109.512 -159.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.793 ' O ' HG23 ' A' ' 30' ' ' THR . 0.2 OUTLIER -117.2 -168.92 1.56 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.88 159.485 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.469 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 21.8 t -119.78 118.61 31.3 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.413 158.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.434 ' HA3' ' CE2' ' A' ' 31' ' ' TYR . . . -86.53 144.11 19.6 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 168.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.72 40.08 1.15 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.379 -0.41 . . . . 0.0 110.314 -164.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.918 ' HB3' HD12 ' A' ' 48' ' ' LEU . 22.1 p-10 -99.49 -45.71 5.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.013 167.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -175.03 -30.1 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.043 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -119.66 154.4 34.1 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.446 -155.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.793 HG23 ' O ' ' A' ' 23' ' ' LEU . 69.9 m -75.71 146.82 39.85 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.047 159.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.459 ' CE1' ' HB2' ' A' ' 40' ' ' ALA . 19.9 m-85 -114.66 127.35 55.72 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.445 -173.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.49 -47.29 91.48 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -167.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -137.64 171.77 13.95 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-O 121.416 0.627 . . . . 0.0 110.438 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.4 ' CE ' HG13 ' A' ' 6' ' ' VAL . 6.8 tttm -70.68 -27.44 64.02 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.531 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.5 t -73.45 -20.66 60.66 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.074 -0.967 . . . . 0.0 110.635 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -102.13 -22.12 14.28 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.833 -178.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.776 ' O ' HG23 ' A' ' 41' ' ' VAL . 75.9 t80 -62.21 -60.04 4.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.952 164.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.525 ' O ' HG22 ' A' ' 42' ' ' VAL . 72.1 m -60.19 -28.87 68.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.946 -173.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.508 ' HA ' HG22 ' A' ' 42' ' ' VAL . 2.2 m-80 -73.98 -31.27 62.91 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.215 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -61.33 -28.59 69.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.326 168.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.895 HG22 ' CD2' ' A' ' 48' ' ' LEU . 28.7 t -88.4 -46.66 15.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.525 -168.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.726 HG23 ' OE1' ' A' ' 43' ' ' GLU . 8.7 m -61.94 -35.36 67.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.346 174.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.726 ' OE1' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -63.11 -46.58 86.67 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.373 178.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.422 ' CB ' HG22 ' A' ' 47' ' ' THR . 5.7 p -76.72 -10.12 59.16 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.847 -168.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.294 0.0 OUTLIER 75.29 27.52 1.08 Allowed 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.209 -1.36 . . . . 0.0 109.626 173.113 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.58 40.32 4.76 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 166.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.422 HG22 ' CB ' ' A' ' 44' ' ' SER . 14.6 t -126.67 -37.47 2.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.981 0.42 . . . . 0.0 110.329 -171.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.918 HD12 ' HB3' ' A' ' 27' ' ' ASP . 1.3 tt -78.94 148.58 32.61 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.171 168.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.503 HG22 ' H ' ' A' ' 50' ' ' LEU . 3.8 m -157.14 167.85 29.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.327 174.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.802 HD22 ' CG2' ' A' ' 6' ' ' VAL . 7.6 tp -74.65 130.95 40.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.157 -169.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.5 t -84.64 -37.28 21.25 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.535 174.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.469 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.6 p80 176.96 151.16 0.17 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.204 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.702 ' CE1' HD21 ' A' ' 50' ' ' LEU . 45.4 m-85 -78.16 166.1 23.16 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.318 177.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 62.71 -179.41 5.06 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.331 -1.107 . . . . 0.0 110.331 -162.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.57 -175.62 1.69 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 114.93 -0.635 . . . . 0.0 110.333 -174.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.458 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 3.0 t . . . . . 0 C--O 1.241 0.632 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.215 -155.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 16.9 tp . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.47 75.67 0.4 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.384 -171.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -116.62 25.24 10.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.233 -167.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.8 p -108.54 19.14 6.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.423 167.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.1 p -118.94 165.62 13.86 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.375 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.847 ' CG2' HD22 ' A' ' 50' ' ' LEU . 11.3 t -131.43 110.96 18.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.283 -166.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -72.35 123.58 23.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.44 166.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.548 ' SG ' HG12 ' A' ' 6' ' ' VAL . 60.7 m -138.51 41.9 2.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.126 175.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.1 59.17 3.49 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.295 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -173.27 -24.58 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 114.137 -1.392 . . . . 0.0 109.467 -174.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.538 ' O ' HG11 ' A' ' 42' ' ' VAL . 42.6 m-85 -58.98 162.82 6.45 Favored Pre-proline 0 C--O 1.24 0.571 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.605 167.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.426 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 31.6 Cg_endo -77.74 141.69 67.98 Favored 'Cis proline' 0 CA--C 1.517 -0.331 0 C-N-CA 122.947 -1.689 . . . . 0.0 109.325 0.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.426 ' HE3' ' HA ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -73.0 172.78 7.1 Favored Pre-proline 0 N--CA 1.455 -0.213 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.163 -178.604 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -53.91 -62.88 0.26 Allowed 'Trans proline' 0 C--N 1.361 1.202 0 C-N-CA 122.754 2.303 . . . . 0.0 110.585 172.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -114.87 116.12 28.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.262 -165.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.2 m -120.06 77.25 1.23 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.46 168.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.4 m -153.25 128.52 9.82 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.391 175.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.549 ' C ' HD13 ' A' ' 18' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.24 0.592 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.234 -173.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.451 ' HA ' HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.474 0.771 0 CA-C-O 121.658 0.742 . . . . 0.0 109.758 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -83.06 -52.66 6.44 Favored 'General case' 0 C--O 1.248 1.023 0 CA-C-O 117.576 -1.202 . . . . 0.0 109.054 165.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.0 ptp85 -53.9 138.07 54.7 Favored Pre-proline 0 CA--C 1.537 0.454 0 O-C-N 120.456 -1.402 . . . . 0.0 110.967 -145.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -101.88 167.34 0.31 Allowed 'Trans proline' 0 N--CA 1.476 0.444 0 C-N-CA 123.978 3.119 . . . . 0.0 109.405 -148.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.632 HD23 ' CD2' ' A' ' 53' ' ' PHE . 0.2 OUTLIER -132.88 -162.27 1.22 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 158.404 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.527 ' O ' HD12 ' A' ' 50' ' ' LEU . 19.9 t -130.18 146.53 51.82 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.478 157.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.04 -167.65 41.69 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.069 -1.213 . . . . 0.0 110.069 175.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.22 27.04 4.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.457 0.646 . . . . 0.0 110.42 166.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.704 ' HB3' HD12 ' A' ' 48' ' ' LEU . 54.5 p-10 -122.48 11.81 9.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.869 -167.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 68.55 34.48 3.56 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.629 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.1 mttp -141.16 138.88 33.73 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.323 -178.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.3 m -76.89 145.94 37.96 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.281 163.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.539 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 3.2 m-85 -121.81 133.69 54.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.434 -175.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.8 -73.11 0.54 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -169.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.417 ' ND2' ' HB3' ' A' ' 35' ' ' CYS . 1.0 OUTLIER -110.13 165.29 11.86 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.256 0.551 . . . . 0.0 110.56 175.464 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -62.84 -15.9 56.31 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.457 172.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.417 ' HB3' ' ND2' ' A' ' 33' ' ' ASN . 2.4 t -80.9 -18.23 47.91 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.463 178.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -103.89 -21.73 13.6 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.656 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.543 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 52.3 t80 -61.47 -64.92 0.79 Allowed 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.779 162.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.603 ' O ' HG22 ' A' ' 42' ' ' VAL . 81.0 m -59.9 -26.64 66.07 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.228 -172.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.566 ' HA ' HG22 ' A' ' 42' ' ' VAL . 2.2 m-80 -73.29 -29.97 63.08 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.135 177.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -61.87 -39.24 91.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.309 165.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.914 HG22 HD23 ' A' ' 48' ' ' LEU . 86.4 t -70.48 -48.79 57.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.476 -174.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.781 HG23 ' OE1' ' A' ' 43' ' ' GLU . 12.8 m -73.49 -34.98 44.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.154 -172.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.781 ' OE1' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -66.66 -31.82 72.75 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.291 -1.322 . . . . 0.0 110.57 170.291 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.809 ' OG ' HG22 ' A' ' 47' ' ' THR . 12.7 t -68.56 -27.95 66.53 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.298 -177.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.8 m120 61.77 16.89 8.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.498 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.43 92.08 2.13 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 176.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.809 HG22 ' OG ' ' A' ' 44' ' ' SER . 5.3 t -175.21 -33.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.362 -0.419 . . . . 0.0 110.171 163.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.914 HD23 HG22 ' A' ' 41' ' ' VAL . 1.0 OUTLIER -67.53 -81.03 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.473 -164.16 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.44 153.1 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.293 178.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.847 HD22 ' CG2' ' A' ' 6' ' ' VAL . 2.7 tp -81.59 158.63 24.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.324 -164.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.469 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 35.8 t -109.11 -46.09 3.65 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.602 177.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.488 ' CD2' ' N ' ' A' ' 52' ' ' HIS . 0.8 OUTLIER -165.99 -178.8 4.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.47 173.055 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.67 ' CE1' HD21 ' A' ' 50' ' ' LEU . 1.8 m-85 -112.44 106.87 15.46 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.271 167.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -170.93 -105.6 0.18 Allowed Glycine 0 CA--C 1.53 1.028 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 164.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.5 64.95 0.88 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 123.121 1.438 . . . . 0.0 110.16 156.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.41 ' CA ' ' HB2' ' A' ' 24' ' ' CYS . 1.1 t . . . . . 0 N--CA 1.47 0.538 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.194 159.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 43.3 tp . . . . . 0 N--CA 1.474 0.746 0 CA-C-O 121.164 0.506 . . . . 0.0 109.811 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.49 79.3 0.26 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.367 -170.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -168.69 75.9 0.11 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.27 -168.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.42 ' O ' HG13 ' A' ' 4' ' ' VAL . 8.6 p -62.54 83.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.358 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.91 -177.08 5.25 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 114.832 -1.077 . . . . 0.0 110.328 -177.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.863 ' CG2' HD22 ' A' ' 50' ' ' LEU . 11.3 t -135.04 120.28 29.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.283 -166.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -72.84 80.65 1.16 Allowed 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.407 177.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 60.8 m -103.02 42.22 1.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.217 174.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.2 59.34 3.03 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.231 -178.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -173.66 -24.6 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 114.074 -1.421 . . . . 0.0 109.239 -173.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.537 ' HB3' ' HA ' ' A' ' 12' ' ' PRO . 47.9 m-85 -58.05 160.3 9.04 Favored Pre-proline 0 C--O 1.237 0.409 0 CA-C-N 113.98 -1.464 . . . . 0.0 110.714 164.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.537 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 33.6 Cg_endo -83.06 139.96 38.51 Favored 'Cis proline' 0 C--O 1.235 0.334 0 C-N-CA 122.894 -1.711 . . . . 0.0 109.409 8.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.423 ' CG ' ' HD3' ' A' ' 14' ' ' PRO . 1.9 tttp -78.83 149.97 74.78 Favored Pre-proline 0 C--O 1.237 0.421 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.937 164.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.423 ' HD3' ' CG ' ' A' ' 13' ' ' LYS . 13.6 Cg_endo -78.33 -21.48 10.35 Favored 'Trans proline' 0 C--O 1.238 0.516 0 C-N-CA 122.714 2.276 . . . . 0.0 110.794 -170.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -129.54 123.64 31.91 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 122.093 -0.38 . . . . 0.0 110.268 -161.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 21.8 m -80.07 -170.68 2.58 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.927 159.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.7 t -145.51 25.2 1.36 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.569 165.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.638 HD13 ' OD1' ' A' ' 33' ' ' ASN . 9.3 tt . . . . . 0 C--O 1.241 0.624 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.496 -174.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.453 ' HG2' ' N ' ' A' ' 20' ' ' TYR . 4.1 tt0 . . . . . 0 N--CA 1.475 0.803 0 CA-C-O 121.114 0.483 . . . . 0.0 109.715 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.466 ' CD1' ' HA ' ' A' ' 21' ' ' ARG . 11.2 t80 -71.63 144.62 49.37 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.165 -175.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.466 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 0.0 OUTLIER 177.3 133.49 0.21 Allowed Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.359 155.179 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.428 ' HB2' ' CD ' ' A' ' 55' ' ' LYS . 57.9 Cg_endo -83.14 134.23 6.85 Favored 'Trans proline' 0 CA--C 1.515 -0.434 0 C-N-CA 123.729 2.953 . . . . 0.0 109.549 -159.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.569 ' O ' HG23 ' A' ' 30' ' ' THR . 0.2 OUTLIER -114.94 -170.12 1.69 Allowed 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.874 166.16 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 18.5 t -133.81 102.9 5.62 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.416 158.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.422 ' H ' ' HD2' ' A' ' 31' ' ' TYR . . . -63.93 155.49 45.34 Favored Glycine 0 N--CA 1.467 0.722 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 164.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.0 p -96.25 41.38 1.11 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.144 -0.528 . . . . 0.0 110.33 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.544 ' HB3' HD12 ' A' ' 48' ' ' LEU . 32.1 p-10 -108.08 21.85 16.79 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.862 0.839 . . . . 0.0 109.994 164.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . 0.399 0.0 OUTLIER 90.79 -17.55 0.18 Allowed 'General case' 0 C--O 1.239 0.53 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.948 -173.232 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.7 mttm -100.94 135.71 41.94 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 122.179 -0.326 . . . . 0.0 110.417 -159.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.569 HG23 ' O ' ' A' ' 23' ' ' LEU . 67.3 m -79.46 130.03 35.03 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.852 157.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.472 ' HE2' HD11 ' A' ' 48' ' ' LEU . 11.0 m-85 -102.21 123.59 46.31 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.449 -168.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.59 -42.21 99.72 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -169.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.638 ' OD1' HD13 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -156.64 161.85 39.87 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 114.918 -0.641 . . . . 0.0 110.231 -175.614 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.82 -29.18 69.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.737 -163.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.2 p -66.54 -31.35 72.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.312 -175.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -92.65 -25.72 18.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.505 -175.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.461 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 37.2 t80 -62.72 -71.65 0.15 Allowed 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.642 166.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 71.1 m -61.45 -32.56 72.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.44 -165.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.563 ' HA ' HG22 ' A' ' 42' ' ' VAL . 2.4 m-80 -67.25 -23.57 65.71 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.019 177.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.611 ' C ' HD22 ' A' ' 48' ' ' LEU . . . -82.38 -22.31 35.48 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 114.351 -1.295 . . . . 0.0 110.377 175.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.823 HG22 HD23 ' A' ' 48' ' ' LEU . 90.2 t -72.27 -59.01 3.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.519 171.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.732 HG23 ' OE1' ' A' ' 43' ' ' GLU . 22.6 m -61.92 -27.28 42.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.07 -170.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.732 ' OE1' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -69.32 -47.42 64.52 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 113.697 -1.592 . . . . 0.0 110.584 174.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.938 ' CB ' HG22 ' A' ' 47' ' ' THR . 1.1 p -62.11 -17.79 58.82 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.697 -177.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 24.8 m120 62.16 16.61 8.47 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.319 -176.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.99 68.24 0.83 Allowed Glycine 0 CA--C 1.527 0.798 0 CA-C-N 114.618 -1.173 . . . . 0.0 110.475 -173.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.938 HG22 ' CB ' ' A' ' 44' ' ' SER . 1.4 t -136.29 -36.28 0.73 Allowed 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.373 0.606 . . . . 0.0 110.684 161.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.823 HD23 HG22 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -75.24 -92.42 0.02 OUTLIER 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.529 -178.52 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 17.3 p 52.3 176.75 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 121.513 -0.742 . . . . 0.0 112.594 -172.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.863 HD22 ' CG2' ' A' ' 6' ' ' VAL . 3.3 tp -91.4 123.03 34.51 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.287 -159.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.9 t -60.64 -61.96 2.21 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.317 162.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.65 ' C ' HD11 ' A' ' 50' ' ' LEU . 2.5 p80 -158.97 163.11 36.76 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.112 173.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.824 ' CZ ' HG22 ' A' ' 6' ' ' VAL . 36.2 m-85 -77.66 176.03 9.35 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.333 169.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.48 173.4 3.31 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -164.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.428 ' CD ' ' HB2' ' A' ' 22' ' ' PRO . 7.7 mmmt -61.56 171.89 1.37 Allowed 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.261 -0.469 . . . . 0.0 110.208 169.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.462 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 1.5 t . . . . . 0 C--O 1.24 0.599 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.932 -158.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.501 HD23 ' O ' ' A' ' 1' ' ' LEU . 1.2 tt . . . . . 0 N--CA 1.473 0.721 0 CA-C-O 121.515 0.674 . . . . 0.0 109.944 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 1' ' ' LEU . . . 61.88 153.43 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.56 -175.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 61.78 98.39 0.03 OUTLIER 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.395 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.44 HG22 ' CZ ' ' A' ' 53' ' ' PHE . 13.2 p -80.39 -20.19 11.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.325 -168.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.3 t -59.99 165.87 3.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.683 -160.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.838 HG23 HD22 ' A' ' 50' ' ' LEU . 6.5 t -107.48 129.84 60.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.976 -159.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -107.58 107.85 18.87 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.537 170.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 35.2 m -111.71 47.1 1.06 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.436 -177.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.6 m -96.24 39.12 1.16 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 114.196 -1.365 . . . . 0.0 110.374 166.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -129.91 25.48 5.29 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.977 161.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.541 ' HB2' HG11 ' A' ' 42' ' ' VAL . 85.1 m-85 -126.63 166.87 19.42 Favored Pre-proline 0 C--O 1.236 0.386 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.704 -170.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.414 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.2 Cg_endo -72.42 138.88 57.18 Favored 'Cis proline' 0 CA--C 1.518 -0.319 0 C-N-CA 122.064 -2.057 . . . . 0.0 108.98 -7.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.476 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -80.7 -178.07 1.08 Allowed Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.264 176.887 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -53.29 -62.75 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.131 0 C-N-CA 122.702 2.268 . . . . 0.0 110.792 174.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -175.49 -163.64 0.12 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.427 -165.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 t -158.3 172.23 18.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.846 -166.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.484 ' O ' HD22 ' A' ' 18' ' ' LEU . 26.4 p -98.26 25.62 6.06 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.486 176.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.484 HD22 ' O ' ' A' ' 17' ' ' THR . 0.1 OUTLIER . . . . . 0 C--O 1.24 0.566 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.329 167.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 N--CA 1.473 0.678 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.469 ' CD1' ' N ' ' A' ' 21' ' ' ARG . 10.9 t80 -76.85 147.05 37.34 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.211 -169.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.469 ' N ' ' CD1' ' A' ' 20' ' ' TYR . 0.0 OUTLIER 177.73 135.61 0.22 Allowed Pre-proline 0 CA--C 1.536 0.413 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.531 155.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.421 ' HB2' ' HB3' ' A' ' 55' ' ' LYS . 47.7 Cg_endo -84.09 143.93 10.49 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.775 2.983 . . . . 0.0 109.593 -158.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.12 -165.52 1.69 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.055 158.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.522 ' O ' HD12 ' A' ' 50' ' ' LEU . 21.1 t -132.6 148.53 52.37 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.293 158.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -81.87 -169.63 43.2 Favored Glycine 0 CA--C 1.531 1.093 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 174.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.4 m -97.62 19.9 12.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.98 -0.61 . . . . 0.0 110.454 161.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.705 ' HB3' HD12 ' A' ' 48' ' ' LEU . 34.1 p-10 -107.14 9.23 30.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.147 -175.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.9 m120 67.91 38.61 2.78 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.587 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.91 137.6 34.95 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 114.583 -1.189 . . . . 0.0 110.342 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.6 m -72.48 147.65 45.84 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.24 162.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -122.74 125.04 44.73 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.394 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.34 -50.27 68.6 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -167.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.421 ' HB3' ' HA ' ' A' ' 20' ' ' TYR . 1.7 p30 -125.04 175.38 7.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.203 -0.498 . . . . 0.0 110.482 170.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.421 ' HE3' ' CG1' ' A' ' 6' ' ' VAL . 4.8 tttp -69.23 -17.57 63.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.414 169.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 22.8 m -60.99 -51.61 68.52 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.545 172.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -80.4 -21.33 42.37 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.859 -171.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.683 ' O ' HG23 ' A' ' 41' ' ' VAL . 57.7 t80 -61.29 -67.64 0.39 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.967 165.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.84 ' O ' HG22 ' A' ' 42' ' ' VAL . 96.8 m -65.05 -29.85 70.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.638 -163.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -65.37 -33.78 76.76 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.02 173.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -69.35 -24.22 63.87 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.324 174.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.936 HG22 HD22 ' A' ' 48' ' ' LEU . 59.3 t -87.9 -55.18 6.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.387 -172.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.84 HG22 ' O ' ' A' ' 38' ' ' CYS . 6.6 m -62.33 -23.09 31.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.149 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.76 ' OE1' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -77.13 -37.99 52.95 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 113.774 -1.557 . . . . 0.0 110.621 173.003 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.1 p -62.28 -19.99 63.82 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.628 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 69.27 41.61 1.33 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.274 -171.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.68 88.12 0.03 OUTLIER Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 172.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.1 t -176.4 -42.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.262 -0.469 . . . . 0.0 110.322 -167.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.936 HD22 HG22 ' A' ' 41' ' ' VAL . 1.0 OUTLIER -61.71 -73.93 0.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.367 172.25 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.858 ' N ' HD23 ' A' ' 48' ' ' LEU . 0.2 OUTLIER 66.89 160.31 0.15 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.431 175.621 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.838 HD22 HG23 ' A' ' 6' ' ' VAL . 5.6 tp -82.7 162.05 21.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.286 -168.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.462 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 16.2 t -112.95 -41.44 3.75 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.671 173.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.431 ' NE2' ' HB3' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -177.79 167.63 2.12 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.371 -173.332 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.756 ' CE1' HD21 ' A' ' 50' ' ' LEU . 2.2 m-85 -108.25 30.81 6.07 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.347 -177.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.67 -140.25 6.6 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 168.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 22' ' ' PRO . 1.2 pttm -131.82 63.84 1.61 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 123.2 1.476 . . . . 0.0 110.29 161.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.24 0.57 0 O-C-N 121.345 -0.847 . . . . 0.0 110.187 158.983 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 1' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.474 0.753 0 CA-C-O 121.29 0.567 . . . . 0.0 109.791 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.48 24.59 14.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.417 171.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -174.38 44.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.305 169.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.555 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.4 p -89.66 83.59 2.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.345 -178.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -159.5 146.84 16.96 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.448 169.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.797 ' CG2' HD22 ' A' ' 50' ' ' LEU . 4.9 t -145.91 111.77 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.998 -177.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -67.81 114.22 6.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.408 167.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.476 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 57.8 m -133.39 37.16 3.36 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.036 177.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.1 m -91.23 58.7 3.75 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.221 -175.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -173.31 -24.19 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 114.081 -1.418 . . . . 0.0 109.488 -174.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.595 ' O ' HG11 ' A' ' 42' ' ' VAL . 74.3 m-85 -58.69 160.38 10.55 Favored Pre-proline 0 C--O 1.238 0.459 0 CA-C-N 113.987 -1.461 . . . . 0.0 110.617 166.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.48 ' HB3' HG21 ' A' ' 42' ' ' VAL . 31.9 Cg_endo -78.32 139.99 58.33 Favored 'Cis proline' 0 C--O 1.233 0.261 0 C-N-CA 122.771 -1.762 . . . . 0.0 109.369 3.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.465 ' HG3' ' HD3' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -70.02 159.13 85.47 Favored Pre-proline 0 C--O 1.24 0.575 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.834 164.249 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.465 ' HD3' ' HG3' ' A' ' 13' ' ' LYS . 30.5 Cg_endo -78.62 -64.24 0.02 OUTLIER 'Trans proline' 0 CA--C 1.519 -0.264 0 C-N-CA 122.885 2.39 . . . . 0.0 109.257 -175.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -135.38 130.73 35.37 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.242 -167.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.2 t -117.03 157.91 25.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.367 -168.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -112.51 130.03 56.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.424 -169.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.24 0.57 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.372 -170.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.721 0 CA-C-O 121.592 0.71 . . . . 0.0 109.841 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.5 ' CD2' ' N ' ' A' ' 21' ' ' ARG . 93.7 t80 -61.62 167.0 3.75 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.026 -177.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.5 ' N ' ' CD2' ' A' ' 20' ' ' TYR . 1.7 ptm180 178.52 172.28 0.44 Allowed Pre-proline 0 C--O 1.248 0.983 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.406 151.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.431 ' HG2' ' CE ' ' A' ' 55' ' ' LYS 0.253 82.6 Cg_endo -110.15 92.52 0.02 OUTLIER 'Trans proline' 0 CA--C 1.515 -0.435 0 C-N-CA 122.252 1.968 . . . . 0.0 109.232 -178.7 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.594 HD23 ' CD2' ' A' ' 53' ' ' PHE . 0.2 OUTLIER -90.15 -171.22 3.04 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.855 162.439 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.439 ' HB3' ' NE2' ' A' ' 52' ' ' HIS . 21.6 t -146.06 135.93 23.45 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.221 156.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.27 -171.75 41.56 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 114.387 -1.278 . . . . 0.0 110.316 -177.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.25 26.62 5.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.42 0.629 . . . . 0.0 110.479 170.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.89 ' HB3' HD12 ' A' ' 48' ' ' LEU . 24.9 p-10 -126.9 13.09 7.33 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.827 -166.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.5 m120 69.24 32.51 3.58 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.289 -0.868 . . . . 0.0 110.59 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.73 137.9 38.78 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.285 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 23' ' ' LEU . 1.3 m -77.73 148.95 34.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.337 164.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -121.55 129.99 53.23 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.455 -176.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.55 -93.01 0.01 OUTLIER Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 168.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.0 p-10 -99.9 157.6 16.41 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.998 -0.601 . . . . 0.0 110.577 -168.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -61.59 -15.53 39.89 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.569 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.1 m -66.13 -45.44 81.06 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.471 173.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -89.59 -23.33 21.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.373 -168.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.492 ' O ' HG23 ' A' ' 41' ' ' VAL . 36.2 t80 -61.84 -69.11 0.26 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.877 162.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.551 ' O ' HG22 ' A' ' 42' ' ' VAL . 85.2 m -61.79 -30.92 71.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.574 -168.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.521 ' HA ' HG22 ' A' ' 42' ' ' VAL . 90.0 m-20 -67.07 -31.44 71.95 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.942 175.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -71.17 -17.24 62.55 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.372 174.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.824 HG22 ' CD2' ' A' ' 48' ' ' LEU . 43.7 t -85.8 -52.5 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.501 177.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.748 HG23 ' OE1' ' A' ' 43' ' ' GLU . 4.4 m -70.1 -32.99 53.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.245 -170.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.748 ' OE1' HG23 ' A' ' 42' ' ' VAL . 2.0 mp0 -70.51 -29.81 66.42 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.498 170.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.66 -30.61 70.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.548 175.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 70.22 51.93 0.38 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.301 -166.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.69 21.93 55.95 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.192 176.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 40.5 m -66.9 -86.82 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 157.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.89 HD12 ' HB3' ' A' ' 27' ' ' ASP . 1.0 OUTLIER -61.3 148.66 40.49 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.302 -163.333 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 77.0 p -138.89 -172.43 3.32 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.921 165.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.797 HD22 ' CG2' ' A' ' 6' ' ' VAL . 5.8 tp -86.8 133.19 33.67 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.369 -173.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.449 ' O ' HG21 ' A' ' 4' ' ' VAL . 36.6 t -82.82 -37.04 24.98 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 113.921 -1.49 . . . . 0.0 110.597 173.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.439 ' NE2' ' HB3' ' A' ' 24' ' ' CYS . 0.7 OUTLIER 173.47 162.66 0.15 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.334 -178.676 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.697 ' CE1' HD21 ' A' ' 50' ' ' LEU . 1.3 m-85 -98.78 74.9 2.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.894 160.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -152.39 21.79 0.84 Allowed Glycine 0 CA--C 1.523 0.57 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.811 -172.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.431 ' CE ' ' HG2' ' A' ' 22' ' ' PRO . 9.1 mttp 61.27 35.25 18.27 Favored 'General case' 0 C--O 1.239 0.506 0 O-C-N 122.753 -0.263 . . . . 0.0 110.307 164.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.427 ' H ' ' CE1' ' A' ' 52' ' ' HIS . 0.7 OUTLIER . . . . . 0 N--CA 1.474 0.734 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.734 156.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.474 0.763 0 CA-C-O 121.181 0.515 . . . . 0.0 109.881 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.85 142.96 48.17 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.274 170.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -174.9 102.02 0.09 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.295 -176.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.3 p -74.35 97.53 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.279 166.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.7 p -164.72 -177.11 4.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.261 -167.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.645 HG13 ' CZ ' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -136.79 -175.58 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.282 -167.248 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -153.94 65.86 0.72 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.342 -168.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.527 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 59.4 m -99.83 32.78 2.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.973 -174.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.72 60.5 5.59 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.196 -176.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -173.71 -24.98 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.326 -172.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.474 ' CE2' ' HD2' ' A' ' 13' ' ' LYS . 79.1 m-85 -58.33 160.29 9.82 Favored Pre-proline 0 C--O 1.236 0.374 0 CA-C-N 113.894 -1.503 . . . . 0.0 110.529 163.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.499 ' HB3' HG21 ' A' ' 42' ' ' VAL . 30.5 Cg_endo -78.69 135.83 38.53 Favored 'Cis proline' 0 CA--C 1.518 -0.277 0 C-N-CA 122.667 -1.806 . . . . 0.0 109.378 6.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.474 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 0.8 OUTLIER -67.91 162.1 61.74 Favored Pre-proline 0 C--O 1.238 0.459 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.065 179.205 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.445 ' HD2' ' H ' ' A' ' 15' ' ' ALA . 30.3 Cg_endo -76.13 -57.57 0.05 OUTLIER 'Trans proline' 0 CA--C 1.516 -0.376 0 C-N-CA 122.615 2.21 . . . . 0.0 109.328 -178.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.445 ' H ' ' HD2' ' A' ' 14' ' ' PRO . . . -130.73 112.14 12.81 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.272 -177.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.6 m -62.49 -165.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.98 164.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 17' ' ' THR . 1.6 t -155.17 49.3 0.56 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.411 169.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.678 HD23 ' ND2' ' A' ' 33' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--O 1.241 0.627 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.367 169.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.475 0.799 0 CA-C-O 121.465 0.65 . . . . 0.0 109.808 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.486 ' CD1' ' N ' ' A' ' 21' ' ' ARG . 10.5 t80 -108.87 146.86 33.04 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.288 -177.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.486 ' N ' ' CD1' ' A' ' 20' ' ' TYR . 0.0 OUTLIER 177.44 135.14 0.21 Allowed Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.712 155.586 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 21' ' ' ARG . 59.5 Cg_endo -86.11 139.14 6.08 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.539 2.826 . . . . 0.0 109.368 -161.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.758 ' O ' HG23 ' A' ' 30' ' ' THR . 0.3 OUTLIER -123.88 -165.09 1.3 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.999 161.57 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.454 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 15.9 t -134.58 118.09 16.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.874 165.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.54 -173.9 2.03 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.7 t -98.81 30.78 3.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.724 0.773 . . . . 0.0 110.356 165.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.832 ' HB3' HD12 ' A' ' 48' ' ' LEU . 32.2 p-10 -123.84 13.71 9.24 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.473 -166.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 66.74 31.97 7.17 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.532 178.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.37 141.96 19.83 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.81 173.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.758 HG23 ' O ' ' A' ' 23' ' ' LEU . 94.0 m -65.82 148.53 51.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.261 165.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -106.85 138.41 43.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.353 166.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.02 -53.58 41.65 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.678 ' ND2' HD23 ' A' ' 18' ' ' LEU . 5.0 p-10 -128.08 169.78 13.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.418 -0.391 . . . . 0.0 110.301 -173.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.38 -31.88 73.26 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.497 174.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.2 t -74.73 -21.84 59.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.573 -173.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -97.75 -22.75 16.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.66 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.502 ' O ' HG23 ' A' ' 41' ' ' VAL . 59.5 t80 -61.59 -68.09 0.35 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.762 164.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.527 ' HB3' ' HB3' ' A' ' 8' ' ' CYS . 64.4 m -61.0 -32.69 72.27 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.538 -167.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.429 ' HA ' HG22 ' A' ' 42' ' ' VAL . 2.6 m-80 -73.45 -25.0 60.3 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.209 -178.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -65.31 -43.0 92.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.183 165.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.842 HG22 ' CD2' ' A' ' 48' ' ' LEU . 60.8 t -61.82 -51.97 66.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.54 -175.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.718 HG23 ' OE1' ' A' ' 43' ' ' GLU . 18.8 m -74.3 -34.07 36.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.1 -168.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.718 ' OE1' HG23 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -65.48 -29.51 70.18 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.442 169.748 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.5 t -80.75 -17.26 51.55 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.332 -172.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 53.3 t30 71.33 50.72 0.28 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.568 167.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.88 -21.2 47.3 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 164.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 46.0 m -62.02 -85.71 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.238 -0.481 . . . . 0.0 110.002 177.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.842 ' CD2' HG22 ' A' ' 41' ' ' VAL . 1.4 tt -59.98 148.19 36.2 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.495 -157.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.417 HG23 ' N ' ' A' ' 50' ' ' LEU . 0.9 OUTLIER -146.81 -163.21 1.7 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.619 167.108 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.66 HD11 ' C ' ' A' ' 52' ' ' HIS . 6.6 tp -94.45 118.68 32.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.15 -169.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.8 t -61.62 -42.16 98.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.493 167.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.66 ' C ' HD11 ' A' ' 50' ' ' LEU . 1.8 p80 173.73 158.1 0.13 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.182 178.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.652 ' CE1' HD21 ' A' ' 50' ' ' LEU . 5.2 m-85 -84.51 170.97 12.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.217 168.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.59 32.08 10.67 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 168.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.447 ' HG2' ' HG2' ' A' ' 22' ' ' PRO . 4.9 mttp 61.14 167.7 0.09 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 114.541 -0.829 . . . . 0.0 110.455 -174.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.457 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 2.2 t . . . . . 0 C--O 1.24 0.594 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.034 -160.447 . . . . . . . . 1 1 . 1 stop_ save_